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ABSTRACT
X-linked retinitis pigmentosa is a severe form of human retinal degeneration and is most
commonly caused by mutations in the RPGR gene, which maps to chromosomal region
Xp21.1. The RPGR gene product is a novel protein containing an amino terminal domain
that is homologous to the guanine nucleotide exchange factor for a small GTP-binding
protein. No other domains of known function are recognisable.
The principal aim of this thesis was to identify proteins that interact with RPGR.
This was done in an attempt to obtain structural or functional information about this novel
protein that could account for its roles in health and disease. The yeast two-hybrid method
was used to screen a variety of expression libraries made from human pancreas and bovine
retina. A novel interacting protein, called RPGRIP, was identified using a bovine retina
library and the human homologue identified by database screening and primer extension
methods. The specificity of the interaction between RPGR and RPGRIP was confirmed by
co-immunoprecipitation. Further evidence for a functionally significant interaction was
obtained using six RPGR mutants, corresponding to known disease-causing mutations, all
of which abolished or severely reduced the interaction.
The expression of human and bovine RPGRIP was examined using northern analysis
and/or RT-PCR. This revealed strong expression of the human transcript in testis and retina
but more widespread expression in bovine tissues. At least three alternatively spliced forms
were identified. The human gene structure was identified and shown to consist of 15 exons
spanning 34 kb and to code for alternatively spliced proteins of 586 amino acids, 837 amino
acids, and 902 amino acids.
A structure-function analysis of RPGRIP by database searching identified two
strongly predicted coiled-coil domains and two calcium-dependent phospholipid-binding C2-
domains. The gene was mapped to chromosomal region 14ql 1 by radiation hybrid mapping
and screening a human monochromosomal hybrid panel. Mutation analysis of three
autosomal recessive retinitis pigmentosa families previously shown to be linked to the 14ql 1
region failed to identify disease-causing mutations. The function of RPGRIP remains to be
elucidated but it is a strong candidate gene for causing another form of human retinopathy.
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ADRP autosomal dominant Retinitis Pigmentosa
AMD age-related macular degeneration
ARF ADP-ribosylation factor
ARP ADP-ribosylation factor-related protein
ARRP autosomal recessive Retinitis Pigmentosa
BAC bacterial artificial chromosome





cAMP cyclic adenosine monophosphate
cGMP-PDE cyclic guanosine monophosphate phosphodiesterase
CHC clathrin heavy chain
CORD6 autosomal dominant cone rod dystrophy
cPLA2 cytoplasmic phospholipase A2
CRalBP cellular retinaldehyde-binding protein
Crbl crumbs homologue 1
CRD cone-rod dystrophy
CRX cone-rod homeobox-containing gene
CSF cerebrospinal fluid











EDTA ethylenediamine tetra-acetic acid
EFEMP1 epidermal growth factor-containing fibrillin-like extracellular matrix
protein-1
ERG electroretinogram
ESCS enhanced S-cone syndrome
EST expressed sequence tag
GA Gyrate atrophy
GAP GTPase activating protein
GCAP guanylyl cyclase activating proteins
GEF guanine nucleotide exchange factor
GEF guanine nucleotide exchange factor
GGTase geranylgeranyltransferase
GMP, GDP, GTP guanosine mono/di/tri-phosphate
GPCR G protein coupled receptor







IRBP interphotoreceptor retinoid-binding protein
kb kilobase pairs
kDa kiloDalton
LCA Leber's Congenital Amaurosis
LiAc lithium acetate
LRAT lecithin retinol acyltransferase
LW long wavelength







NBT Nitro blue tetrazolium
NMCP1 nuclear matrix constituent protein 1
NR2E3 nuclear receptor subfamily 2, group E, member 3
NRL neural retina leucine zipper
N-terminus amino terminus
OAT ornithine aminotransferase
OMIM On-line Mendelian Inheritance In Man
ORF open reading frame
PBD peroxisome biogenesis disorder
PCR polymerase chain reaction
PDE-a cyclic guanosine monophosphate phosphodiesterase alpha subunit
PDE-p cyclic guanosine monophosphate phosphodiesterase beta subunit
PDE-8 cyclic guanosine monophosphate phosphodiesterase delta subunit
PDE-y cyclic guanosine monophosphate phosphodiesterase gamma subunit
PEG polyethylene glycol
PKC protein kinase C
PLC phospholipase C
PLC81 inositol phospholipid-specific phospholipase C delta 1 subunit
pnr photoreceptor-specific nuclear receptor
PPRPE preserved para-arteriolar retinal pigment epithelium
PROML1 prominin (mouse)-like-l
R* metarhodopsin II
RACE rapid amplification of cDNA ends
RCC1 regulator of chromosome condensation 1
rd retinal degeneration
rds retinal degeneration slow
REP-1 rab escort protein-1
retGC retinal guanylate cyclase
RGR RPE-retinal G protein-coupled receptor
RED RCC1 -like domain
RNA ribonucleic acid
RNase ribonuclease
ROM1 rod outer segment membrane protein-1
vii
RP Retinitis Pigmentosa
RPE retinal pigment epithelial cell





SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis
SFD Sorsby's fundus dystrophy
STS sequence tagged sites
SW short wavelength
TE Tris-EDTA
TEMED N,N,N' ,N' -tetramethylethylene-diamine
TGN trans-Golgi network
TIMP-3 tissue inhibitor ofmetalloproteinase-3
Tm melting temperature
TTPA tocopherol transfer protein alpha
TULP tubby-like protein
Ta-GTP active transducin
UAS upstream activation sequence
UTR untranslated region
X-gal 5-bromo-4-chloro-3-Indoyl-P-D-galactoside
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Approximately 1 in 2000 people suffer from inherited retinal degenerations, about half of
whom suffer from retinitis pigmentosa (RP) (Boughman, Conneally, and Nance, 1980;
Rattner, Sun and Nathans 1999). In a study of blindness and partial sight in England and
Wales between 1990 and 1991, Evans (1995) found that, as a group, the hereditary retinal
dystrophies were among the most important causes of loss of vision in the 16 to 64 years
(working) age-group, accounting for 11.5% of cases (Figure 1.1). This compared with
glaucoma (12%), diabetes mellitus (11.9%) and degeneration of the macula and posterior
pole (mostly consisting of age-related macular degeneration; 11.3%). RP is one of the most
common causes of blindness in the working years of life and is inherited in autosomal
dominant (AD), autosomal recessive (AR), X-linked (XL), mitochondrial and digenic
modes, depending on the nature and location of the genetic lesion. XLRP tends to manifest
itself in a more aggressive manner than the other genetic types, but all forms of RP
commence with night blindness, followed by deterioration of peripheral vision, which can
progress to legal blindness. The following sections will summarise information on the
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Figure 1.1: Causes of blindness in England and Wales in people aged 16 to 64 (Evans
1995).
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1.1 - DEVELOPMENT AND STRUCTURE OF THE EYE
The development of the eye commences at the beginning of the fourth week of gestation.
Populations of cells in the anterior neural plate of the prosencephalon (forebrain), at the
cranial end of the embryo, form the so-called 'eye fields'. Optic pits, or sulci, appear in the
cranial neural folds as some of the cells in the eye fields invaginate (Figure 1.2, E8.5).
E8.5 E9.5 E10
Figure 1.2: Development of the eye (numbers indicate the age of the embryo in days).
As the edges of the cranial neural folds come together to create the forebrain vesicle, the
optic pits invaginate and form hollow pockets called optic vesicles. These project into the
adjacent mesenchyme from the sides of the forebrain and their cavities are continuous with
the lumen of the forebrain vesicle. As the optic vesicles grow they make contact with the
overlying ectoderm and induce it to develop into lens tissue. The induced regions become
thickened and form the lens placodes (Figure 1.2, E9.5), the central regions of which








invaginate to create the lens pits (Figure 1.2, E10). The edges of the lens pits move towards
each other and fuse, so establishing the lens vesicles, which are eventually pinched off from
the surface ectoderm. While this is happening, the proximal parts of the optic vesicles
constrict and become the hollow optic stalks, and the lateral parts move away from the
invaginating lens placodes to form the double-walled optic cups. The inner layer of the optic
cup proliferates under the influence of the developing lens and develops into the neural
retina (Figure 1.2, E10.5 and El 1.5). The striated, laminar pattern of the retina is created by
the lateral migration of postmitotic cells generated in the germinal layer. These cells
differentiate into Muller glial cells and into the three major classes of neuronal cells. These
are retinal ganglion cells, interneurons (bipolar, horizontal and amacrine cells) and the light-
sensitive photoreceptors (the rods and cones). The outer layer of the optic cup develops into
the retinal pigment epithelium. This is a non-neural layer of epithelial cells of
neuroectodermal origin.
As the eye develops, the junction between the optic cup and optic stalk narrows and
forms the optic disc. The ganglion cell axons in the superficial layer of the neural retina
project through the optic disc and grow proximally in the wall of optic stalk. The cavity of
the optic stalk becomes obliterated as a result and the ganglion cell axons form the optic
nerve.
Following the development of the lens vesicle into the mature lens, the overlying
surface ectoderm is induced to develop into the epithelium of the cornea and the conjunctiva.
This in turn allows the immigration of mesenchymal cells of neural crest origin, which form
the endothelium of the cornea. The region on the outer lip of the optic cup where the
prospective neural and pigmented retinal layers meet develops into the ciliary body and the
iris. The mesenchymal cells surrounding the optic cup differentiate into an outer fibrous
layer, the sclera, which is continuous with the substantia propria of the cornea, and an inner
vascular layer, the choroid. The vitreous body, which is composed of vitreous humor, a
transparent, gel-like, avascular material, is derived from the vascular mesenchyme in the
optic cup.
For recent reviews of eye development see Treisman (1999); Gilbert (1997);
Morrow, Fumkawa, and Cepko, (1998) and Jean, Ewan, and Gruss, (1998).
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1.2 - THE RETINA
The role of the retina is to transmit neural signals conveying visual information from the eye
to the brain. The RPE and neural retina together contain in excess of 100 different cell types
and are divided histologically into 10 distinct layers (Figure 1.3).
Figure 1.3: Schematic diagram showing the ten histological layers of the retina. The
elongated cell on the left of the figure represents a Muller cell. Only bipolar cells are
represented in the inner nuclear layer.
The outermost layer consists of retinal pigment epithelial (RPE) cells (layer 1) and is
separated from the choroid by Bruch's membrane. The role of the RPE cell layer is
essentially to maintain the physiology of the photoreceptors. It has several functions,
including photoreceptor disc renewal, transport ofwater and metabolites, immunoregulation,
maintenance of the blood-retinal barrier, free radical scavenging and retinal attachment.
RPE cells also contain granules of melanin pigment that serve to reduce the scattering of
light within the eye, so enhancing visual acuity. The choroid is the vascular coat of the eye
and its blood vessels supply the outer retina via the RPE. Layer 2 consists of the outer and
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inner segments of rod and cone photoreceptors. Layer 3 is the outer limiting membrane,
which is not a true membrane but rather the zonulae adherentes, in which the Muller cell
processes make contact with photoreceptor cells. The abundant Muller cells (Figure 1.3) are
analogous to the neuroglia of the central nervous system and extend from the interface
between the vitreous body and the junction of the inner and outer segments of rods and
cones. This layer also marks the internal border of the subretinal space (the external border
being the RPE cell layer). This space contains photoreceptor inner and outer segments and
the interphotoreceptor matrix (IPM). The IPM is extremely narrow and contains numerous
molecules important for retinal function. These include several proteoglycan species, which
coat the photoreceptor outer segment, and interphotoreceptor retinoid-binding protein
(IRBP), which accounts for at least 70% of the IPM protein content. IRBP is responsible for
the transport of retinoids between RPE cells and photoreceptors (see section 1.5). Layer 4 is
the outer nuclear layer, which contains the nuclei of rod and cone photoreceptors. Layer 5 is
the outer plexiform layer, which contains rod and cone fibres and the dendrites of bipolar
cells. Bipolar cells are true neurons interposed between photoreceptor cells and ganglion
cells. Their dendrites contact rod photoreceptors only, or cones only, never both. Bipolar
cells receive signals from varying numbers of rods (from 10, near the macula (see section
1.4), to 100 at the periphery), and while there is some convergence of cones on bipolar cells
on the fringes of the human retina, this does not occur at the fovea centralis (see section 1.4).
Here each cone fibre synapses with the dendrites of several bipolar cells, reflecting the
higher visual acuity at this point. Layer 6 is the inner nuclear layer, which consists of the
nuclei of bipolar, horizontal, amacrine, interplexiform and Muller cells. Horizontal cells are
association neurons, which are capable of modifying synaptic transmission in the human
retina, and are found in the outer part of the zone occupied by the cell bodies of bipolar cells.
Their dendrites make contact with the synaptic terminals of photoreceptors and with the
dendrites of bipolar cells. Amacrine cells are also association neurons and are located in the
inner part of the zone occupied by the cell bodies of bipolar cells. They receive signals from
other amacrine cells and from bipolar cells and send signals to ganglion cells, amacrine cells
and bipolar cells. Interplexiform cells are a third class of association neuron, which are
interspersed among the cell bodies of bipolar cells. Layer 7, the inner plexiform layer,
contains the synaptic termini of inner nuclear layer neurons and dendritic processes of
ganglion cells. Layer 8 is the ganglion cell layer and contains the cell bodies of ganglion
cells. The axons of ganglion cells constitute layer 9, the nerve fibre layer. These axons form
the optic nerve after leaving the lamina cribrosa. The ganglion cells embody the last retinal
link in the visual pathway. They transmit signals to the brain in the form of a continuous
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background rhythm of action potentials. The visual signal is superimposed on this
background, either increasing or decreasing the rate of nerve impulses. Layer 10 is the inner
limiting membrane, which is formed by the expanded inner processes of Muller cells and
separates the retina from the vitreous body.
1.3 - ROD AND CONE PHOTORECEPTOR CELLS
Photoreceptors are the primary neurons of the visual pathway. Photoreactive pigments within
these cells initiate the transduction of energy stored in photons into electrical signals. There













Figure 1.4: Schematic diagram of rod (grey, left) and cone (red, right) photoreceptors.
dim light, to movement and shapes, whereas cones mediate colour vision. The central
portion of the retina, the macula, is the area providing highest acuity of vision and is the
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principal part of the retina used for colour discrimination. The centre of the macula is called




Figure 1.5: Distribution of rod and cone photoreceptors in the human retina (Osterberg,
1935).
The human retina contains approximately 130 million rods, almost 20 times the number of
cones. The retina remains rod-free until approximately 0.28 mm from the centre of the fovea
centralis and rod density increases from here to the ora serrata, an irregular border
representing the functional anterior perimeter of the retina (Figure 1.5). Because of their
more peripheral distribution (compared to cones) rods are important for peripheral vision.
Rods are maximally sensitive in dim light, while cones mediate vision in ambient light,
centrally and peripherally. Rods are slender cells, consisting of three portions: the outer
segment, the inner segment and the nucleus and synaptic terminus (rod fibre). The outer and
inner segments have a combined length of 40 pm at the periphery and 60 pm near the fovea
centralis and are approximately 2 pm thick. The rod fibre is a slender thread that contains
the nucleus in a central expansion and terminates as an end bulb that makes synaptic contact
with bipolar and association neurons. The light sensitive part of the rod is the outer segment,
a modified cilium extending from the apical surface, which contains the phototransduction
proteins including the pigment rhodopsin. Most of the outer segment is occupied by 700-
1000 closely spaced, double layered membranous discs, approximately 2 pm in diameter and
14 nm thick. These derive from the cell membrane but, unlike in cones, they are independent
of the cell membrane and of each other. The discs are formed at the base of the outer
segment and shed at the tip in a circadian manner. Pseudopodia extend from the underlying
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RPE cells so that each RPE cell is in contact with approximately 45 photoreceptor outer
segments. Shed discs are phagocytosed by the RPE cells and quickly degraded. Shedding of
the discs occurs continuously and, in primates, the entire outer segment is renewed every 10
days or so. The inner segment contains the organelles of the photoreceptor. The ellipsoid is
a region adjacent to the outer segment and contains many elongated mitochondria. From one
of two centrioles at the junction of the inner and outer segments, a cilium 0.2-0.3 pm in
diameter, consisting of 9 pairs ofmicrotubules, extends into the outer segments. The central
pair of single microtubules, dynein spokes and radial arms characteristic of motile cilia are
absent here. The cilium is encircled by 9 to 12 microvilli extending from the plasma
membrane of the inner segment. These surround the base of the outer segment and
constitute the calyx. The remainder of the inner segment, the myoid region, contains
vesicles, neurofibrils and granular endoplasmic reticulum. The myoid is so called because in
lower vertebrates it is able to contract in response to changes in light intensity.
Cone photoreceptors are less abundant than rods (approximately 7 million in the
human retina) but are important for visual acuity and colour vision. There are an estimated
100,000 cones in the fovea centralis (with 35,000 of these in the central area, the foveola)
and their density decreases toward the periphery of the retina. They have a longer and
thinner shape at the fovea centralis than elsewhere: 75 pm long and 1 pm thick centrally
compared to 40 pm long and 6 pm thick at the periphery. Cones are also made up of an
outer segment, inner segment and cone fibre. Cone fibres are thicker than rod fibres and
contain the nucleus in an expanded portion next to the inner segment. They terminate with a
bulbous end that makes synaptic contact with bipolar and association neurons. In addition,
processes from cone synaptic termini extend to form interphotoreceptor junctions with other
cones and (via gap junctions) with rods. The light-sensitive outer segment is tapered and
contains a varying number of double layered membranous discs, from 1000 in foveal cones
to several hundred at the periphery. Cone discs are not produced in the same way as rod
discs and the rhythm of the circadian phagocytosis by RPE cells is different from rods (cones
are shed at night, following light offset whereas rods are shed after light onset). They are
stacked more closely than in rods, and unlike rod discs, which are surrounded by a plasma
membrane, they are in free communication with the interphotoreceptor space. There are
three types of pigment found in cone outer segment discs, commonly referred to as blue
(short wavelength, SW), green (medium wavelength, MW) and red (long wavelength, LW).
These are each maximally sensitive to a specific light wavelength: 430-440 nm for the blue
pigment, 535-540 nm for green and 560-565 nm for red. Cone inner segments are thicker
than the equivalent structures in rods and contain a larger ellipsoid and a more dense
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granular endoplasmic reticulum. The cone cilium is comparable to that of rods. For more
comprehensive descriptions of photoreceptors see Ahnelt (1998), Forrester et al. (1995) and
Molday (1998).
1.4 - PHOTOTRANSDUCTION
The conversion of light energy into electrical signals is achieved by a series of amplification
steps within the phototransduction cascade (Figure 1.6). Central to this is the visual pigment,
consisting of an integral membrane apoprotein bound to a chromophore, 11 retinal. The
cascade is initiated in rods when the absorption of a single photon by the 11-c/s retinal
chromophore of rhodopsin causes it to isomerise to the all form. This leads to a
conformational change in the rhodopsin protein to a form called metarhodopsin II (R*),
which, in turn, catalyses the exchange of GDP for GTP on the heterotrimeric G protein
transducin. The resultant dissociation of the catalytic a-subunit from the P- and y-subunits
Figure 1.6: Photoexcitation and recovery of components of the phototransduction cascade.
Red arrows indicate phototransduction events, blue arrows indicate photorecovery events.
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causes transducin to enter the active state (Ta-GTP). The initial signal is amplified at this
stage as a single meta II rhodopsin molecule activates several hundred transducin molecules.
Ta-GTP interacts with cyclic guanosine monophosphate phosphodiesterase (cGMP PDE) to
release the inhibitory y-subunits from the aPy2 holoenzyme. Active cGMP PDE in turn
catalyses the hydrolysis of cGMP to 5'GMP, and the signal is again amplified. The result of
this cascade is to reduce the level of cGMP in the cell, which in turn closes the cGMP-gated
cation channels in the photoreceptor plasma membrane. In the dark, the cGMP-gated
channels transport sodium and calcium ions into the outer segment (the "dark current") while
other channels continuously export sodium and calcium. This leads to a partial
depolarisation of the photoreceptor and, consequently, a steady neurotransmitter release.
Closure of the cGMP-gated channels leads to a reduction in intracellular calcium and sodium
and the photoreceptor cell membrane becomes hyperpolarised. Photoreceptor
hyperpolarisation slows the ongoing release of glutamate at the synaptic terminal and so
generates a neural signal (see reviews by Molday (1998), Pepe (1999), and Rispoli (1998)).
1.5 - PHOTORECOVERY AND THE VISUAL CYCLE
Calcium-binding proteins including recoverin and guanylyl cyclase activating proteins
(GCAP I, II) mediate the recovery phase by responding to falling intracellular calcium
[Ca2+]j following a bleach of light. Recoverin inhibits the activity of rhodopsin kinase when
it is in its calcium-bound state. After a bleach of light the decline in [Ca2+]j releases calcium
from recoverin and the inhibition of rhodopsin kinase is relieved. Rhodopsin is deactivated
when it is phosphorylated at its C terminus in an ATP-dependent manner by rhodopsin
kinase and becomes bound to the protein arrestin. Arrestin-binding prevents further
transducin activation and permits the release of 11 -trans retinal from rhodopsin. This rapid
shut down of the cascade mechanism prevents further cGMP PDE stimulation. GCAP,
which is inactive in the calcium-bound form, becomes active as [Ca2+]j drops and stimulates
a membrane-bound retinal guanylate cyclase to increase synthesis of cGMP. The cGMP-
gated channels can then bind cGMP and open once more, restoring the depolarised state. In
addition to these calcium-responsive elements, the activation of PDE is abolished following
the hydrolysis of GTP to GDP on Ta, catalysed by its intrinsic GTPase activity. The
transducin a-subunit reassociates with the Py-subunits to form the inactive heterotrimer (see
reviews by Jindeova (1998) and Scott and Zuker (1997).
One of the major functions of the RPE is to regenerate 11 -cis retinal from all-trans
retinal, which is released from the photoreceptor discs for this purpose. Al\-trans retinal
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appears to be transported out of the discs following light exposure as a complex with
phosphatidylethanolamine (Weng et al.,1999) by the ABCA4 (ABCR) protein and then
reduced to all -transretinol by all -transretinaldehydrogenase (Rattner, Smallwood and
Nathans, 2000). Retinoid-binding proteins associate with the hydrophobic retinoids in order
to solubilise them and to protect them from oxidation. Transport of all-trara-retinol from the
rod outer segments to the RPE cells is mediated by IRBP. Once it has entered the RPE, the
all-fram-retinol is esterified by lecithin retinol acyltransferase (LRAT) to form all-trans-
retinyl esters and then converted to 11 -cisretinol by an RPE-specific isomero-hydrolase,
following which it becomes bound to the cellular retinaldehyde-binding protein (CRalBP).
The RPE65 protein appears to be a component of the isomero-hydrolase step, although its
precise role is unknown (see section 1.6.3.i). 11 retinol is then oxidised to 11 retinal
by 11 -cisretinol dehydrogenase in association with CRalBP and is subsequently released
from the RPE cells and transported to the outer segments, at which stage it is again
associated with IRBP, where it regenerates rhodopsin.
1.6 - GENE DEFECTS IN RETINAL DEGENERATIVE DISEASES
Figure 1.7: Retinal disease genes that were mapped and cloned between 1980 and 2000
(from RetNet, the Retinal Information Network http://www.sph.uth.tmc.edu/RetNet/).
In April 2000, the number of genes containing one or more allelic variants associated with a
human disease recorded in the On-line Mendelian Inheritance In Man (OMIM) database
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reached 1,000 (Antonarakis and McKusick, 2000). This is an up-to-date catalogue of human
genes and genetic disorders (http://www.ncbi.nlm.nih.gov/omim). 98 different OMIM gene
entries contain allelic variants that have been identified in association with ocular
phenotypes. The number of retinal disease genes that have been mapped over the last twenty
years is in excess of 120 (Figure 1.7). A large number of these genes encode either structural
components of the photoreceptors and other parts of the retina, or the biochemical
components of vision such as the proteins involved in phototransduction, photorecovery and
the visual cycle. In the following sections, the genes that are known to be mutated in
monogenic retinal degenerative diseases are described. The functions of many of the gene
products are largely unknown, although hints tend to be provided by homology to
characterised proteins or the presence ofmotifs found in other proteins. Most of the genetic
disorders listed here are untreatable (with the exceptions of Refsum disease and
abetalipoproteinaemia). The genes are presented in six groups according to their proposed




Rhodopsin is the visual pigment found in rod photoreceptors. It functions in dim light and
absorbs light maximally at a wavelength of 495 nm (Nathans et al., 1984). The gene
encoding human rhodopsin was isolated and characterised by Nathans and Hogness (1984)
who showed that it maps to 3q21-q24 and that the amino acid sequence is 41% identical to
those of the three colour photopigments (Nathans et al., 1986a). Rhodopsin is a member of
the G protein coupled receptor (GPCR) superfamily and contains seven transmembrane a-
helices, oriented perpendicular to the plane of the disc membrane, that constitute up to 60%
of its secondary structure (Pepe, 1999). The crystal structure of rhodopsin was determined
recently by Palczewski et al. (2000). They showed that the seven-helix transmembrane
region of the protein has its basis in the highly organised structure of the extracellular region
and that the 11 -cis retinal chromophore maintains this transmembrane region in an inactive
conformation. Mutations in the rhodopsin gene cause dominant retinitis pigmentosa (RP),
recessive RP and dominant congenital stationary night blindness (CSNB). More than 100
different disease-causing rhodopsin mutations are known (Dryja and Li, 1995) and those
causing autosomal dominant RP account for 25% of cases (Dryja et al., 2000). The majority
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of rhodopsin mutations fall into one of two categories: class I or class II. Class I mutant
rhodopsin proteins are indistinguishable from wild-type rhodopsin in vitro in all
characteristics examined. However, in transgenic mice carrying the Q344ter class I
mutation, rhodopsin is inefficiently localised to the outer segment while the endogenous
wild-type rhodopsin is processed normally (Sung et al., 1994). Another class I mutation,
P347S, causes rhodopsin to accumulate in vesicles at the outer segment base (Li et al.,
1996). Class I mutations are found at the carboxyl (C) terminus, which is involved in protein
sorting and transport to the outer segment. The C-terminus of rhodopsin binds to the protein
Tctex-1, a widely expressed dynein light chain abundant in photoreceptor inner segments.
Several autosomal dominant RP-causing class I mutations abolish binding to Tctex-1 and it
is thought that this prevents the proper guidance of post-Golgi vesicles carrying rhodopsin to
the outer segment (Tai et al., 1999).
Class II mutant rhodopsins are defective in terms of thermal stability and/or protein
folding, so that they fail to fully regenerate with 11 -cis retinal and are retained in the
endoplasmic reticulum (Liu, Garriga and Khorana, 1996; Min et al., 1993; Sung et al.,
1993). These types of mutations usually affect the transmembrane and intradiscal domains
of rhodopsin. In transgenic mice bearing the T17M class II mutation, the administration of
vitamin A supplements led to a decrease in the rate of retinal degeneration (Li et al., 1998).
The same treatment had no significant effect on mice carrying the P347S class I mutation.
This work extended the findings of Berson et al. (1993) showing that vitamin A supplements
retard the progress of retinal degeneration in adults with retinitis pigmentosa. In binding to
the 11 -cis retinal chromophore, the thermal stability of wild-type rhodopsin is increased
(Hubbard 1958). It is thought that the increased availability of vitamin A stabilises the
T17M mutant rhodopsin. Evidence supporting the latter proposal came from the observation
that the stability of the T17M mutant opsin expressed in vitro was increased by including 11 -
cis retinal in the culture medium (Li et al., 1998).
1.6.1.H - cGMP Phosphodiesterase
Rod cGMP (type 6) PDE is a heterotetrameric protein consisting of a, P and two y subunits.
The a subunit of transducin, when bound to GTP, induces the gamma subunits to detach
from the inactive 011P1Y2 heterotetramer, leaving the enzymatically active a-P dimer.
Mutations in the gene encoding the 90 kDa PDE-P protein, located in 4pl6.3
(Altherr et al., 1992), are found in 3-4% of recessive RP cases (McLaughlin et al., 1995).
Mutations in the N-terminal half of PDE-P are responsible for dominant CSNB in a single
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family (Gal et al., 1994) whereas the majority of the autosomal recessive RP-associated
mutations are found in the C-terminal catalytic domain (McLaughlin et al., 1995). The
retinal degeneration (rd) mouse carries a mutated PDE-fi gene and, in homozygotes, the rod
photoreceptor cells start to degenerate at postnatal day 8 and disappear by 4 weeks of age
(Bowes et al., 1990). Subretinal injection of an adenovirus construct containing wild-type
murine PDE-p cDNA 4 days postnatally led to the production of detectable PDE-
(3 transcripts and enzyme, and a short-lived retardation of photoreceptor degeneration
(Bennett et al., 1996).
The 90 kDa alpha subunit is encoded by a 22 exon gene in 5q31.2-q34 (Pittler et al.,
1990). Because null mutations in the PDE-fi gene were known to cause retinitis pigmentosa
and since both a and p subunits of the protein are required for catalytic activity, Huang et al.
(1995) searched for and found mutations in the PDE-a. gene in RP patients. Such mutations
have been estimated to cause 3-4% of cases of recessive RP in North America (Dryja et al.,
1999).
No disease-causing mutations have been found in the PDE-y gene, which is located
in 17q21.1. However, disruption of the murine PDE-y gene resulted in a rapid retinal
degeneration similar to retinitis pigmentosa (Tsang et al., 1996).
The PDE5 subunit is a highly conserved protein (Hurwitz et al., 1985), the precise
role of which in photoreceptors is not understood. It is known to solubilise the membrane-
bound PDE holoenzyme (Florio, Prusti, and Beavo, 1996) and the addition of a recombinant
epitope-tagged form of the protein to a preparation of permeablised bovine rod outer
segments was recently shown to reduce the maximal rate of light-induced cGMP hydrolysis
(Cook et al., 2000). It maps to chromsomal region 2q35-q36 and so far no mutations in the
PDE8 gene have been found in patients with retinal degenerative disorders.
1.6.1.iii - cGMP-gated channel-a
The rod cGMP-gated channel is a heterotetramer composed of homologous alpha and beta
subunits. These each have a pore region, 6 putative transmembrane domains and
cytoplasmic N- and C-termini. The gene encoding the alpha subunit is located at 4pl2-cen
and mutations affecting it are responsible for an estimated 1-2% of autosomal recessive RP
(Dryja et al., 1995). Known mutations include nonsense mutations situated near the start of
the open reading frame, a deletion which removes almost the whole of the open reading
frame, a frame-shift mutation and missense mutations, suggesting that RP results from loss-
of-function. Frame-shift and missense mutations were investigated in vitro and found to
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prevent the proteins from being correctly targeted to the plasma membrane (Dryja et al.,
1995). Mutations in the cone cGMP gated channel alpha subunit gene (CNGA3) at
chromosomal region 2qll have been found in patients with autosomal recessive rod
monochromacy, a non-progressive disease marked by an absence of cone function (Kohl et
al., 1998).
The cone CNGB3 gene, encoding the cone cGMP-gated channel (33 subunit, is
localised in chromosomal region 8q21-q22 and is mutated in another form of recessive rod
monochromacy (achromatopsia). This disorder is found in 4 to 10% of the Pingelapese
people of the Eastern Caroline Islands and the symptoms include nystagmus, complete
colour blindness and photophobia (Sundin et al., 2000).
1.6.1.iv - Retinal Guanylate Cyclase and Guanylate Cyclase Activating Proteins
The retinal guanylate cyclases (retGC-1 and retGC-2) are the enzymes responsible for the
formation of cyclic-GMP. In the photoreceptor cell, the level of this second messenger is
regulated both by guanylate cyclase and by cGMP-PDE hydrolysis. Guanylate cyclases are
either of the particulate (membrane) type or the soluble type. Membrane guanylate cyclases,
ofwhich the retinal enzymes are examples, are located in outer segment disc membranes and
consist of a cytoplasmic protein kinase homology domain, a C-terminal catalytic domain and
a ligand-binding N-terminal portion. Mutations in the gene encoding retGC-1 (designated
GUCY2D), which maps to 17p 13.1, cause recessive Leber's congenital amaurosis (LCA)
(Perrault et al., 1996) and autosomal dominant cone-rod dystrophy (Kelsell et al., 1998).
LCA is a group of autosomal recessive retinopathies and is the most common cause of severe
inherited visual impairment in infants and children. The symptoms of LCA are seen within a
few months of birth and include severe visual impairment, nystagmus, and an absent or
poorly recordable electroretinogram (Perrault et al., 1999). Besides GUCY2D, mutations at
additional loci are responsible for LCA (see sections 1.6.3.i (RPE65), 1.6.4.i (CRX) and table
1.1 (AIPL1)). It is not known why a defect in retGC-1 is not compensated by the presence of
a functional retGC-2. Interestingly, two missense mutations in codons 837 and 838 of the
GUCY2D gene (encoding residues within the retGC-1 dimerisation domain) were found to
cause autosomal dominant cone rod dystrophy (CORD6). Heterozygous carriers of recessive
null GUCY2D mutations do not display a phenotype, suggesting that the CORD6 mutations
impart a gain-of-function and that the cone-rod dystrophy is not due to haploinsufficiency
(Kelsell et al., 1998). The biochemical characteristics of the R838C GUCY2D/CORD6
mutation were investigated in vitro by Tucker et al. (1999). They found that the mutation
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increases the affinity for GCAP-1 and modifies the Ca2+-sensitivity of the GCAP-1 response
such that mutant retGC-1 is activated by GCAP-1 at higher concentrations of Ca2+ than wild-
type. Wilkie et al. (2000) investigated the effects of additional GUCY2D/CORD6 mutations
at codon 838 in vitro and found a direct correlation between disease severity and residual
GCAP-1-stimulated activity at high Ca2+ concentrations.
The guanylate cyclase activating proteins, GCAP-1 and GCAP-2, stimulate the
synthesis of cyclic GMP by retGC in photoreceptor cells. The mammalian GCAP proteins,
which are greater than 90% similar, consist of 201-205 amino acids, and contain three
calcium binding sites (Subbaraya et al., 1994). They share homology with recoverin,
another photoreceptor calcium-binding protein. The two GCAP genes in humans, GUCA1A
and GUCA1B, are arranged in a tail-to-tail array in chromosomal region 6p21.1 (Surguchov
et al., 1997). Twenty-seven members of a four generation family with autosomal dominant
cone dystrophy were found to carry a Tyr99Cys (Y99C) mutation in the GUCA1A gene
(encoding GCAP-1) (Payne et al., 1998). The fact that GUCA1A mutations cause
degeneration of cones may be because of the higher relative expression of this gene in cones
than rods (Howes et al., 1998).
1.6.1.V - Arrestin
Arrestin (also known as S-antigen (SAG) and 48-kDa protein) is a 405 amino acid protein
involved in the recovery phase of phototransduction. Following photoactivation, arrestin
works together with rhodopsin kinase to shut down rhodopsin activity: rhodopsin kinase
phosphorylates rhodopsin, which is then bound by arrestin. The SAG gene shows homology
to bovine alpha transducin and is located in chromosomal region 2q37 (Calabrese et al.,
1994). Mutations in this gene cause Oguchi disease and RP. Oguchi disease is a rare,
autosomal recessive form of CSNB. In this disorder, light adaptation occurs very slowly in
rods, while the process in cones occurs as normal. One characteristic of Oguchi disease is
the Mizuo-Nakamura phenomenon, whereby the fundus undergoes a light-induced metallic
golden-yellow colour transformation. The SAG gene was first implicated in Oguchi disease
when Fuchs et al. (1995) identified a homozygous frame-shift mutation at codon 309 in
Japanese patients. It is interesting to note that this same mutation is also found in a small
percentage of Japanese ARRP patients (Nakazawa et al., 1998). In one example, described
by Nakazawa et al., one of two siblings carrying the frame-shift mutation at codon 309 had
Oguchi disease and the other had classic RP without the Mizuo-Nakamura phenomenon.
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1.6.1.vi - Rhodopsin Kinase
Rhodopsin kinase is a highly specific protein kinase that initiates the recovery phase of
phototransduction by catalysing the phosphorylation of rhodopsin. The gene encoding
rhodopsin kinase maps to 13q34 (Khani et al., 1996). Following the identification of
mutations in the SAG gene in Oguchi disease patients, it was postulated that, since rhodopsin
kinase has a similar function, mutations in this gene may also lead to Oguchi disease. This
was found to be the case by Yamamoto et al. (1997).
1.6.1.vii - Transducin
Transducin is a heterotrimeric G-protein that transduces the light-response signal from
photoexcited rhodopsin to cGMP PDE. A G38D mutation in the alpha subunit of transducin
has been found in autosomal dominant CSNB patients within a single French family (Dryja
et al., 1996). Codon 38 is a highly conserved residue within a region that is important for
GTP hydrolysis (Lambright et al., 1994). In addition to retinal cells, rod transducin is also
found in cells concerned with taste, and is related to Gustducin, which is a G-protein
specifically found in taste receptor cells (Ruiz-Avila et al., 1995).
1.6.1.viii - Cone Pigments
The cone visual pigments also consist of a cone opsin apoprotein covalently linked to the 11-
cis retinal chromophore. Three different cone pigments exist, each with a different
absorption spectrum. A single cone will contain only one pigment type, so there are three
types of cone cell: red (LW), green (MW) and blue (SW). The differences in absorption
spectra are thought to be attributable to amino acid sequence differences in the pigment
apoproteins. At the protein level, the cone pigments are 41% identical to rhodopsin, with the
red and green pigments sharing 96% identity with each other and 43% with the blue pigment
(Nathans et al., 1986a). The blue pigment gene is autosomal and the red and green pigment
genes are located on the X chromosome. In approximately 8-10% of Caucasian males,
rearrangements affecting the red and green pigment gene array produce stationary defects in
colour vision (Nathans et al., 1986b). Less frequently, loss of both red and green pigment
function can produce blue cone monochromacy or a variant of this (Nathans et al., 1989;
Nathans et al., 1993; Reichel et al., 1989), disorders that are characterised by a loss of visual
acuity and severe colour blindness. In a number of these patients there is a progressive
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deterioration of the central retina, which is potentially analogous to the peripheral
degeneration seen in RP patients with mutations in the rhodopsin gene (Nathans et al., 1993).
Autosomal dominant blue colour-blindness (tritanopia) is a stationary disorder caused by
mutations in the transmembrane domains of the blue pigment gene in chromosomal region
7q31.3-q32 (Weitz, Went and Nathans, 1992).
1.6.2 - OUTER SEGMENT STRUCTURE
1.6.2.i - RDS and Rod Outer Segment Membrane Protein-1 (ROM1)
RDS (formerly peripherin/RDS) and ROM1 are homologous proteins which interact to form
oligomeric complexes. They are thought to be involved in the maintenance of the membrane
curvature at the rod outer segment disc rim (Goldberg and Molday, 1996; Molday, 1998).
The gene encoding RDS maps to 6p21.2-cen (Travis et al., 1991) and its orthologue is
mutated in the retinal degeneration slow (rds) mouse, which displays a degenerative
retinopathy (Travis et al., 1989). Over 40 RDS mutations have been found in patients
suffering from a variety of dominantly inherited retinal diseases, including dominant RP,
dominant macular degeneration, RPE pattern dystrophies and dominant adult vitelliform
macular degeneration (Keen and Inglehearn., 1996). A simple genotype-phenotype
correlation for different RDS alleles does not exist. For example, different members of the
same family with a single RDS mutation suffer from RP, pattern dystrophy and fundus
flavimaculatus (Weleber et al., 1993). Also, in several families, individuals carrying a
L185P mutation in the RDS gene and a null ROM1 allele suffer from RP while individuals
carrying either mutation alone are not affected (Dryja et al., 1997). This was the first
example of a digenic disorder in man.
The ROM1 gene maps to llql3 and became an obvious candidate gene for
monogenic retinopathies (Bascom et al,. 1992). Although ROM] sequence variants have
been found among RP patients, a causative relationship with the disease has not been
established (Bascom et al., 1993). However, in Roml(-/-) mice, the rod outer segments were
found to be highly disorganised, with unusually large discs, and the rod photoreceptors
slowly apoptosed. This suggested that the rodent Roml gene is essential for the viability of
rod photoreceptors and for the regulation of outer segment disc morphogenesis.
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1.6.2.ii - Myosin VIIA
Usher syndrome affects approximately 1 in 25,000 people and is a genetically heterogeneous
autosomal recessive group of disorders characterised by congenital hearing loss and RP
(Boughman et al., 1983). Three subtypes are separated according to severity of hearing loss
and vestibular dysfunction: type I patients lack vestibular function and suffer a profound
deafness, type II patients have normal vestibular function with a less severe hearing loss and
type III patients have an inconsistent vestibular function and progressive hearing deficiency.
In developed countries, Usher syndrome is the most common cause of combined deafness
and blindness (Boughman, Vernon, Shaver, 1983). Several loci are involved in type I Usher
syndrome but type IB, which maps to llql3.5, accounts for approximately 75% of type 1
patients (Weil et al., 1995). The myosin VIIA (MY07A) gene is mutated in Usher syndrome
type IB (Weil et al., 1995). Myosin VTIA is an unconventional myosin with a predicted
molecular weight of approximately 250 kDa. It was localised in primates to the apical
microvilli of the RPE and to the ciliary base of rod and cone outer segments (Liu et al.,
1997). A role has been proposed for myosin VIIA in outer segment biogenesis (El-Amraoui
etal., 1996; Liu etal., 1997).
1.6.2.iii - REP1
Choroideremia is an X-linked disorder, similar to RP, which affects some 1 in 50,000 males
(Cremers and Rogers 1995). At an early age, patients experience night blindness which
progresses in middle life to visual field loss and choroido-retinal atrophy (Heckenlively and
Bird, 1988). The gene encoding subunit A of the rab geranylgeranyltransferase (GGTase)
enzyme was found to be mutated in choroideremia by positional cloning (Cremers et al.,
1990). This protein, which is also referred to as rab escort protein-1 (REP-1), forms part of
the rab GGTase, which attaches the geranylgeranyl isoprenoid group to certain members of
the Rab family of small GTPases (Seabra et al., 1992). It has been suggested that subunit A
of the holoenzyme binds to the Rab protein and presents it to subunit B - which transfers the
geranylgeranyl moiety - and then delivers the Rab to its target membrane (Alexandrov et al.,
1994). The Rab proteins are involved in intracellular trafficking and prenylation is required
for correct membrane targeting. Another subunit, called REP-2, has been identified which is
homologous to REP-1 and has a partially overlapping substrate specificity (Seabra et al.,
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1995). REP-1 is ubiquitously expressed, so it is unclear why mutations do not cause
systemic disease. It has been suggested that REP-2 and other homologous proteins may
compensate for REP-1 in other tissues. The majority of REP-1 mutations are null (van den
Hurk et al., 1997), suggesting that mutations which do not completely abolish activity either
fail to impair normal function or result in an extraocular phenotype.
1.6.2.iv - Prominin (mouse)-like-l (PROML1)
The PROML1 protein is encoded by a gene which localises to 4p and is mutated in recessive
retinal degeneration (Maw et al., 2000). Prominin is a well conserved protein which, in the
mouse, localises to plasma membrane protrusions in a range of epithelial cells.
Immunocytochemistry data suggest that PROML1 accumulates in the membranous
evaginations at the base of the rod outer segments (Maw et al., 2000). This led to the
proposal that loss of prominin impairs the formation of the evaginations and/or development
of the evaginations into discs, leading to retinal degeneration.
1.6.2.V - MERTK
In the Royal College of Surgeons (RCS) rat, a model for recessive retinal degeneration,
phagocytosis by the RPE of shed outer segment discs is defective, leading to photoreceptor
cell death. D'Cruz et al. (2000) found a deletion in the gene encoding the Mertk receptor
tyrosine kinase in the RCS rat. The human orthologue, MERTK (c-mer proto-oncogene
receptor tyrosine kinase), localises to chromosomal region 2ql4.1. A panel of 328 patients
with a variety of retinal dystrophies were screened for mutations in this gene and three
mutations were found in three RP patients (Gal et al., 2000). This was the first report to
show a link between defective RPE phagocytosis and human retinal disease.
1.6.3 - THE VISUAL CYCLE
1.6.3.i - RPE65
RPE65 is a microsomal protein found in large amounts in the RPE (Hamel et al., 1993). The
RPE65 gene was mapped to lp31 (Hamel et al., 1994) and mutations in it were subsequently
found in patients with LCA (Marlhens et al., 1997), ARRP (Morimura et al., 1998) and
autosomal recessive childhood-onset severe retinal dystrophy (Gu, et al., 1997). RPE65
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knockout mice display an absence of rhodopsin and rod-mediated light responses, although
they retain cone-mediated responses (Redmond et ah, 1998). In the RPE of these mice there
is an accumulation of all-trans retinyl esters but a lack of 11 -cis retinyl esters, indicating that
the a\\-trans to 11 -cis isomerisation step is blocked. Van Hooser et al (2000) orally
administered 9-cis retinal to RPE (-/-) mice in an attempt to relieve the effects of this block.
Commercially available 9-cis retinal was used because it is thermodynamically more stable
than 11 -cis retinal, for which it is a functional substitute. They observed the formation of
rod photopigment and a dramatic improvement in rod physiology within 48 hours,
suggesting that such a strategy may have the potential to lessen the effects of RPE65
mutations in LCA patients.
1.6.3.ii - ABCA4 (AJBCR)
Stargardt disease is the most common autosomal recessive macular dystrophy, affecting an
estimated 1 in 10,000 people (Blacharski, 1988). Mutations in the ABCA4 (ABCR) gene,
located in Ip21-p22, are found in Stargardt disease patients (Allikmets et al., 1997a). This
gene encodes a member of the ATP-binding cassette (ABC) superfamily, which includes
transmembrane proteins implicated in the active transport of a variety of substrates across
membranes. Mutations in genes encoding members of this family result in diseases
associated with defective transport (e.g. CFTR in cystic fibrosis). The ABCA4 protein
localises to the rim of rod and cone outer segment disc membranes (Sun and Nathans, 1997;
Molday, Rabin and Molday, 2000). In ABCA4 knockout mice there is a reduction in all-
trans retinol and an increase in all-trans retinal in the retina after exposure to light
suggesting an accumulation of all-trans retinal within the disc lumen or membranes (Weng
et ah, 1999). This has led to the suggestion that the role of ABCA4 is to transport all-trans
retinal from the disc interior through the disc membrane (see section 1.5).
Stargardt disease patients are usually compound heterozygotes for ABCA4
mutations, only one of which is predicted to be a complete null. Patients with two
(predicted) null mutations in ABCA4 suffer from autosomal recessive RP (Martinez-Mir et
ah, 1998). This implies that Stargardt disease may be a partial loss-of-function phenotype
while the null phenotype is RP. Since approximately 2% of the human population carry an
ABCA4 allele conferring partial or complete loss-of-function, it would be interesting to know
whether such carriers develop a retinal disease, particularly age-related macular degeneration
(AMD). Two groups recently addressed this question but reported conflicting findings
(Allikmets et ah, 1997b; Stone et ah, 1998). Another study however, found either of two
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heterozygous ABCA4 mutations in 4% ofAMD patients but only 0.9% of control individuals
(Allikmets et al., 1999). This would imply that carriers of these specific ABCA4 mutations
are at a higher risk for AMD, although data from ongoing studies will be important in
resolving this issue.
1.6.3.iii - CRalBP
The gene encoding the cellular retinaldehyde binding protein (CRalBP) localises to 15q26
and is mutated in recessive RP (Maw et al., 1997), recessive Bothnia dystrophy (Burstedt et
al., 1999) and recessive retinitis punctata albescens (Morimura, Berson and Dryja, 1999).
The 36 kDa protein is found in Muller cells and RPE and preferentially binds 1 l-cis retinol.
In vitro, CRalBP promotes 11 -cis retinol oxidation to form 11 -cis retinal (the final step in the
recycling of the rhodopsin chromophore) and inhibits the esterification of 11 -cis retinol to
form the stored retinol ester (Saari, et al., 1994). Recombinant CRalBP bearing a disease-
causing mutation fails to bind 11 -cis retinal. This suggests that, in vivo, defective CRalBP is
unable to complete the regeneration of rhodopsin (Maw et al., 1997). CralBP deficient mice
demonstrated a more than 10-fold delay in rhodopsin regeneration, 11 -cis retinal production
and dark adaptation after illumination (Saari et al., 2001). During the delay, the
accumulation of all-trans retinyl esters was observed, indicating a block at the all-trans to
11-ezs retinal isomerization step.
1.6.3.iv - 11-cis Retinol Dehydrogenase
The enzyme 11 -cis retinol dehydrogenase catalyses the conversion of 11 -cis retinol to 11 -cis
retinal (Simon et al., 1995) and is found in abundance in the RPE. The RDH5 gene encoding
this enzyme maps to 12ql3-ql4 and is mutated in patients suffering from fundus
albipunctatus. This is a rare form of autosomal recessive stationary night blindness in which
rod and cone photopigment regeneration is delayed (Yamamoto et al., 1999). The fact that
both rods and cones are affected in this disease suggests that the same retinol dehydrogenase
processes 11 -cis retinal for both photoreceptor types.
1.6.3.V - RPE-Retinal G Protein-Coupled Receptor
Mutations in the gene for RPE-retinal G protein-coupled receptor (RGR), located at 10q23,
have been found in patients with recessive RP and dominant choroidal sclerosis (Morimura
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et al., 1999). This gene is abundantly expressed in the RPE and Muller cells and is related to
opsin and other GPCR family members (Jiang, Pandey and Fong, 1993). The protein, which
has seven transmembrane segments, preferentially binds all-trans retinal, in contrast to
rhodopsin, which binds 11-cis retinal. In mammalian RGR, it is proposed that light
stimulates the conversion of all-trans retinal to 11-cis retinal; this contrasts with rhodopsin,
where the reverse isomerisation reaction occurs.
1.6.4 - TRANSCRIPTION FACTORS
1.6.4.i - Cone Rod Homeobox (CRX)
The CRX gene (for 'cone-rod homeobox-containing gene') maps to 19ql3.3 and is mutated
in LCA (Freund et al., 1998; Sohocki et al., 1998), dominant RP (Jacobson et al., 1998) and
dominant cone-rod dystrophy (CRD) (Freund et al., 1997). CRD is characterised by an early
deterioration in colour vision and visual acuity, followed by night blindness and loss of
peripheral vision. The CRX protein is a transcription factor involved in the maintenance and
differentiation of photoreceptor cells, stimulating the expression of retinal genes such as
opsins, arrestin and interphotoreceptor retinoid-binding protein (Furukawa, Morrow and
Cepko, 1997). The variety of phenotypes associated with CRX mutations suggests a
diversity of downstream effects. These are predominantly dominant disorders (although
CRX mutations are assocaited with recessive LCA) and it is not yet clear whether the
phenotypes are due to haploinsufficiency or a dominant negative effect.
1.6.4.ii - Neural Retina Leucine Zipper
The Neural retina leucine zipper (NRL) gene maps to 14ql 1.1-ql 1.2 and encodes a retina-
specific transcription factor (Yang-Feng and Swaroop, 1992). NRL promotes the
transcription of rhodopsin and other retinal genes, and functions both alone and
synergistically with CRX (Chen et al., 1997). A T-to-A transversion at nucleotide 1942 of
the NRL gene, which results in a ser-to-thr substitution at codon 50 of the NRL protein, was
identified in all affected members of a large autosomal dominant RP family (Bessant et al.,
1999). In combination with CRX, the mutant NRL protein was found to promote
transcription from the rhodopsin promoter more efficiently than the wild-type protein in vitro
(Bessant et al., 1999). It is possible that this effect could result in a retinopathy since
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transgenic mice over-expressing rhodopsin are associated with photoreceptor degeneration
(Olsson et al., 1992).
1.6.5 - METABOLISM
1.6.5.i - Ornithine Aminotransferase
Gyrate atrophy (GA) is an autosomal recessive disorder resembling RP, which is
characterised by night blindness, loss of peripheral vision, a decline in visual acuity and
sharply demarcated circular areas of chorioretinal atrophy (Weleber and Kennaway, 1988).
The disorder is caused by mutations in the gene encoding ornithine aminotransferase (OAT),
which maps to 10q26 (Valle and Simell, 1995). OAT is found in mitochondria in all tissues
and links glutamate, proline and ornithine metabolism. In the mouse model of gyrate
atrophy, disruption of the murine OAT gene causes early morphological damage in the RPE
and a slow progressive photoreceptor degeneration (Wang et al., 1996). The authors
subsequently showed that long-term dietary changes in the mouse model alleviate the effects
of the gene disruption (Wang et al., 2000). They used an arginine-restricted diet to lower
ornithine levels and observed a complete absence of retinal degeneration in oat (-/-) mice.
This demonstrates that the accumulation of ornithine is required for the retinal degeneration
in GA and that effective treatment does not require the restoration of retinal OAT activity.
1.6.5.ii - PEX1, PEX2 and PAH
Mutations in the PEX1 gene cause the infantile form of Refsum disease, a recessive
peroxisome biogenesis disorder (PBD), which is characterised by RP, peripheral neuropathy,
hearing defects, cerebellar ataxia, dysmorphic features and mental retardation associated
with raised plasma phytanic acid (Reuber et al., 1997). PEX1 is localised to 7q21-q22 and is
the human orthologue of a yeast gene that is required for peroxisomal matrix import. PBDs
are caused by disrupted peroxisome function and aberrant peroxisome assembly.
Shimozawa et al. (1999) identified PEX2 mutations in a patient with infantile Refsum
disease. Mutations in this gene were shown in vitro to deleteriously affect the peroxisomal
protein import machinery and other peroxisome activities.
Adult Refsum disease is also associated with elevated plasma phytanic acid levels
and results from mutations in the gene encoding phytanoyl-CoA hydoxylase (PAH), which
maps to 10pl5.3-pl2.2 (Jansen et al., 1997; Mihalik et al., 1997). Other charactersitics of
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the disease are RP, peripheral polyneuropathy, cerebellar ataxia, high CSF protein (but no
dysmorphic features or mental retardation) with onset varying between early childhood and
the fifth decade. Phytanoyl-CoA hydroxylase is also a peroxisomal enzyme and catalyses
the initial step in phytanic acid a-oxidation. Elimination of phytanic acid from the diet
results in neurological improvement and prevents progression of the retinal dystrophy.
1.6.6 - MISCELLANEOUS
There is a growing group of retinal degenerative disorders associated with mutations in
genes with miscellaneous functions; these are described below. In others, there is little
functional information available regarding the gene product; these have been entered into
Table 1.1 at the end of this section.
1.6.6.i - Usherin (USH2A)
Usher syndrome type Ha is caused by mutations in the usherin (USH2A) gene located in
1 q41 (Eudy et al., 1998). Mutations in this gene account for 95% of type 2 Usher syndrome
patients. The gene encodes a predicted 171.5 kDa product containing laminin epidermal
growth factor and fibronectin type III motifs. These motifs tend to be found in cell adhesion
molecules and in components of the extracellular matrix and basal lamina. Bruch's
membrane, the interphotoreceptor cell matrix and the cochlea are all rich in extracellular
matrix proteins.
1.6.6.ii - Epidermal Growth Factor (EGF)-Containing Fibrillin-Like Extracellular
Matrix Protein-1 (EFEMP1)
Dominant Doyne honeycomb retinal degeneration (DHRD, clinically similar to Malattia
Leventinese) is an autosomal dominant disorder that closely resembles AMD.
Approximately 50% of registered blindness in the Western world is due to AMD (Stone et
al., 1999). DHRD is characterised by the presence of yellow/white deposits (drusen)
beneath the RPE and a progressive central vision loss. An R345W mutation was found in
the EFEMP1 gene in 5 DHRD families (Stone et al., 1999). This widely expressed gene




Sorsby's fundus dystrophy (SFD) is a rare autosomal dominant retinal degeneration. The
characteristics of this disorder include a slow recovery following exposure to bright light and
a loss of central vision. The gene encoding tissue inhibitor ofmetalloproteinase-3 (TIMP-3),
which maps to 22ql2.1-ql3.2, is mutated in this disease (Weber et al., 1994). TEVIPs act as
inhibitors of the matrix metalloproteinases that function in the degradation of the
extracellular matrix (Apte, Mattei and Olsen, 1994). In SFD there is an abnormal
accumulation of a lipid-rich material between the choroid and the photoreceptor cell layers.
It was initially suggested that this arises because of an imbalance in the breakdown and
synthesis of the extracellular matrix (caused by the TIMP-3 mutation) and prevents the
normal supply of nutrients (including Vitamin A) from the choroidal blood supply to the
photoreceptors. In testing this hypothesis Jacobson et al. (1995) found that high doses of
oral vitamin A (reversibly) corrected the reduced rod sensitivity in patients at early stages of
the disease. A recent report however, showed that mutant TIMP-3 genes are expressed and
that the proteins retain the ability to inhibit metalloproteinases (Langton et al., 2000). Unlike
wild-type TIMP-3 however, all of the mutant proteins studied formed dimers. This, together
with the recent observation that TIMP-3 expression is increased in SFD (Chong et al., 2000)
suggests that accumulated, dimerised mutant TIMP-3 plays an active role in the disease
process.
1.6.6.iv - TULP1
In tubby mice, a recessive mutation in the tub gene leads to retinal degeneration, cochlear
deafness, obesity and insulin resistance (Kleyn et al., 1996). In humans, TUB and Tubby-like
proteins 1 (TULP1) and 2 (TULP2) are homologous genes with a highly conserved C-
terminal domain (North et al., 1997). TULP1 is expressed solely in the retina and maps to
6p21.3 so was considered a candidate gene for a recessive RP locus (RP14) which had been
mapped to this chromosomal location by linkage analysis. TULP1 mutations were
subsequently found in recessive RP patients (Baneijee et al., 1998; Hagstrom et al., 1998;
Gu et al., 1998). Tulpl(-/-) mice display a retinal degeneration of early-onset, with a
progressive, rapid photoreceptor loss (Ikeda et al., 2000) and substantial extracellular vesicle
accumulation around the distal inner segments (Hagstrom et al., 1999). The results of
experiments carried out to characterise the mouse tubby protein indicate that the tubby-like
proteins belong to a unique category ofbipartite transcription factors (Boggon et al., 1999).
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1.6.6.V - Tocopherol Transfer Protein Alpha (TTPA)
TTPA is an intracellular vitamin E (a-tocopherol) carrier protein that is structurally similar
to CRalBP. The primary antioxidant in photoreceptor outer segments is vitamin E, which is
presumed to prevent photo-oxidation damage. When experimental animals are deprived of
vitamin E they develop RP (Robinson, Kuwabara and Bieri, 1982). Two patients with
autosomal recessive RP and low serum vitamin E were studied and found to carry
HislOlGln mutations in the TTPA gene (Yokota et al., 1996). Mutations in this gene, which
maps to 8ql3.1 -ql3.3, are also associated with ataxia with isolated vitamin E deficiency
(Ouahchi et al., 1995).
1.6.6.vi - Crumbs Homologue 1 (Crbl)
The human homologue of the Drosophila melanogaster crumbs (CRB) protein is encoded by
a gene, crumbs homologue 1 (CRB1), which is mutated in a severe form of autosomal
recessive RP called RP with para-arteriolar preservation of the RPE (see section 1.7.2) (Den
Hollander et al., 1999). The CRB1 cDNA was cloned using a subtractive hybridisation
technique in an attempt to identify genes expressed in the retina and RPE. The CRB1 gene
mapped to chromosomal region Iq31-q32.1, a region implicated in RP. On the basis of the
homology to the Drosophila protein a role has been proposed for CRB 1 in the maintenance
of cell polarity in the retina and in cell-cell interaction.
CRB1 mutations have also been found to result in Leber congenital amaurosis
(Lotery et al., 2001). Mutations were detected in 21 patients out of a cohort of 233,
amounting to 9% of the total.
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Table 1.1: Miscellaneous genes mutated in retinal degenerative diseases.
Disorder Gene/Protein Location References
Abetalipoproteinemia Microsomal triglyceride transfer
protein
4q24 Sharp et al., 1993;
Shoulders et al., 1993.
Bardet-Biedl syndrome MKKS (McKusick-Kaufman
syndrome), protein is putative
chaperonin molecule




Bestrophin 1 lql3 Marquardt et al., 1998.
Dominant RP (RP1) Oxygen-regulated photoreceptor-
specific protein/ RP1 protein
8ql l-ql3 Pierce et al., 1999;
Sullivan et al., 1999.
Enhanced S-cone
syndrome (ESCS)
Nuclear receptor subfamily 2, group
E, member 3 (NR2E3) gene/
photoreceptor-specific nuclear
receptor (pnr) protein
15q23 Haider et al., 2000.
LCA type 4 Arylhydrocarbon-Interacting
Receptor Protein-Like 1 (AIPL1)
17p 13.1 Sohocki et al., 2000.
Recessive Batten disease CLN3 gene/ Batten disease protein 16p 12.1 International Batten
Disease Consortium,
1995.






David et al., 1997.
Usher syndrome type 1C USHJC/Harmonin, a PDZ-domain
containing protein
1 lp 14.3 Verpy et al., 2000;
Bitner-Glindzicz et al.,
2000.
Usher syndrome type ID Novel cadherin gene CDH23 10q21-
q22






Xp22.2 Sauer et al., 1997.
X-linked RP (RP2) RP2 gene, RP2 protein Xpll.3 Schwahn et al., 1998.
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1.7 - RETINITIS PIGMENTOSA
1.7.1 - Symptoms ofRetinitis Pigmentosa
There is wide clinical variation among RP patients but common to all sufferers are night
blindness (nyctalopia) and a progressive visual field loss. This leads to a severe visual
disability and can include loss of central vision. The combination of peripheral and central
visual loss is particularly debilitating. Many patients aged between 60 and 70 have little or
no functional vision and a little under half of all RP patients develop cataracts, usually in the
later stages of the disease. RP is generally caused by a primary or secondary degeneration of
rod photoreceptor cells, but cone photoreceptors also degenerate as the disease progresses.
Rod cell death starts at the mid-periphery of the retina, the most rod-dense region, but then
spreads to involve the far periphery and macula. Rod cells respond to dim light and are
found in all areas of the retina except the fovea centralis, and the nyctalopia and visual field
contraction characteristic of RP reflect this. Towards the end of the disease process,
photoreceptor cell degeneration is accompanied by reactive changes in the RPE and Muller
cells, atrophy of the retinal vasculature and death of inner retinal neurons (Milam and Li,
1995).
Ophthalmic examination of RP patients reveals varying degrees of depigmentation
or atrophy of the RPE, pigment deposition in the retina and narrowing of the retinal
arterioles (secondary to retinal atrophy) (Deutmann, 1977). Pigment-laden cells from the
RPE migrate to the mid-periphery of the retina. The pigment deposits appear as black
clumps and strands. They are found most prominently in the periphery, and frequently,
pigment deposition within blood vessel walls produces a perivascular pattern, the so-called
'bone spicule pigment'. Small, irregular clumps and spots of pigment may be seen almost as
often and, occasionally, patients have a mixture of clumped pigment and bone spicule
pigment. In many cases, regions of the retinal fundus (the posterior aspect of the eyeball,
visible through the pupil with an ophthalmoscope) not involved in pigment deposition are
described as appearing "moth eaten", or as having a "salt and pepper" pigment distribution.
Figures 1.8 and 1.9 show fundus photographs from unaffected and RP-affected individuals
respectively. Nearly all RP patients go through a stage in which there is little or no visible
pigment deposition. This stage persists in some patients and their condition was formerly
described as retinitis pigmentosa sine pigmento, to demarcate an atypical type of the RP.
However, the majority of these patients have since been found to produce an
electroretinogram (ERG) pattern indicative of the cone-rod degeneration form of RP (see
section 1.7.2).
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A scotopic ERG measures the electrical activity in a dark-adapted retina in response
to flashes of light and can be used to assess rod photoreceptor function (the photopic ERG is
performed in the light-adapted state and measures the cone-mediated response). Scotopic
ERGs typically show reduced or absent amplitudes in RP patients and may also be delayed
temporally (Heckenlively, 1988a). Occasionally, it is possible to identify ERG changes in
presymptomatic cases ofRP (Humphries, Kenna and Farrar, 1992).
Figure 1.8: Photograph of a fundus from an unaffected individual.
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Figure 1.9: Photograph of a fundus from an RP patient.
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As RP progresses and rod photoreceptor cells continue to degenerate, the optic nerve head
develops a waxy, pale appearance, the retinal blood supply declines following blood vessel
attenuation and the retina becomes thinner in appearance. Staining retinal sections from RP
patients with anti-rhodopsin antibodies revealed that rod and cone photoreceptor cell death is
preceded by a shortening of the outer segments (Milam and Li, 1995). In most patients, the
macula, and central vision, is spared until relatively late in the course of the disease. When
central vision does eventually deteriorate it is frequently due to macular involvement,
macular cysts or posterior subcapsular cataracts, which are characterised by yellow
crystalline changes in the lens (Heckenlively, 1988b). In addition, it is thought that dying or
defective rod photoreceptors induces cell death in adjacent cones (Reme et al., 1998).
1.7.2 - Subtypes ofRetinitis Pigmentosa
RP can be divided into two large subgroups: primary RP, where the disease process affects
only the eyes, and secondary RP, where the retinal degeneration accompanies a single or
multiple organ system disease (Heckenlively, 1988c). Usher syndrome and Bardet-Biedl
syndrome are the most common causes of secondary RP (Wright et al., 1995). Primary RP
is, in turn, subdivided into rod-cone degenerations, cone-rod degenerations and those with
congenital onset (Heckenlively 1988c). Rod-cone and cone-rod degenerations are
discriminated on the basis of the ERG. In typical RP, rods are involved to a greater degree
than cones and the rod-mediated (scotopic) ERG is more affected than the cone-mediated
(photopic) ERG: this is rod-cone degeneration. Some patients have a progressive visual field
loss with absent or late-onset night blindness and a more severely affected cone-mediated
ERG: this is cone-rod degeneration. The cone-rod and rod-cone degenerations can be
inherited in autosomal dominant, autosomal recessive or X-linked recessive fashion. It is
generally accepted that X-linked and autosomal recessive RP are usually more severe than
autosomal dominant RP (Bird and Jay, 1994). Cone-rod and rod-cone degenerations can
present as simplex or multiplex cases. If there is no family history of RP and the patient is
the only affected member of a pedigree the term simplex is used. The term sporadic is
appropriate only when an environmental or new mutational event is suspected to be the
cause of the disease. This may be the case following exposure to chloroquine (used in the
treatment of arthritis or malaria), or thioridazine (used to treat psychoses), or as a result of
rubella or cytomegalovirus infection (Heckenlively, 1988a). When two or more siblings but
no other members of the family are affected, the term multiplex is used. Although multiplex
sibships do not all follow the same mode of inheritance, most are considered likely to be
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autosomal recessive (Heckenlively, 1988b).
Two broad clinical subdivisions of autosomal dominant RP exist: type I, a so-called
"diffuse" form, and type II, a "regional" form (Massof and Finkelstein, 1981; Lyness et al,
1985). Type I is characterised by a childhood-onset night-blindness, widespread
degeneration of rods and delayed cone involvement. In type II there is an adult-onset night-
blindness and regionalised loss of rod and cone function. An additional variant of autosomal
dominant RP is sector RP, where the retinopathy is restricted to the inferior nasal quadrant
(and less commonly the inferior temporal quadrant). Sector RP can be inherited by all
modes but the autosomal dominant condition is the most common (Heckenlively, 1988d).
ARRP has been subdivided into two broad groups by Kaplan et al. (1990) on the
basis of age of onset: precocious onset with severe progression (mean age of onset of 7.5
years), and later onset with mild progression (mean age of onset 17 years). Grondahl
(1987a) and Bonneau et al. (1992) also described a "senile" form of ARRP, where vision is
unimpaired until the fifth or sixth decade. Subtypes of ARRP include retinitis punctata
albescens (in some cases due to mutations affecting rhodopsin (Souied et al., 1996) or
CRalBP (Morimura, Berson and Dryja, 1999)) and preserved para-arteriolar retinal pigment
epithelium (PPRPE; due to CRB1 mutations, see section 1.6.6.vi), both of which are rod-
cone degenerations. Retinitis punctata albescens is distinct from other forms of RP and is
characterised by a fundus marked with numerous punctate spots of a whitish-yellow colour
(Ellis and Heckenlively, 1988). PPRPE is a severe, childhood onset RP variant in which
there is some preservation of the RPE around blood vessels (Ellis and Heckenlively, 1988).
Choroideremia is another example of a rod-cone dystrophy. This is an X-linked,
progressive degeneration, in which the choroid and retina ultimately become atrophic
(Forrester et al., 1995). Among the different types of congenital RP are Leber congenital
amaurosis (typical form) and congenital RP with macular coloboma.
1.7.3 - Prevalence of Retinitis Pigmentosa
Retinitis Pigmentosa is a major cause of blindness and a number of studies have attempted to
determine its frequency in the general population. These estimates range from 1 in 1333 in
Birmingham, UK (Bundey and Crews, 1984a) to 1 in 7000 in Switzerland (Ammann et al.,
1965) but a figure close to 1 in 4000 is generally accepted. Table 1.2 presents the results of
several of these studies.
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Table 1.2: Prevalence of Retinitis Pigmentosa
COUNTRY PREVALENCE REFERENCE
China 1 in 4016 Hu (1987).
Israel 1 in 4500 Merin and Auerbach (1976).
North America 1 in 3700 Boughman et al. (1980).
Norway 1 in 4440 Grondahl (1987b).
Sardinia 1 in 3355 Fossarello et al. (1993).
Switzerland 1 in 7000 Ammann et al. (1965).
UK 1 in 1333-1666 Bundey and Crews (1984a).
USA 1 in 4756 Bunker et al. (1984).
RP is present in all ethnic groups, and tends to affect similar percentages of the population.
Efforts have been made to determine the percentage of RP patients in each genetic subgroup
and the results of several studies are summarised in Table 1.3. The relative proportions vary
from study to study. This may be attributable to differences in the methods used by the
researchers, different sample sizes or differences in the populations being studied, such as
levels of consanguinity or sex and age distribution. For example, consanguineous marriages
are more common in the Sardinian population than in others and this may lead to greater
numbers of patients with autosomal recessive RP.
Some of these studies suffer from the authors' reliance on questionnaires to collect
information about diagnoses and family histories. Boughman et al. (1980) used this method
exclusively to determine the frequency of each inheritance pattern for RP in America. They
counted the number of autosomal dominant and X-linked RP patients and then assigned
those remaining to the autosomal recessive and sporadic categories. They did not attempt to
actively identify and count ARRP cases, to confirm the diagnoses clinically or to separate
these as a group from isolated cases. Several of the ARRP cases may have been ADRP: if
penetrance was lower than the authors presume, as suggested by Bundey and Crews (1984b),
then it is possible that some apparently unaffected relatives of isolated RP patients carried
RP alleles. These cases may have been detected had family members been examined so that
asymptomatic or presymptomatic signs of the disease could have been observed. Similarly,
some of the sporadic cases may have been XLRP. By examining female relatives of isolated
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male patients, carrier females could have been detected and these families correctly
classified. Macrae (1982) studied 698 Canadian RP patients (in 274 families), 130 (in 110
families) by examination and the rest by questionnaire. When the mode of inheritance could
not be established relatives were not examined. A high proportion of simplex RP was
reported, some of which could possibly have been assigned to other classifications had
relatives been examined. Bunker et al. (1984) made great efforts to identify all the RP
patients within the state of Maine, USA. Information was collected through patient
interviews and, when the mode of inheritance was unclear, examinations were made. In the
case of isolated males, the mother or daughter was examined for evidence of XLRP carrier
status.
Table 1.3: Proportions of RP according to mode of inheritance. Numbers indicate































837 (633) Haim 1992.




15.8 42.5 - 5.0++ 120(113) Bundey andCrews 1984b.
USA 19 (19) 19 (26) 8(16) 52 (38) 2(1)** 173 (124) Fishman 1978
USA 84* 10 6 - - - 670 (648) Boughman etal., 1980.
USA 20(19) 43 (19) 8(8) 23 (46) 6(8) - 168 (85)
Bunker et al.,
1984.
USA 16(16) 28 (22) 12(9) 41 (50) - 3 (3)** 370 (300) Boughman andFishman 1983.
*This category described as "autosomal recessive and sporadic" by the authors; ** uncertain
classification;f adopted; t+ includes blind-registered XLRP carrier female (0.7%) and unclassifiable
(3.6%), 18 patients (13% of families) with autosomal recessive syndromes have been removed from
this category.
One of the most thorough studies was reported by Bundey and Crews (1984b). They
investigated 138 cases of RP within the city of Birmingham, UK, examining a large number
of patients and their relatives (18 autosomal recessive RP syndrome cases were removed
from this set for comparison with the other data in table 1.3). Of 30 individuals with ADRP,
eight had asymptomatic parents and the correct mode of inheritance was only determined
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after examining these family members. Without this practice these eight (21% of the ADRP
cases) would have been added to the simplex group. Seven out of 19 (37%) XLRP patients
were classified in the same way. As a result of examining family members, 25 cases were
removed from the initial group of 76 isolated patients and reassigned to the ADRP, ARRP
and XLRP categories. The remaining 51 cases comprised 26 females and 25 males, so an
excess of unrecognised XLRP is unlikely to have been concealed within this figure. Bundey
and Crews also reported one of the lowest incidences of ARRP (11.7% of the total) of the
studies discussed here. Moreover, half of these ARRP patients had consanguineous parents,
indicating that, in Birmingham (UK) at least, this is a rare disease and individual disease
gene frequencies are low. The results of this study are presented separately in Figure 1.10.
Unlike Bundey and Crews (1984b), Jay (1982) estimated the proportion of simplex cases
that will have been inherited in an autosomal recessive manner and added these to the ARRP
category (Table 1.3). Jay consequently reported a much larger proportion of ARRP than
Bundey and Crews (1984b) despite both studying RP in UK cities.
Autosomal dominant (21.7%)
Figure 1.10: Genetic categories of RP patients resident in Birmingham in 1978 (Bundey and
Crews 1984b).
Ascertainment bias may also alter the proportion of each genetic subtype. Bundey and
Crews (1984b) showed that the relative proportions of each of the genetic subtypes of RP
vary according to the mode of ascertainment. This implies that the results of some studies
will suffer if they rely on a single mode of ascertainment, whereas the authors of other
studies, such as Bundey and Crews (1984), Haim (1992) and Bunker el al. (1984) have
attempted to minimise such errors.
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Some of the differences between the various studies will be real and not due to sampling
error, ascertainment bias or incorrect assignment. Genuine differences between studies
reflect population differences (see the studies of Swiss RP by Ammann et al. (1965) and
Sardinian RP by Fossarello et al. (1993)). What none of these studies can accurately
measure is the proportion of isolated patients with non-genetic RP. Jay (1982) attempted to
estimate this by segregation analysis and concluded that as many as 19.4% of simplex cases
may be non-genetic. Between different population groups, environmental differences may
lead to a greater or lesser contribution of phenocopies and novel mutations to the isolated
classification.
1.7.4 - X-Iinked RP-affected males (hemizygotes)
RP has been found to affect more men than women, first by Nettleship in 1908 when he
established that 61.21% of RP patients were male (Nettleship, 1908), and again, in 1966,
when Sorsby concluded that 59.5% of people who were blind due to RP or allied disorders
were male (Sorsby, 1966). This sex-bias may arise either because of ascertainment bias (at
the time of early studies, men who experienced visual difficulties in the workplace may have
been more likely to have been ascertained than women who worked in the home (Bunker et
al., 1984)) or due to the presence of X-linked inheritance: males with one defective X-linked
recessive gene (hemizygotes) develop the disease, while females with one defective gene
(carriers) generally show few or no symptoms. The average age of onset in XLRP-affected
males has been estimated to be 7.2 (±1.7) years (Hussels-Maumenee et al., 1975), the first
common symptom being night blindness. Diagnosis may be made as early as age 4 in
families associated with the disease, or as late as the middle teenage years if there are no
currently affected family members. In excess of half of all XLRP males exhibit symptoms
by ten years of age (Bundey and Crews 1984b). Visual loss tends to be severe in XLRP
patients. During the second decade, the majority of patients develop increased visual
difficulties, and by the mid-teens there is a noticeable visual field loss and a reduction in
visual acuity (Bird and Heckenlively, 1998). Visual acuity continues to deteriorate in the
third decade, something that usually happens later in other forms of RP, and subcapsular
cataracts may develop. By the end of the fourth decade, most males are in the advanced
stages of the disease and only 16% retain any useful vision (Bundey and Crews 1984b).
Some patients develop nystagmus (involuntary, rapid movements of the eyeball) and, as a
consequence of this, a phenomenon called oscillopsia, which is a disturbing visual sensation
that stationary objects are swaying back and forth.
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1.7.5 - Carrier females (heterozygotes)
The term obligate carrier is used to describe a woman who unambiguously carries a
mutation on one X chromosome because she is the daughter or mother of an affected male.
Female carriers may show no evidence of the disease, or conversely, they may appear to be
as severely affected as male XLRP patients (Fishman, Weinberg, and McMahon, 1986).
This variation may be explained by Lyonisation, the random inactivation of one of the two
X-chromosomes early in embryogenesis, which is a feature of X-linked inheritance (Lyon,
1972). Any visual loss in carrier females tends to commence much later in life than in
hemizygous patients, but once it has started, progression may be as rapid as in affected males
(Bird and Heckenlively, 1988). Carrier females may display abnormal dark adaptation,
reduced ERG amplitudes, visual field defects and abnormal cone flicker tests. However,
most tend to suffer only a mild, late-onset retinal degeneration with few clinical symptoms.
1.8 - GENETIC MAPPING OF XLRP LOCI
Six loci on the X chromosome have been associated with XLRP: RP2 (Schwahn et al.,
1998), RP3 (Meindl et al., 1996), RP6 (Breuer, Musarella and Swaroop, (2000), RP15
(McGuire et al., 1995), RP23 (Hardcastle et al., 1999) and RP24 (Gieser et al., 1998) (Figure
1.11). The vast majority of kindreds are of the RP2 or RP3 types (as indicated by
heterogeneity and homogeneity analyses of large numbers ofXLRP families from around the
world (Ott et al., 1990; Teague et al., 1994; Musarella et al., 1990)) and the remaining loci
have each been implicated following the examination of single XLRP families (with RP15
eventually being withdrawn (Mears et al., 2000), see below). RP2 accounts for an estimated
20-25% of XLRP cases, and RP3 for an estimated 70-75%. (Ott et al., 1990; Teague et al.,
1994).
RP2 was the first XLRP locus to be genetically mapped (Bhattacharya et al., 1984)
and subsequent haplotype analysis placed the RP2 gene in a 5 cM interval between the
markers DXS8083 (at Xpll.3) and DXS6616 (at Xp 11.23) (Thiselton et al., 1996). By
targeting this interval using the YAC representation hybridisation technique, the gene was
positionally cloned by Schwahn et al. (1998). The RP2 gene is ubiquitously expressed and
consists of 5 exons encoding a 350 amino acid polypeptide. The role of the protein is yet to
be determined, but it shows homology to cofactor C, which plays a role in the P -tubulin
folding pathway. In a subsequent study, Hardcastle et al. (1999) found that 6 out of 33
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patients (18.2%) carried RP2 mutations (one missense and three nonsense mutations, one 5

















Figure 1.11: Locations of retinal degenerative disease genes on the X-chromosome (Breuer
et al., 2001). XLRS1/RS1: X-linked retinoschisis/retinoschisin protein; OPA2: X-linked optic
atrophy; DMD: Duchenne muscular dystrophy; CSNB1: X-linked CSNB/nyctalopin protein;
Norrie/NDP: Norrie disease/Norrie disease protein; COD1: X-linked cone dystrophy; PRD:
primary retinal dysplasia; CSNB2/CACNAIF: 1 X-linked CSNB/L-type voltage-gated calcium
channel alpha-1 subunit; CHM/REP2: choroideremia/geranylgeranyl transferase Rab escort
protein 1; COD2: X-linked progressive cone dystrophy 2; GCP: protanopia and rare macular
dystrophy in blue cone monochromacy/red cone opsin; RCP: deuteranopia and rare macular
dystrophy in blue cone monochromacy/green cone opsin.
Statistical evidence for the RP6 locus was initially presented by Ott et al. in 1990 (Ott et al.,
1990). Later, Breuer, Musarella and Swaroop (2000) carried out genetic analysis in a single
XLRP family by analysing microsatellite markers spanning the X-chromosome. Markers
from RP2, RP3, RP15, RP23 and RP24 excluded these loci as responsible for the disease in
this family. The workers concluded that the RP6 gene lies in a 2 cM interval between
markers DXS1036 and DXS1017. It was subsequently reported, however, that the mother in
this family displays an RP phenotype (Breuer et al., 2001). This raises the possibility that
the RP in this family is inherited in an autosomal dominant fashion rather than X-linked.
McGuire et al. (1995) described a new RP locus, RP15, in a family with dominant
cone-rod degeneration. Microsatellite markers were used to test for linkage to the disease
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locus and in this way they excluded other X-linked disease loci causing retinal degeneration.
Linkage was detected for one marker however, DXS989 (LOD score 3.3), and subsequent
haplotype analysis, carried out using 9 additional microsatellite markers, indicated that the
disease locus was in chromosomal region Xp22.13-p22.11. However, when a female in this
pedigree was identified as affected following a clinical re-evaluation, the disease was
remapped to a 19.5-cM interval in Xpl 1.4-p21.1 that overlapped with RP3. A mutation was
found in this family in RPGR exon ORF15 (see section 1.10 below) (Mears et al., 2000).
Hardcastle et al. (2000) performed haplotype analysis (in a single XLRP family)
with 34 polymorphic markers spanning the entire X chromosome. They presented linkage
data describing a new locus for RP distinct from RP2 and RP3. RP23 (an atypical form of
XLRP, characterised by very early onset loss of vision (at approximately 2 years of age))
was localised to the distal short arm of the X chromosome (Xp22) between markers
DXS1223 and DXS7161. The authors determined that the RSI gene (Sauer et al., 1997),
which is found in this large interval, is not mutated in this family.
Gieser et al. (1998) mapped the RP24 locus by haplotype and linkage analysis in a
single large XLRP pedigree with seven affected members. RP24 patients suffer early-onset
rod dysfunction, then at later stages they have little or no rod or cone function and display
the clinical hallmarks of RP. Mapping was achieved by genotyping 52 microsatellite
markers spanning the entire X chromosome. The RP24 locus was narrowed down to a 23
cM interval between markers DXS8094 and DXS8043. A LOD score of 4.21 was obtained
with the marker DXS8106 at Xq26-27.
1.9 - Positional cloning of the RP3 gene
Positional cloning is a strategy used to identify genes responsible for inherited disease in the
absence of prior information about the location of the gene or function of the gene product.
Genetic analysis of affected families is first carried out using polymorphic markers to
establish the chromosomal location of the disease locus. Gross chromosomal
rearrangements can aid this process by identifying a genomic region in which efforts can be
concentrated. The RP2 locus was the second disease gene to be assigned an accurate
chromosomal localisation using recombinant DNA methods (after Huntington disease in
1983; Gusella et al., 1983) when it was linked to a polymorphic marker at Xpl 1.3 in 1984
(Bhattacharya et al., 1984). A second XLRP locus, at Xp21, was implicated following the
study of a single large XLRP kindred and the analysis of a deletion in an individual (BB)
suffering from Duchenne muscular dystrophy, chronic granulomatous disease, McLeod
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syndrome and RP (Nussbaum et al., 1985; Francke, et al., 1985). RP3 was mapped to a
narrow region (approximately 520 kilobases (kb) in size) flanked by the markers OTC and
DXS1110 following the scrutiny of deletions in XLRP patients and recombinations
identified by haplotype analysis (Musarella et al., 1991; Roux et al., 1993). The proximal
breakpoint of the BB deletion is 40 kb centromeric to DXS1110, therefore initial attempts to
find the RP3 gene focused on identifying transcribed sequences within this region. It
transpired that the RP3 gene was not within the BB deletion. A patient was identified, NF,
suffering from Duchenne muscular dystrophy and chronic granulomatous disease but not RP,
with a deletion extending through the proximal portion of the BB deletion for several
kilobases in a centromeric direction (Brown et al., 1996). A deletion in another patient, SB
(De Saint-Basile et al., 1988), who had chronic granulomatous disease, McLeod syndrome
and RP, extended 400 kb centromeric to the BB proximal deletion breakpoint (Brown et al.,
1996). A 75 kb deletion in another patient, MO, who suffered from classic RP, overlapped
with the proximal part of the SB deletion and led to the identification of a novel retina-
expressed gene (called ETXHSRPX), although no causative mutations could be found (Dry et
al., 1995; Meindl et al., 1995). RPGR was identified as the RP3 gene after the sequencing of
85 kb of genomic DNA from two cosmid clones spanning the MO deletion. Sequence
analysis using gene recognition programs identified two expressed sequence tags (EST) and
seven putative exons. Polymerase chain reaction (PCR)-amplification of the region between
one of the ESTs (Accession number D20187) and the most 5' predicted exon, and exhaustive
5' and 3' primer extension and rapid amplification of cDNA ends (RACE) revealed a
transcript of 2784 bp with an open reading frame of 2445 bp, encoding an 815 amino acid
translation product (Meindl et al, 1996). Loss-of-function mutations (two small intragenic
deletions, two nonsense and three missense mutations in highly conserved residues) were
found in the RPGR gene in seven families with XLRP but not in control chromosomes.
1.10-RPGR
RPGR appears to be ubiquitously expressed: hybridising an RPGR probe to a northern blot
revealed the presence of a 2.9 kb band in all tissues examined except, paradoxically, retina.
However, RPGR was detected in retina and RPE cDNA libraries, and foetal RPE cells by
RT-PCR. The RPGR gene was reported to consist of 19 exons, covering 60 kb of genomic
sequence (Meindl et al., 1996; Roepman et al., 1996).
The outstanding feature of the predicted RPGR protein is the homology of its N-
terminal half to the Regulator of Chromosome Condensation 1 (RCC1) protein. The RCC1-
41
like domain of RPGR extends from amino acid number 39 (corresponding to the middle of
exon 2) to amino acid 365 (corresponding to the middle of exon 10). RCC1 consists of
seven tandem repeat units, 51-68 residues long, and is a guanine nucleotide exchange factor
(GEF) for the small nuclear GTPase Ran, which is concerned with nucleocytoplasmic
transport and cell cycle control (Ohtsubo et al.,1987; Sazer and Dasso, 2000). An RCC1-
like domain occurs in several other proteins, including p532 (Rosa 1996), which
appears to act as a GEF for Rab and ArfGTPases, suggesting that its presence indicates GEF
activity.
The crystal structure of RCC1 was solved and found to have a pseudo-sevenfold
symmetry and the appearance of a seven-bladed propeller (Renault et al., 1998; Figure 1.12).
Figure 1.12: Ribbon diagram of the seven-bladed propeller structure of RCC1 viewed along
(a) or perpendicular (b) to the shaft through the centre (from Renault et al., 1998).
The propeller blades are each formed by a four-stranded antiparallel P-sheet, the four strands
being referred to as A, B, C and D. This propeller structure is similar to that of the P-subunit
of the heterotrimeric G proteins and some enzymes (Lambright, et al., 1996). G-protein P-
subunits contain WD40 repeats; these ~40-residue configurations terminate in conserved
Trp-Asp (WD) motifs and are distinct from RCC1 repeats (Neer, et al., 1994). The seven
RCC1 sequence repeats do not coincide directly with the seven structural repeats, but are
one-half of a repeat out of step with each other. The first half of each sequence repeat
encodes strands C and D of the corresponding structural repeat (propeller blade), and the
second half of the sequence repeat encodes the A and B strands of the next structural repeat.
For example, the first half of the third sequence repeat encodes strands C and D of blade 3,
and the second half of the third sequence repeat encodes strands A and B of blade 4, and so
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on. Strands C and D of the first repeat are encoded by the first half of the first sequence
repeat, and strands A and B are encoded by the second half of the seventh sequence repeat
(Figure 1.13). This means that the two ends of the polypeptide chain come together in the
first propeller blade. It is suggested that one of the P-sheets acts as a molecular clasp,
holding together and stabilising the circular structure of the propeller. The authors speculate
that one side of the propeller constitutes the Ran-interaction site and the other side the DNA-
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Figure 1.13: Alignment of RCC1 homologues from (from top) human, hamster, Drosophila,
Schizosaccharomyces pombe and Saccharomyces cerevisiae with human RPGR (from
Renault et al., 1998). The coloured arrows indicate the residues that form the seven
propeller blades shown in Figure 1.12. Residues conserved in the RCC1 homologues are
boxed, residues conserved in RCC1 and RPGR are highlighted orange.
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Thirty-six mutations in the RPGR gene were initially detected in 10-20% of XLRP patients
(Meindl et al., 1996; Roepman et al., 1996; Miano et al., 1999; Buraczynska et al., 1997),
well short of the 70-100% predicted by linkage studies (Ott et al., 1990; Musarella et al.,
1990; Chen et al., 1989; Teague et al., 1994; Bergen et al., 1995). None of these mutations
were found in exons 16-19 - the majority affected conserved residues in the RCC1-
homologous domain of RPGR, suggesting that this is a functionally important region.
However, Vervoort et al. (2000) recently detected novel RPGR exons, one ofwhich contains
a mutation hotspot. They sequenced and analysed 172 kb of genomic DNA in the region of
the RPGR gene and four new exons were identified: 15bl, 15b2, ORF14 and ORF15. The
expression of these new sequences was verified with RT-PCR experiments, which also
showed skipping of exons 14 and 15. Exons 15b 1 and 15b2 and exon 15a, which was first
identified by Kirschner et al. (1999), are small exons within intron 15, each of which
contains a premature stop codon. Exons ORF14, which is 948 bp long, and ORF15, 2834 bp
long (with a 1706 bp coding region), are derived from a 2.5 kb open reading frame situated
downstream from the start of exon 14. Exon ORE14 includes the whole of exons 14 and 15
plus intron 14. Exon ORF15, which overlaps with ORF14, contains exon 15 and 2.8 kb of
intron 15 sequence. A total of 17 different ORF15 mutations (representing at least 24
separate mutation events) were identified in 28 out of 47 unrelated XLRP patients. They all
lead to premature termination of translation and were found within a 1061 bp stretch. None
of these mutations were detected in 150 control chromosomes.
Neither the ORF14 nor ORF15 predicted amino acid sequences contain any known
protein motifs. The ORF15 translation, however, contains a repetitive, purine-rich region
that has been named the "plaid" domain. This domain, which is conserved in mouse, cow
and Fugu rubripes, has unusually low sequence complexity and high glutamic acid and
glycine content. It is made up of imperfect direct EEEGEGEGE repeats and has only a 2.5%
pyrimidine content (Figure 1.14). The repetitive nature of the sequence, or its atypical
nucleotide constitution, may account for the high mutability. For example, it is possible that
this type of DNA sequence may adopt a triplex structure, a configuration that is associated
with reduced replication fidelity (Wang, Seeidman, And Glazer, 1996). There are also
numerous potential DNA polymerase arrest sites in exon ORF15 (Cooper and Krawczak,
1993) and since many of the ORF15 mutations involve direct repeats, pauses at these arrest
sites during replication may lead to slipped-strand mispairing events (Weaver and
DePamphilis, 1982).
RPGR mutations have now been found in 72% ofXLRP patients, 20% in exons 1-14
and 80% in exons ORF15, accounting for at least 11% of all RP patients (Meindl et al.,
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1996; Vervoort et al, 2000). The presence ofmutations in exons 1-14 and ORF15, but not
in exons 16-19, in RP3 patients, suggests that a transcript containing exons 1-14 and ORF15
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Figure 1.14: Predicted amino acid sequence of human RPGR exon ORF15, showing the
repetitive plaid domain (from Vervoort et al., 2000). Glutamic and/or aspartic acid (green)
and glycine (red) residues are highlighted.
1.11 - Interaction of RPGR with the cGMP PDE6 subunit
Using the yeast two hybrid system, Linari et al. (1999) screened a mouse embryo cDNA
library to identify RPGR-interacting proteins. The RPGR bait construct encoded amino
acids 1-392, encompassing the whole of the RCCl-like domain. Eight out of 40 initial
putative interacting clones encoded the cGMP phosphodiesterase 8 subunit (PDE8). The
identities of the remaining 32 putative interacting clones were not reported. Human
PDE 8 was observed to interact with the human RPGR bait and with full length human
RPGR (amino acids 1-815/exons 1-19, this work was carried out prior to the identification of
additional RPGR exons by Vervoort et al (2000)) but not with the C-terminal half ofRPGR
(amino acids 579-815/end of exon 14-exon 19). The interaction was confirmed by in vitro
protein binding (pull-down) assays and affinity measurements (KD = 90 nM). Furthermore,
the presence of any of six disease-associated missense mutations in the RCCl-like domain of
RPGR decreased or abolished binding to PDE8, while a non-disease-associated missense
mutation located outside the RCCl-like domain did not.
PDE8 was isolated as the fourth subunit of bovine rod PDE and is highly conserved
across evolution (Hurwitz et al, 1985; Figure 1.15). PDE is bound through the
isoprenylated carboxy termini of the catalytic a and p subunits to rod disc membranes (Qin,
Pittler, and Baehr, 1992; Anant et al, 1992). The isoprenylated membrane-bound PDE is
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recognised and solubilised by PDE5 under physiological conditions (Florio, Prusti, and
Beavo, 1996). Since the activity of the PDE holoenzyme is not affected by this PDE8-
mediated solubilisation, it is possible that in translocating PDE from the membrane to the
cytoplasm PDE8 is serving some form of regulatory role. Cook (2000) recently
reported that the addition of bovine PDE5 to a preparation of permeablised bovine rod outer
segments reduced the maximal rate of light-induced cGMP hydrolysis. PDE8 has also been
shown to bind a number of small GTPases, including Rabl3 (Marzesco 1998), Rho6,
Arl3 and Aril84 (Linari et al, 1999). It has been suggested that RPGR may act as a GEF for
a small GTPase, on the basis of its homology to RCC1 and the association with PDES
provides an indirect link with several small GTPases, although Linari et al. (1999) were
unable to detect GEF activity in RPGR in the presence ofArl3 orAril 84. They similarly did



















Figure 1.15: CLUSTAL W alignment (Thompson et al., 1994) of the human, dog, bovine and
mouse cGMP PDE delta subunit proteins (* = single, fully conserved residue,: = conservation
of strong groups, . = conservation of weak groups, blank space = no consensus).
Two other groups have isolated a novel RPGR-interacting protein, identical to that described
in this thesis and in Boylan and Wright (2000). The findings of Roepman et al. (2000) and
Boylan and Wright (2000) were published at the same time and those ofHong et al. (2000a)
subsequently. These will be discussed in chapters 3, 4 and 5.
1.12 - Mouse RPGR
Yan et al. (1998) isolated and characterised the murine RPGR homologue ( ). The
gene was found to have two in-frame initiation codons and a number of splicing variants
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were detected. Northern blot studies of mouse RNA revealed a 2.7 kb transcript widely
expressed in murine tissues, with greater abundance in brain and testis. A faint brain-
specific band of 2.8 kb was observed, and two transcripts, one of 3 kb and one of 3.3 kb,
were testis-specific. In transfected COS cells, mRPGR was found to be isoprenylated and
localised to the Golgi complex.
Hong et al. (2000b) prepared an RPGR-deficient mouse model of RP3.
Immunoblots from wild-type and knockout mice were probed with anti-RPGR antibodies
and, in the wild-type only, a band of 95 kDa was detected in a variety of tissues, and an
additional larger band of 165 kDa was seen in testis only. Tissue sections from the RPGR-
deficient mice were stained to reveal the presence of the P-galactosidase reporter, the
transcription of which was driven by the endogenous mRPGR promoter. In this way,
evidence was found of widespread mRPGR promoter activity in the brain, and in the
ganglion and photoreceptor cell layers of the retina. Wild-type retinas were then examined
immunocytochemically to establish the normal subcellular position of RPGR. There was
prominent staining in the region of the photoreceptor connecting cilium at the junction
between the inner and outer segments. To investigate whether RPGR has a similar location
in cones, attention was switched from mouse to squirrel. Mouse retinas contain large
numbers of rods but very few cones, whereas in the squirrel, cones dominate. The
immunocytochemistry data indicated that, in the squirrel retina, RPGR localises to the
connecting cilium of cones. The subcellular localisation of RPGR was further investigated
by examining mechanically-dissociated mouse photoreceptors. These predominantly
consisted of outer segments attached to the connecting cilia, with the occasional inner
segment fragment. Staining with anti-RPGR antibodies confirmed the ciliary location. This
staining was absent in preparations from RPGR-deficient mice. It should be noted that the
antibodies used by Hong et al. (2000b) recognise the carboxyl-terminal 250 amino acids of
mRPGR, corresponding to the hRPGR residues encoded by exons 12 to 13 and 16 to 19
(although the nucleotide sequence of mRPGR is subtantially different from human RPGR in
exons 11-17 (Yan et al., 1998)). Kirschner et al. (1999) had previously reported that the
mouse gene is subject to extensive alternative splicing, particularly the 3' half of the gene.
The restricted localisation of mRPGR reported by Hong et al. may therefore reflect this
alternative splicing. At an early age (approximately 30 days postnatal) retinal function
appeared normal in the knockout mice, as measured by ERG, although the authors noted
slight immunohistochemistry irregularities in rods and cones. In cones, the blue and green
opsins, which are normally found in the outer segments, localised to the inner segments,
perinuclear and synaptic regions. In rods, the rhodopsin content was reduced. Retinal
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degenerative changes had begun by 2 months of age, and after 6 months there was
substantial photoreceptor loss with reduced outer segment length and reduced photoreceptor
nuclear layer thickness. In addition, there was disorganisation of the newly formed disc
membranes at outer segment bases. The cilia of the knockout mice did not appear to be
affected structurally.
1.13 - Aim of this thesis
The aim of this thesis was to contribute to the characterisation of the RPGR protein,
mutations in which are responsible for RP3-type XLRP by identifying proteins that interact
with RPGR. It was hoped that this could provide a step in the assembly of functional
information about this protein and the biochemical pathways it is involved in. The initial
goal was to use the RCCl-like domain of RPGR (which was affected by the majority of the
RP3 mutations reported at the time this work began) in a yeast two-hybrid screen of
candidate interactors and expression libraries in an effort to isolate potential interacting
partners. The work that was carried out to achieve this is described in Chapter 3 (The yeast
two-hybrid system, page 84). A novel RPGR-interacting protein was identified and was
characterised in terms of expression, genomic structure and chromosomal localisation. The
results that were obtained and the preliminary screening of this gene for mutations in a
subgroup of Sardinian ARRP patients are presented in Chapter 4 (Characterisation of





2.1 - Media, antibiotics and additives.
All media were sterilised by autoclaving at 121 °C/15 pounds per square inch for twenty
minutes (all autoclaving was carried out in this way unless unless otherwise specified). All
chemicals in this and the following sections were purchased from Sigma Chemical Co., St
Louis, USA.
LB Medium/litre
Bacto-tryptone (Difco, West Molesey, UK) 10 g
Bacto yeast extract (Difco) 5 g
NaCl 10 g
Distilled water (dH20) to 1 litre
Adjust pH to 7.0. For agar plates, 15 g/litre agar (Difco) was added.
M9 Minimal Medium/litre
5x M9 salts 200 ml
dH20 to litre
1 M MgS04.7 H20 1 ml
20% glucose 10 ml
1 M CaCl2 0.1ml











Ampicillin is kept at -20°C as a stock solution at 50 mg/ml in dF^O and added to a final
concentration of 50 pg/ml. Added to media following sterilisation, immediately before use,
or when the temperature of the media was below 45°C.
IPTG (Isopropvlthio-(3-D-galactosidel
Stored at -20 °C at 200 mg/ml in dH20. 4 pi was spread onto an L-agar plate as required for
a-complementation/blue-white colour selection (Melford laboratories Ltd, Ipswich, UK).
X-gal (5-Bromo-4-chloro-3-Indovl- [3 -D-galactoside)
Stored at -20 °C at 20 mg/ml in dimethylformamide. 40 pi was spread onto an L-agar plate
as required for a-complementation/blue-white colour selection (Melford laboratories Ltd).
2.2 - Bacterial Strains
DH5a (Gibco BRL, Paisley, UK) [Genotype: supEAA, A(lacZYA-argF)U169,
<t>80d/acZAM15, hsdRM, recA 1, endA 1, gyrA96, thi-l, relAl.] A recombination-deficient
suppressing strain used for plating and growth of plasmids and cosmids.
HB101 (Gibco BRL) [Genotype: supEAA, hsdS20, recA 13, ara-\A, proAl, lacYl, galK2,
rpsL20, xyl-5, mtl-1.] A suppressing strain commonly used for large-scale production of
plasmids. It is an E. Coli K12 x E. Coli B hybrid that is highly transformable.
DH10B (Gibco BRL) [Genotype: F", mrcA, A(mrr-hsdRMS-mrcBC), ())80d/acZAM15,
AlacXIA, endAl, recA 1, deoR, A (ara, /ew)7697, araD139, galU, galK, nupG, rpsL, A,-.] An
E. coli strain (Electro-competent cells) used here for amplifying a cDNA library because of
the high level of transformation efficiency possible.
INVaF' One Shot (Invitrogen Corp., Abingdon, UK) [Genotype: F', endA 1, recA 1, hsdRM,
supEAA, thi-l, gyrA96, relAl, (j)80d /acZAM15, A(lacZYA-argF)U169.] Cells used with
the Invitrogen 'TA' cloning system. Allows stable replication of high-copy number
plasmids.
Kev
ara: confers an inability to utilise arabinose
deoR: allows uptake of large plasmids
endA: abolishes non-specific endonuclease I activity and improves the quality of plasmid
DNA isolations
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F': F' episome, male E. coli host, necessary for M13 infection
galK: inability to use galactose; galactokinase mutation
gall]: inability to utilise galactose; glucose-1 -phosphate uridyltransferase mutation
gyrA: mutation confers resistance to nalidixic acid; DNA gyrase mutation
hsdR: restriction minus, modification positive - transformed DNA will not be cleaved by
endogenous restriction endonucleases
hsdS: restriction minus, modification minus - transformed DNA will not be cleaved by
endogenous restriction endonucleases; protective methylation abolished
lacY: inability to use lactose; galactoside permease mutation
lacZAMI5: partial deletion of (3-D-galactosidase; allows a-complementation of (3-
galactosidase activity
leuB: requires leucine for growth on minimal media; (3-isopropyl malate dehydrogenase
mutation
mrcA: blocks restriction ofmethyl-cytosine-specific DNA sequences
mrr: absence of the mrr gene product allows more efficient cloning of DNA containing
methyladenine residues
mtl: inability to use mannitol
nupG: alters nucleoside uptake
proAB: requires proline for growth on minimal media
recA: prevents recombination between introduced DNA and host DNA
relA: allows RNA synthesis in the absence ofprotein synthesis
rpsL: resistance to streptomycin; mutation in protein S12 of 30S ribosomal subunit
supE: mutation suppresses amber (UAG) mutations
thi-1: strains cannot make thiamine and therefore require thiamine to grow on minimal
media
xyl-5: confers an inability to utilise xylose
2.3 - Cloning vectors
pASl (Harper et al., 1993): has amino acids 1-147 of the GAL4 transcriptional activator,
high-level fusion protein expression driven by the ADH1 promoter and terminated at the
ADH1 terminator. High level of expression during logarithmic growth of the yeast host
cells, but then is repressed in late log phase by the ethanol that accumulates in the medium
as a by-product of yeast metabolism. Fusion proteins have the haemagglutinin tag between
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the cloned portion and the GAL4 domain. Expresses the TRP1 gene in yeast, which encodes
tryptophan prototrophy. Ampicillin resistant in E. coli. 8.5 kb in length. Carries the CYHS2
gene, which confers sensitivity to cycloheximide.
pACTII (Durfee et al., 1993): has amino acids 768-881 of the GAL4 transcriptional
activator, high-level fusion protein expression driven by the ADH1 promoter and terminated
at the ADH1 terminator. Fusion proteins have the haemagglutinin tag inbetween the cloned
portion and the GAL4 domain. Expresses the LEU2 gene in yeast, which encodes leucine
prototrophy. Ampicillin resistant in E. coli. 7.55 kb in length.
pCR2.1 TQPO (Invitrogen): has 3'-T overhangs for ligation of Tag-amplified PCR products.
Ampicillin and kanamycin resistance genes. Blue/white colony screening. 3.9 kb in length.
2.4 - Small scale preparation of plasmid DNA (miniprep)
To prepare small amounts of plasmid DNA (1-10 pg) from bacterial cultures the Promega
Wizard miniprep kit (Promega, Southampton, UK) was used, based on the alkaline lysis
method of Birnboim and Doly (1979). Generally an overnight culture was set up by
inoculating 10 ml LB-amp with a single isolated bacterial colony from an agar plate and
incubating at 37 °C with shaking. The cells were pelleted by spinning in a Sorvall RT 6000D
centrifuge at 3000 rpm for ten minutes and the supernatant poured away. The pellet was
then treated as directed by the kit protocol. Briefly:
1. The pellet was resuspended in 400 pi 'cell resuspension solution' (50 mM Tris-HCl pH
7.5, 10 mM Na2EDTA, 100 pg/ml RNase A).
2. 400 pi 'cell lysis solution' (0.2 M NaOH, 1% SDS) added and gently mixed by
inversion.
3. 400 pi 'neutralising solution' (1.32 M potassium acetate) added and mixed by inversion.
4. Tubes spun in an Eppendorf centrifuge for 5 minutes at room temperature to pellet cell
debris and bacterial DNA.
5. Supernatant transferred to a syringe which had been attached to a Wizard minicolumn
and 1 ml of the provided silca gel resin added.
6. Syringe plunger inserted and slurry pushed through the column.
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7. Column washed with 2 ml 'column wash solution' (0.1 M NaCl, 10 mM Tris-HCl pH
7.5, 2.5 mM Na2EDTA, 50% (v/v) ethanol).
8. Column transferred to a fresh 1.5 ml eppendorf tube and spun for 2 minutes to dry the
resin.
9. Column transferred to a fresh 1.5 ml eppendorf tube and 50 pi water or Tris-EDTA (TE,
0.01 M Tris-HCl, ImM EDTA, pH 7.5) added. Spun for 1 minute to elute the DNA.
2.5 - Large scale preparation of plasmid DNA (maxiprep)
To obtain milligram amounts of plasmid DNA, a procedure based on the methods of
Birnboim and Doly (1979) and Ish-Horowicz and Burke (1981) was used. A single isolated
bacterial colony was used to innoculate 30 ml of LB containing 50 pg/ml ampicillin. This
was incubated at 37 °C with shaking for 8 hours (when the culture reaches late log phase,
corresponding to an OD600 of 0.6). 25 ml of the culture was used to inoculate 500 ml of LB-
amp (prewarmed to 37 °C), which was then incubated at 37 °C with vigorous shaking
overnight. The bacterial cells were harvested by centrifugation at 4000 rpm for 15 minutes
at 4°C and the supernatant discarded. The pelleted cells were washed in 18 ml of a sterile
solution containing 50 mM glucose, 25 mM Tris-HCl (pH 8.0) and 10 mM EDTA. 2 ml of
freshly prepared lysozyme (10 mg/ml; Sigma) was added and then 40 ml of a freshly
prepared solution containing 0.2N NaOH and 1% SDS. The mixture was agitated and left to
stand at room temperature for 5 to 10 minutes while the cells lysed. To the bottle containing
the lysate was added 20 ml of an ice cold solution containing 60 ml 5M potassium acetate
11.5 ml glacial acetic acid and 28.5 ml H20. The bottle was shaken and incubated on ice for
10 minutes and then centrifuged at 4000 rpm for 15 minutes at 4°C. The supernatant
containing the plasmid DNA was filtered through 4 layers of cheesecloth and to it was
added 0.6 volumes of isopropanol. The bottle was mixed well and stored for 10 minutes at
room temperature. The precipitated nucleic acid was pelleted by centrifugation at 5000 rpm
for 15 minutes at 4° C. After discarding the supernatant, the pellet was washed in 70%
ethanol, air dried and then dissolved in 3 ml of TE (pH 8.0). The plasmid DNA was then
purifed by polyethylene glycol precipitation as described below. The 3 ml solution of
nucleic acid was transferred to a 15-ml Corex tube and to it was added 3 ml of ice-cold 5M
lithium chloride. The contents of the tube were mixed well and centrifuged at 9000 rpm for
10 minutes at 37 °C. The supernatant was transferred to a 30 ml Corex tube and mixed with
an equal volume of isopropanol. The precipitated nucleic acids were recovered by
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centrifugation at 9000 rpm for 10 minutes at room temperature. The pellet was washed
carefully in 70% ethanol and air dried and then dissolved in 500 pi TE (pH 8.0) containing
DNAase free pancreatic RNAase (20 pg/ml; Boehringer Mannheim, Mannheim, Germany).
The solution was transferred to a 1.5-ml microfuge tube and stored at room temperature for
30 minutes. 500 pi of 1.6M NaCl containing 13% (w.v) polethylene glycol (PEG 8000) was
added and the tube agitated. The plasmid DNA was recovered by centrifugation at 12,000 x
g for 5 minutes in a microfuge. The supernatant was removed and the pellet of DNA
dissolved in 400 pi of TE (pH 8.0). The solution was extracted once with
phenol:chloroform and once with chloroform. The aqueous phase was transferred to a fresh
tube and to it was added 100 pi of 10M ammonium acetate (the solution was mixed) and 2
volumes of ethanol. The tube was stored at room temperature for 10 minutes and then
centrifuged at 12,000 x g for 5 minutes at 4°C. The pellet was washed in 200 pi of 70%
ethanol, air dried thoroughly and finally dissolved in 200 pi of TE (pH 8.0) and the OD26o
measured.
2.6 - Phenol-chloroform extraction and ethanol precipitation of DNA
Phenol-chloroform extraction: DNA was extracted from solution (following restriction
enzyme digestion, etc) once by addition of an equal volume of phenol:chloroform:isoamyl
alcohol (25:24:1). The mixture was vortexed vigorously and centrifuged at 12,000 rpm for 5
minutes The upper, aqueous phase was carefully removed, avoiding precipitated proteins
found at the interface between the two layers. The DNA was then extracted in the same way
with one volume of chloroform.
Ethanol precipitation: To concentrate DNA and remove salts, a 1/10 volume of 3M sodium
acetate pH 5.2 was added to the DNA solution, followed by 2.5 volumes of absolute ethanol.
20 mg of glycogen (Boehringer) was added as carrier when necessary. The mixture was
vortexed vigorously and left at -20°C for between 1 hour and overnight. The tube was
centrifuged at 12,000 rpm for 30 minutes at 4°C. The supernatant was discarded, and the
pellet washed with 70% ethanol. The tube was centrifuged at 12.000 rpm for 10 minutes at
4°C. The supernatant was discarded, and the pellet air dried. The pellet was then
resuspended in the appropriate volume of TE or dH20.
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2.7 - Agarose gel electrophoresis
Electrophoresis solutions
0.5.x TBE: 45 mM Tris-borate, 0.1 mM EDTA pH 8.0
6 x DNA Loading Buffer: 0.25% Bromophenol blue, 30% glycerol in H20
Size marker
2 (0,1 (250 ng/jil) of the Boehringer Mannheim molecular weight marker X was used to
compare fragment sizes on agarose gels. The sizes of the fragments (in bp) are: 12216,
11198, 10180, 9162, 8144, 7126, 6108, 5090, 4072, 3054, 2036, 1636, 1018, 517, 506, 396,
344, 298, 220, 201, 154, 134.
Agarose gel electrophoresis
DNA was separated according to size in horizontal agarose gels ('Hi-Pure' Low EEO
agarose, BioGene, Kimbolton, UK) using Anachem horizontal electrophoresis units. The
amount of agarose used to make the gel depended on the size range of the DNA to be
resolved but most commonly a 0.9% gel was prepared. All agarose gels were made with 0.5
x TBE. To stain the DNA, ethidium bromide was added to agarose gels to a final
concentration of 1 mg/ml. One-sixth of the sample volume of 6 x Loading Buffer was added
to the DNA prior to loading the sample on the gel. Gels were run at 30-150V depending on
resolution and running time required, in 0.5 x TBE. DNA fragments were visualised on a
UV transilluminator and photographed using a video copy processor (Mitsubishi, Hatfield,
UK).
2.8 - Purification of DNA from agarose gels - Geneclean
To purify DNA from agarose gel slices the Geneclean spin kit (BIO 101, Harefield, UK) was
used, in which DNA became bound to a silica matrix while the molten agarose was eluted.
The kit protocol was followed. Briefly:
1. The gel slice was put into the upper cavity of a Geneclean 'Spin filter' and 400 jul
glassmilk added. Spin filter was floated in a 55°C water bath for 5 minutes to melt the
agarose, and inverted every minute to prevent sedimentation of the glassmilk.
2. The filter was spun in an Eppendorf centrifuge for 1 minute. Flow through was
discarded.
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3. 500 jllI of the provided Geneclean wash solution was added and the filter spun again for 1
minute. Flow through was discarded.
4. Filter was spun for 2 minutes to dry the glassmilk.
5. Between 10 and 30 pi elution solution (nuclease free water) was added to the filter,
which was spun for 1 minute to elute the DNA.
2.9 - Purification of DNA from solution - Geneclean
To purify small amounts of DNA from solution the Geneclean spin kit was used. The
protocol is the same as for purifying DNA from agarose gels except that the intial 55°C
incubation is carried out at room temperature.
2.10 - Restriction endonuclease digestion of DNA
Restriction endonucleases were purchased from Boehringer Mannheim and New Enland
Biolabs (Bishops Stortford, UK) and came provided with an optimal 10 x buffer stock.
Digestion reactions were generally carried out in 20 pi volumes in 1 x buffer at the directed
temperature (usually 37°C) for between 2 and 4 hours. The volume of enzyme added to the
digest was no more than 10% of the total reaction volume to keep the glycerol concentration
to below 5% (v/v) and prevent non-specific ("star") activity.
2.11 - Subcloning into plasmids
2.11.1 - Ligation
Ligation reactions were performed using the Boehringer Mannheim Rapid Ligation kit.
Generally, equal masses of insert and vector DNA were used and the following protocol was
followed:
1. Add 1 pi vector DNA and 7 pi insert DNA to a 1 ml Eppendorf microfuge tube. Add 2 pi
of the provided 5x DNA dilution buffer and mix well.
2. Add 10 pi of the provided ligation buffer and mix well.
3. Add 1 pi T4 DNA ligase (5 U/pl), mix well and briefly spin down. Incubate at room
temperature for 5 minutes.
4. Between 1 and 5 pi of the ligation reaction is transformed into 50 pi competent cells.
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2.11.2 - Transformation of competent cells by heat shock
Competent cells were transformed according to the manufacturer's instructions. Briefly: for
routine subcloning, 50 pi aliqouts of E. coli strain DH5a cells were incubated with 5 pi of
ligation reaction products on ice for 30 minutes. The cells were transferred to a 37°C water
bath for 20 seconds and then returned to ice for 2 minutes. 950 pi LB medium at room
temperature was added and the cells incubated at 37 °C with shaking for 1 hour. The cells
were pelleted by brief centrifugation and resuspended in approximately 50 pi supernatant.
The cells were then spread onto fresh L-agar plates containing 50 pg/ml ampicillin and
incubated at 37 °C overnight.
2.11.3 - Transformation of competent cells by electroporation
A 40 pi aliquot of electro-competent DH10B or HB101 cells was thawed on ice and
transferred to a chilled, sterile, electroporation cuvette. The DNA, resuspended in a low
ionic strength medium such as TE, was added to the cuvette, and the mixture subjected to a
pulse of 2.5 kV (200 Ohms, 25 pF) in a Bio-Rad Gene Pulser (Bio-Rad Laboratories Ltd.,
Hemel Hempstead, UK). This produced a pulse with a time constant of 4.5 to 5 msec. 900
pi of LB medium was immediately added to the cells, which were transferred to an
eppendorf tube and incubated for 1 hour at 37°C in shaking incubator. The cells were
pelleted by brief centrifugation and resuspended in approximately 50 pi supernatant. They
were spread onto fresh pre-warmed L-agar plates containing 50 pg/ml ampicillin and
incubated at 37°C overnight.
2.11.4- 'TA' cloning
The TOPO TA Cloning kit (Invitrogen) takes advantage of the non-template dependant
terminal transferase activity of Taq polymerase, which adds a single deoxyadenosine to the
3' ends of PCR products. These 3-A overhangs are used to insert the PCR product into a
vector (pCR2.1-TOPO) which has single 3'deoxythymidine overhangs at its insertion site.
In the case of PCR products that had been generated by proof-reading enzymes, which
remove the 3'-A overhangs, it was necessary to add overhangs proir to subcloning. 7 pi of
gel purified PCR product was incubated with 1 pi Taq polymerase, 1 pi of dATP (2mM) and
1 pi lOx Taq polymerase buffer at 72°C for 10 minutes. 2 pi of this was incubated with 0.5
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fxl of pCR2.1-TOPO vector and incubated at room temperature for 5 minutes. 0.5 pi of 6x
STOP solution (0.3 M NaCl, 0.06 M MgCl2) was added and the solution mixed for
approximately 10 seconds at room temperature. The entire reaction was then used to
transform 50 pi competent DH5a cells. The transformed cells were plated onto L-agar
plates containing 50 pg/ml ampicillin which had been pre-spread with 40 pi of 20 mg/ml X-
gal and 40 pi of 100 mM IPTG. Blue/white colour selection was used to identify colonies
containing recombinant plasmids. The positive colonies were used to inoculate 10 ml
aliquots of LB containing 50 pg/ml ampicillin, which were incubated overnight at 37°C and
then used to prepare plasmid DNA.
2.11.5 - PCR screening for positive colonies
In the absence of blue-white colour selection, a PCR screening technique was used to
quickly identify bacterial colonies containing recombinant plasmids. This was carried out as
follows: a PCR master mix was prepared (using primers specific for the plasmid insert), that
was sufficient for ten reactions and was aliquoted into separate numbered tubes. Using
filtered pipette tips, half of a separate colony was added to each of the ten tubes. The other
half of each colony was used to inoculate one of ten numbered tubes containing 1.5 ml LB
containing 50 pg/ml ampicillin. The PCR reaction was carried out and the results analysed
using agarose gel electrophoresis. The 1.5 ml cultures corresponding to the positive PCR
results were used to prepare glycerol stocks and plasmid DNA.
2.11.6 - Preparation of glycerol stocks of bacterial transformants
A single isolated bacterial colony from an L-agar plate was used to inoculate an overnight
culture. The next day, 820 pi of the culture was mixed thoroughly with 180 pi sterile
glycerol and put into storage at -70°C.
2.12 - Polymerase chain reaction
Oligonucleotides were designed to have a melting temperature (Tm) of between 55°C and
70°C, if possible, and were synthesised by Genosys (Cambridge, U.K.). The lyophilised
pellets were resuspended in sterile dH20 at a concentration of 100 pM and, from these,
working stock solutions of 10 pM were prepared and stored at -20°C
For most PCR applications, the Expand High Fidelity PCR system (Boehringer
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Mannheim) was used according to the manufacturer's instructions. This incorporates a mix
of Taq and Pwo DNA polymerases. Reaction volumes of 25 or 50 pi were used, in 0.5 ml
microfuge tubes. Reactions were carried out in either an MJ Research (Waltham, USA)
PTC-200 Peltier thermal cycler (using a heated lid) or a Perkin Elmer-Cetus (Beaconsfield,
UK) DNA thermal cycler (in which case reaction mixtures were overlaid with 1 drop of
light mineral oil (Sigma).
PCR programmes had the following cycling parameters: (i) an initial single
denaturation step of 2 minutes at 95°C, followed by (ii) 30 cycles consisting of a
denaturation step of between 15 seconds and 1 minute at 95°C, an annealing step of between
30 seconds and 1 minute, if possible at Tm - 5°C and an extension step of variable duration
according to the size of the product, at 72°C, then (iii) a final extension step of 7 minutes at
72°C.
The duration of the extension step varied according to the expected size of the PCR product:
Extension time 45s 1 minute 2 minutes 4 minutes 8 minutes
Size of PCR product (kb) Up to 0.75 1.5 3 6 10
One fifth of the volume of the PCR reaction was analysed by agarose gel electrophoresis.
Oligonucleotide primers used in this project are listed in Table 2.1.
Table 2.1: Oligonucleotide PCR primer information.
Name Tm(°C) Sequence (5' to 3')
1048 Fwd 69.8 AACATGGCAAAAGAATAGGTGTTCAAGG
1153 Fwd 66.7 CAGCAGGTGAATTACACTGAGTGG
139 Fwd 71.0 TGTCATAGTGCCACCCATGTCTCAG
19 Rev 67.3 TGTAGAGGTTCCTTCTGTTTCAGTGC
-26 Fwd 67.8 CATATCACACCCCTTGGTATCCATC
4 Rev 67.5 TGTTTCAGTGCTGAATGGGATAATG
419 Fwd 57.6 GAAGAAATCCACTTTCACTTTAG
430 Fwd 54.1 AGAGAACACTCAGATCGAG
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44 Rev 65.9 TTCAGAGGATTCTTTGTCATTTACAGG
?4/5 junction REV 71.1 CAGTGTTTCCAAACATAACGACAACGG
494 Rev 55.6 GTGATACTTGCAACTCATTTAG
522 Rev 64.0 GATCAGGATCTTGTCCATTCAG
544 Rev 54.8 CTAACAATGTCTAGCTCTTGCTCTAG
-6 Fwd 63.0 TGAGAGCTTGCTTTCCATTG
638 Fwd 43.8 CTGACAATGATAATACAG
670 Rev 65.6 CTTAGATCGGTTATTCTTGAGGTCTAGATG
686 Fwd 68.8 GAGGTTGACTCGACATCTAGACCTCAAG
761 Rev 70.0 CTTCAGTCATCTCCTTGTAAATAGC
801 Fwd 63.7 TGGATTGGAAGTTTCCCTACATAC
845 Rev 70.7 GTATCCTTCCCCTTAGTCTGAGCTTCTGG
869 Fwd 72.3 GAAACCAGAAGCTCAGACTAAGGGGAAGG
962 Rev 69.3 AGGTTTTCTCTTAGATCGATACTGGCCAG
ARFlATGNcol 79.5 ACAACCATGGGGAACATCTTCGCCAACCTC
ARFStopBamHI 75.9 TTGGATCCTTCACTTCTGGTTCCGGAGCTG
Bov Fwd 64.6 CCCTAAGGCAGATTCAGAGAAGAT







Genscan exonl 60.5 CATGTATTACTTTATTCGGATCAAAG
Genscan exonlO 64.6 TGAAAGAAATGCTTCATTGGTTATG
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Genscan exonl 1 67.0 GAAGAGCCAACTGGAAGATGTGTC
Genscan exonl 2 61.1 GAAAATTGCTGAATGACAATTATG
Genscan exonl7 67.5 GCTCAAAGATGTTGCTTATGGCAC
Genscan exonl8 66.9 ACAGGCGTGCAATAAACGAAAG
Genscan exonl9 76.1 CCCAGTGCTTGTGACCTCTGACCTGG
Genscan exon2 58.9 GAGATTTAATTACAAACGTAAGCTG
Genscan exon3 67.4 GAGCATCACGATCTTCATTTTCATG
Genscan exon4 79.9 CTGCCGCCGAGGCGAAGGCCTAG
Genscan exon5 71.3 CACATCTGGTGGACCCTACATCAGG
Genscan exon6 68.1 ACATGTTGGTGAAGGAGCTTTCTTG
Genscan exon7 80.7 TGCAAGGGCATTTCCACTGCGTCGG
Genscan exon8 66.7 GAGGTGAAGTAGCCAGTAAACCCAG
Genscan exon9 70.1 GCTCATTGGAGTGTGCTCAGAAGG
Intron 3 Fwd 74.6 GCAGTCTTCTTGACCTAGCCAGTGCCAC
Intron 4 Fwd 69.0 AAAATGGGAAGGAAGTAGATAAGGTGCTG
Intron 4 Rev 67.0 GATAAGTCATATGCTAAGGGTATGAGAGGC
Intron 5 Fwd 78.0 GGAGCGAAAGCCTGGGTTTTACTGCGG
Intron 5 Rev 82.4 GCTGGGATTACAGGCGTGAGCCACTGCACC
M13F 64.0 CCCAGTCACGACGTTGTAAAACG
M13R 58.0 AGCGGATAACAATTTCACACAGG










r93221 Fwd 2 64.1 GAACAAGGTTCTGAAGTCAGTGAAG
r93221BamHI 74.0 AAGGATCCATGTTCTCATCAGACATC
r9322 INcol 74.0 TATACCATGGTTATGACATTATCCCATTCAGCA
Rabl3BamHI 80.0 ATGGATCCTCAGCCCAGGGAGCACTTGTTG




RCC1 StopBamHI 75.5 AGGGATCCTCAGCTCTGTTCTTTGTCCTTGAC
Rev 3 72.0 TTCAATGCACATCTTCTCTGAATCTG
RG32 Bam HI 88.0 GAGGATCCCAGAGACTTTTAGATTGGAATAG
RG32 long Rev 71.5 GCCATCACCTATGAAGCTGTTAGTCTCTGAG
RPGRATGNcol 77.3 TAATCCATGGTAATGAGGGAGCCGGAAGAGC
Stop +36 57.3 TTTACTATGGTTCCCTCAGAG
Stop +6: 54.4 TTAGATTGGAATAGCACTTG
StopBamHI 73.6 CATGGATCCTTCACAGGTCATCATCCTC
2.13 - Reverse Transcriptase PCR
The Access RT-PCR kit (Promega) was used to amplify RPGRIP from samples of total
human or bovine RNA using gene specific primers as indicated in Chapters 3 and 4. The kit
uses AMV reverse transcriptase from Avian Myeloblastosis Virus for first strand DNA
synthesis and Tfl DNA polymerase for second strand cDNA synthesis and DNA
amplification. 25 pi reactions were set up according to the manufacturer's instructions.
RNA samples were provided by Dr. Raf Vervoort and Sandy Edgar (both MRC Human
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Genetics Unit, Edinburgh). The reactions were carried out in an MJ Research PTC-200
Peltier thermal cycler using the following programme: 48 °C for 45 minutes; 94 °C for 2
minutes; 35 cycles of 94 °C for 1 minute, 60 °C (for RPGRlP)/55°C (for G3PDH) for 1
minute, 72 °C for 1 minute; then 72 °C for 10 minutes.
The primers used were:
Product Forward primer Reverse primer
Human RPGR1P 1048F 544Rev
Human G3PDH G3PDHF G3PDHR
Bovine RPGRIP BOV FWD BOV REV
Bovine G3PDH BovG3PDHS BovG3PDHAS
2.14 - Sequencing of DNA
2.14.1 - Method 1
DNA was sequenced using the BigDye terminator cycle sequencing ready reaction kit (PE
Applied Biosystems, Beaconsfield, UK). Typically, a reaction was made up of 4 pi of the
provided reaction mix, 4 pi 2.5x buffer (200 mM Tris-HCl pH 9.0, 5 mM MgCl2), 15 ng
(PCR product) or 1 mg (plasmid) DNA template, 3.2 pmol primer and dH20 to 20 pi.
Prior to sequencing plasmid DNA, it was first linearised by enzymatic digestion,
phenol extracted and ethanol precipitated. If a PCR product was sequenced, the DNA was
purified using the Geneclean spin kit. 30 cycle sequencing reactions were carried out in a
Perkin Elmer-Cetus DNA thermal cycler using the following program: 94°C for 30 seconds,
50°C for 15 seconds and 60°C for 4 minutes. The samples were ethanol precipitated and the
pellet washed with 70% ethanol and air dried. The samples were loaded by Agnes Gallacher
(MRC Human Genetics Unit) on an ABI 377 automated sequencer, and the results analysed
using the ABI Sequencing Analysis 3.0 software.
2.14.2 - Method 2
The Thermo Sequenase radiolabelled terminator cycle sequencing kit (Amersham Pharmacia
Biotech, Little Chalfont, UK) was also used to sequence DNA. To prepare the termination
master mixes (G,A,T and C) 2 pi of the provided dGTP nucleotide master mix was mixed on
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ice with 0.5 pi of the [a-33P]dideoxynucleotide (ddNTP) terminators as shown in the table
below.
To prepare termination mixes for (n) reactions:
G A T C
Nucleotide master mix (2 x n) pi (2 x n) pi (2 x n) pi (2 x n) pi
[a-33P]ddNTP (0.5 x n) pi (0.5 x n) pi (0.5 x n) pi (0.5 x n) pi
Total (2.5 x n) pi (2.5 x n) pi (2.5 x n) pi (2.5 x n) pi
Four tubes were labelled G,A,T or C and filled with 2.5 pi of the respective termination mix.
The individual reaction mixtures were prepared by mixing 2 pi of the provided reaction
buffer, 50-500 ng template DNA, 0.5-2.5 pmol primer, 2 pi thermo sequenase polymerase (4
U/pl) and H20 to 20 pi. The cycling termination reactions were set up by adding 4.5 pi of
the reaction mixture to each of the 4 tubes containing the termination mixes. The contents
of the tubes were mixed well and overlayed with one drop of light mineral oil (Sigma). The
30-cycle reactions were carried out in a Perkin Elmer-Cetus DNA thermal cycler using the
following program: 95°C for 30 seconds, 55°C for 30 seconds, 72°C for 1 minute. 4 pi of
stop solution (containing 95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05%
xylene cyanol FF) was added to each tube, which was then vortexed and centrifuged briefly
to separate the mineral oil from the aqueous phase. Before loading 3-5 pi of each reaction
onto the gel the samples were heated to 72°C for 2-10 minutes. Gels were run at 50 W for
between 1.5 hours and 5 hours depending on which region of the sequence needed to be
read.
Pre-treatment of PCR templates
Before sequencing PCR products they were treated with shrimp alkaline phosphatase
(Amersham Pharmacia Biotech) and exonuclease I (Amersham Pharmacia Biotech). 5 pi
out of the 50 pi PCR product was mixed with 1 pi of shrimp alkaline phosphatase and 1 pi
exonuclease I and incubated at 37°C for 15 minutes and then at 80°C for 15 minutes.
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2.14.3 - Preparation of electrophoresis gels
Solutions
8% acrvlamide:
40 g acrylamide/bis-acrylamide (19:1) (BDH Ltd. Poole, UK)
250 g urea (Gibco BRL)
25 ml 20 x glycerol tolerant gel buffer
H20 to 500 ml
20 x glycerol tolerant gel buffer:
108 g Tris base
36 g taurine (ICN Biomedicals, Inc., Basingstoke, UK)
2 g Na2EDTA.2H20 (BDH Ltd)
H20 to 500 ml.
A Bio-Rad sequi-gen sequencing cell apparatus was used to prepare electrophoresis gels.
Prior to assembly of the apparatus, 2-5 ml of dimethyldichlorosilane solution was applied to
the fixed glass plate to encourage the gel to preferentially adhere to the free glass plate when
dismantling the apparatus after electrophoresis. To plug the bottom gap between the plates
the apparatus was placed in a casting tray and a mix of 15 ml 8% acrylamide, 240 pi
ammonium persulphate and 40 pi N,N,N',N'-Tetramethylethylene-diamine (TEMED)
(Gibco BRL) was poured in and allowed to set for 20 minutes. The gel was poured
(containing 45 ml 8% acrylamide, 350 pi ammonium persulphate and 50 pi TEMED) and
allowed to set for 1.5 hours.
2.15 - Autoradiography
Autoradiography were prepared by exposing radioactive gels to Kodak Biomax film (Kodak,
Cambridge, UK) overnight or for longer periods, and then processing the film in a Fuji RGII
X-ray processor (Fujifilm, Bedford, UK).
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2.16 - Northern Blotting
When preparing or probing northern blots, precautions were taken to prevent ribonuclease
(RNase) contamination. Disposable gloves were always worn and were changed frequently,
sterile, disposable plasticware was used, and solutions were treated by adding
diethylpyrocarbonate (DEPC) to 0.01%, leaving overnight and then autoclaving.
2.17 - Preparation ofRNA
Samples of human tissue from a recently deceased 83 yr old female were obtained from the
Western General Hospital, Edinburgh. 100 mg pieces were removed from each sample and
used to prepare total RNA using TRIzol Reagent (Gibco BRL), a mono-phasic solution of
phenol and guanidine isothiocyanate. Human retina tissue was obtained separately by Dr.
Julie Kenyon (MRC Human Genetics Unit, Edinburgh) and then treated in the same way as
the other tissues. The procedures were carried out at room temperature unless otherwise
stated. The pieces of tissue were each homogenised in 1 ml of TRIzol Reagent in a glass
homogeniser, then removed to sterile microfuge tubes and allowed to stand for 15 minutes.
0.2 ml chloroform was added to each tube, which was then shaken vigorously for 15 minutes
and left for 2 to 3 minutes before being centrifuged at 12,000 x g for 15 minutes at 4°C. The
aqueous phase was transferred to a fresh tube and the RNA precipitated by adding 0.5 ml
isopropanol. After 10 minutes the tubes were centrifuged at 12,000 x g for 10 minutes at
4°C. The supernatant was removed and the pellet of RNA washed once with 1 ml of 75%
ethanol. The tubes were vortexed and centrifuged at 7,500 x g for 5 minutes at 4°C. The
pellet was briefly air-dried and then redissolved in DEPC-treated dH20. The RNA yield
was estimated by measuring the absorbance at 260 nm and the purity of the preparations
assessed by measuring the A260/A280 ratio.
2.18 - Poly(A)+ RNA purification
Poly(A)+ RNA was purified from the total RNA preparations by affinity purification on
oligo(dT)-cellulose using the Pharmacia Biotech mRNA purification kit. Oligo(dT)-
cellulose columns were inverted several times and the top and bottom closures removed.
The columns were placed in a 50 ml centrifuge tube and the storage buffer allowed to drain
away. 1 ml of the provided high-salt buffer (10 mM Tris-HCl pH 7.5,1 mM EDTA, 0.5 M
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NaCl) was added and allowed to drain through under gravity. This step was repeated and
then the centrifuge tube emptied of the collected buffers. The RNA samples were heated at
65°C for 5 minutes, then placed on ice and supplemented with 0.2 ml of the provided sample
buffer (10 mM Tris-HCl pH 7.5,1 mM EDTA, 3.0 M NaCl). The samples were applied to
the top of the cellulose beds in the columns and allowed to soak in under gravity. The
columns were centrifuged at 350 x g for 2 minutes. 0.25 ml of the high-salt buffer was
added and the columns spun again. This high-salt wash step was repeated. The column was
then washed with 0.25 ml of low-salt buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.1 M
NaCl) and centrifuged at 350 x g for 2 minutes a total of three times. The collected buffers
were removed from the centrifuge tubes and replaced with sterile 1.5 ml microcentrifuge
tubes. The poly(A)+ RNA was eluted from the columns by washing with four successive
0.25 ml aliquots of the provided elution buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA),
prewarmed to 65°C. The tubes were centrifuged at 350 x g for 2 minutes after each
application and the entire eluate collected in the same tube. According to the manufacturer,
after one such round of purification, approximately 50% of the recovered RNA is poly(A)+
RNA. Again, the RNA yield was estimated by measuring the absorbance at 260 nm and the
purity of the preparations assessed by measuring the A260/A280 ratio.
2.19 - Electrophoresis of RNA through agarose gels
The method used to prepare northern blots was based on the protocols of Sambrook et al.
(1989).
Solutions
5 x Formaldehyde gel running buffer
0.1 M MOPS (pH 7.0)
40 mM sodium acetate
5 mM EDTA (pH 8.0)
Formaldehyde gel-loading buffer
50% glycerol
1 mM EDTA (pH 8.0)
0.25% bromophenol blue
0.25% xylene cyanol FF
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A 1.4% gel was poured using agarose reserved exclusively for RNA work. 1.4 g of agarose
('Hi-Pure' Low EEO agarose, BioGene) was melted in 62 ml of DEPC-treated H20. It was
then cooled to 60°C before the addition of 20 ml 5 x formaldehyde gel running buffer and 18
ml formaldehyde (Fisher Scientific, Manchester, UK). The 6 pg RNA samples (containing
approximately 50% poly(A)+ RNA) were prepared by mixing them with 25 pi formamide,
8.75 pi formaldehyde and 5 pi 5 x formaldehyde gel running buffer. The samples were
incubated at 65°C for 15 minutes, chilled on ice and then briefly centrifuged. 5 pi of
formaldehyde gel-loading buffer was added to each sample. The gel was pre-run in 1 x
formaldehyde gel running buffer for 5 minutes at 75 V before loading, and then at 60 V until
the bromophenol blue had migrated 10 cm.
2.20 - Northern blotting
The RNA was tranferred from the agarose gel to a Zeta probe GT nylon blotting membrane
(Bio-Rad). A deep rectangular tray was filled with 10 x SSC buffer. A rectangular sheet of
glass was placed on top of the tray with its long axis perpendicular to that of the tray. 3
sheets of 3MM Whatman (Maidstone, UK) paper were placed on top of the glass plate so
that the ends of the paper were immersed in the buffer in the tray. The paper was flooded
with buffer. The agarose gel containing the separated RNA was put on top of the paper and
covered with Saran wrap. A window was cut in the Saran wrap with a sterile razor blade,
allowing only the gel to emerge from the window. The surface of the gel was wetted with
10 x SSC and the membrane placed onto the gel. One corner was cut from the gel and the
membrane to allow the membrane to be correctly orientated at a later time. Care was taken
to remove any bubbles in the assembly. The top of the membrane was wetted with 10 x SSC
and then covered with 2 pieces of 3MM Whatman paper of the same size which had been
pre-soaked in 10 x SSC. A large stack of paper towels was placed over the 3MM paper and
a glass plate put on top. Transfer was allowed to continue overnight. The membrane was
removed and briefly washed in 2 x SSC. The RNA was fixed onto the membrane in a
Spectrolinker XL-1500 ultraviolet crosslinker using the automatic crosslink setting
(Spectronics Corporation, New York, USA) and the membrane air dried. The marker lane
was cut off and soaked in 1 M acetic acid for 15 minutes and then immersed for 45 minutes
in a staining solution containing 100 mg methylene blue, 25 ml 0.4 M sodium acetate and 25
ml 0.4 M acetic acid. It was rinsed in dH20 to allow the bands to develop.
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2.21 - Preparation of radiolabeled probes
The High Prime reagent (Boehringer Mannheim) was used to prepare radiolabeled nucleic
acid probes by a random primer extension method (Feinberg and Vogelstein 1983). High
Prime contains random hexameric oligonucleotides, Klenow polymerase, dATP, dGTP,
dTTP and a reaction buffer. Typically 50-100 ng denatured DNA template was added to 4 pi
High Prime and 5 pi [a32P] dCTP (50pCi) and incubated at 37°C for 15 to 30 minutes. The
reaction was stopped by adding 2 pi 0.2 M EDTA (pH 8.0). The radiolabeled probe was
separated from unincorporated counts using gravity flow chromatography by passing it
through a Sephadex G-50 Nick column (Pharmacia Biotech) that had been pre-equilibrated
with TE and eluting in 400 pi TE. The activity of an aliquot of the purified probe was
measured in a Packard Tri-Carb 1500 liquid scintillation analyser.
2.22 - Hybridisation of radiolabeled cDNA probes to northern blots
A PCR fragment consisting of the 3'-half ofRPGRIP (from the middle of exon 10 to the end
of exon 15) was used to generate a [a-32P]dCTP-labelled radioactive probe. A human
multiple tissue northern blot (MTN2; Clontech, Basingstoke, UK) was incubated with 10 ml
Ultrahyb hybridisation solution (containing 50% formamide; Ambion, Austin, USA) for 1
hour at 42 °C. The RPGRIP 3' probe was added to the hybridisation solution and incubated
overnight at the same temperature. The blot was then washed twice for five minutes each in
2 x SSC, 0.1% SDS at 42°C and then exposed to a phosphor screen overnight. The screen
was processed using the Molecular Dynamics Storm 840 imaging system (Amersham
Pharmacia Biotech).
A second radioactive probe was prepared using a PCR fragment comprising exons
1-4 and 8-15 of RPGRIP as the template. This was hybridised to another human multiple
tissue northern blot (MTN; Clontech), which had been incubated in 5 ml Expresshyb, a
premade aqueous hybridisation solution (Clontech), for 30 minutes at 68°C. The blot was
incubated with the probe at the same temperature for one hour. The blot was then washed
three times, for ten minutes each, in 2 x SSC, 0.05% SDS at room temperature and exposed
to a phosphor screen overnight. The screen was processed as above.
The two commercial northern blots were then hybridised to a control [a-32P]dCTP-
labelled radioactive human G3PDH probe (obtained by radiolabelling a PCR product
generated from a retinal cDNA library (Clontech, Basingstoke) using the G3PDHF and
G3PDHR oligonucleotides, table 2.1). The blots were prehybridised in 10 ml Expresshyb
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for 30 minutes at 68°C. The probe was added and the blots incubated for an hour at 68°C.
The blots were then washed three times, for ten minutes each, in 2 x SSC, 0.05% SDS at
room temperature and exposed to a phosphor screen overnight. The screen was processed as
before.
A RPGR1P PCR product (from the FWD2 and 761 oligonucleotide primers)
consisting of exons 11 to 15 was used to prepare a [a-32P]dCTP-labelled probe. This probe
was hybridised to a northern blot containing poly(A)+ RNA purified from a range of human
tissues. The blot was incubated in 15 ml Ultrahyb hybridisation solution for 1 hour at 42 °C
and then the probe was added and the blot left at the same temperature overnight. The blot
was washed twice for five minutes in 2 x SSC, 0.1% SDS and then once in in 0.1 X SSC,
0.1% SDS at room temperature. The blot was exposed to Kodak Biomax X-ray film for 4
days. This blot was then probed with radiolabelled (3-actin. A random-primed [a-
32P]dCTP-labelled probe was prepared from a commercial actin template (Clontech). The
blot was pre-hybridised in 15 ml Ultrahyb hybridisation solution for 1 hour at 42 °C. The
probe was added to the solution and left overnight at 42 °C. The probe was washed twice for
5 minutes in 2 x SSC, 0.1% SDS and then twice for 15 minutes in 0.1 x SSC, 0.1% SDS, at
42 °C. The blot was exposed to a phosphor screen for 30 minutes.
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0.25 M Tris-HCl pH 7.5
1% Triton X-100/Tween 20
NTMT
100 mM NaCl
100 mM Tris-HCl pH 9.5
50 mM MgCl2
0.1% Triton X-100/Tween 20
Nitro blue tetrazolium (NBT)
75 mg/ml in dimethylformamide (store at -20°C)
5 '-Bromo-4-chloro-3-indolylphosphate (BCIP)
50 mg/ml in 70% dimethylformamide (store at -20°C)
A mouse IMAGE EST clone was obtained (accession number aa204546) was obtained from
the HGMP RC. The plasmid backbone, pT3T7-Pac, has the T7 promoter immediately
upstream of the polylinker and the T3 promoter downstream. The orientation of the clone
was checked by PCR-amplifying between the 544 REV primer (this primer will anneal to
the sense strand of the mouse RPGR1P cDNA) and either the pT3T7-FWD or pT3T7-REV
primers (these primers anneal to the T7 and T3 promoters respectively). If the insert was in
the correct orientation only the 544 REV/pT3T7-FWD reaction would give a product. This
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was found to be the case. Two aliquots of aa204546 DNA were seperately cut with either
Hindlll or Xhol and then phenol-chloroform extracted. The first enzyme cuts near the T3
promoter, downstream of the plasmid insert; this DNA was used with T7 RNA polymerase
to produce a mouse RPGRIP sense transcript terminating at the Hindlll cut. Xhol cuts on
the other side of the insert so this DNA was used with T3 RNA polymerase to produce the
antisense transcript. The RNA probes were made using the DIG RNA Labeling Kit
(SP6/T7) (Boehringer Mannheim). For the sense transcript the T7 RNA polymerase
supplied with the kit was used; for the antisense transcript a separate T3 RNA polymerase
and its buffer (containing 0.4 M Tris-HCl, pH 8.0, 60 mM MgCl2, 100 mM dithiothreitol, 20
mM spermidine; Boehringer Mannheim) were used. The RNA probes were ethanol
precipitated in the following way: 2.5 pi of 4 M lithium chloride and 75 pi ethanol (at -
20°C) were added to the standard labeling reactions (produced according to the DIG RNA
Labeling Kit manufacturer's instructions), then mixed and incubated at -70°C for 30 minutes
or -20°C for 2 hours. They were then centrifuged at 12,000 x g at 4°C for 15 minutes and the
pellets washed carefully with 50 pi of 70% ethanol (at -20°C). The tubes were centrifuged
in the same way again and the pellets dried under vacuum before being dissolved in 100 pi
sterile RNase-ffee H20.
12.5 and 15 day old mouse embryo sections were supplied by Judy Fletcher (MRC
Human Genetics Unit, Edinburgh). These were defrosted at room temperature for 1 hour.
The riboprobes were diluted 1:200 in hybridisation buffer and vortexed before being
denatured for 5-10 minutes at 70°C. 100 pi of each probe mix was added to the appropriate
slide which was then overlayed with a coverslip. The slides were incubated overnight at
65°C in a sealed perspex box with 2 sheets of Whatman paper wetted with 1 x salt/50%
formamide. After hybridisation, the slides were transferred to a coplin jar and washed for
15 minutes at 65°C in solution A to allow the coverslips to fall off. They were washed
again, twice, in solution A for 30 minutes at 65°C, and twice more for 30 minutes at room
temperature in 1 x TBST. The slides were blocked in 10% heat-inactivated sheep serum in 1
x TBST for at least 1 hour at room temperature. They were dried in the regions of the
sections and then 100 pi 1:2000 anti-DIG AP-Fab fragment in 10% heat-inactivated sheep
serum in 1 x TBST was added. The slides were incubated overnight in a humidified
chamber at 4°C. They were washed 4 to 5 times for 20 minutes in 1 x TBST at room
temperature and then twice for 10 minutes in 1 x NTMT at room temperature. The slides
were stained in a coplin jar in the dark (i.e. wrapped in foil) at room temperature with 4.5 pi
NBT plus 3.5 pi BCIP/1 ml NTMT. The staining reaction was checked after a few hours
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and then left to proceed overnight at 4°C. The reaction was stopped by washing the slides
twice in distilled water. The sections were fixed in 4% paraformaldehyde/0.1%
glutaraldehyde for 20 minutes and then dehydrated through an alcohol series (30 seconds
each wash). They were counterstained with filtered 0.1% eosin in 95% ethanol for 20 to 30
seconds and then rinsed twice for 30 seconds in 95% ethanol and washed twice for 5
minutes in 100% ethanol. They were transferred to xylene for 2 x 5 minutes and then
mounted in DPX mounting medium (Fisher Scientific, Manchester, UK).
2.24 - Two hybrid library transformation into bacteria and amplification
The two hybrid retinal library constructed by C.H. Sung in the pACTII vector (Kumar et al.,
1996) contained 2 x 106 independent clones and was provided as 10 pi of DNA at a
concentration of 66 ng/pl. A 40 pi aliquot of electro-competent Electromax DH10B E. coli
cells was transformed with 300 ng of library DNA by electroporation. 1 ml of pre-warmed
LB was added to the cells which were incubated in a rotary shaker at 37°C for 1 hour.
Twenty 50 pi aliquots of this recovery culture were added to twenty 500 pi aliquots of LB
and spread onto twenty 22 cm square L-agar plates containing 50 pg/ml ampicillin. At the
same time, 0.01 pi of one 500 pi aliquot was spread onto a small L-agar plates containing 50
pg/ml ampicillin to assess transformation efficiency. The plates were incubated at 30°C for
24 hours instead of 37°C (on the advice of the commercial manufacturer (Clontech) of the
pACTII vector) because at the higher temperature there was a risk that a temperature
sensitive X repressor would be inactivated leading to lysis by residual X phages. Using the
transformation control plate the total number of transformants was estimated to be 2.91 x
107. Several pastettes of LB medium containing 50 pg/ml ampicillin were added to each
plate and the bacterial colonies scraped off and mixed into 2 litres of LB medium containing
50 pg/ml ampicillin. This was incubated at 30°C for 2 hours. After this, 5 ml was removed
and used to make glycerol stocks and the rest used to prepare plasmid DNA.
2.26 - Yeast Two-Hybrid System
2.26.1 - Strain, media and solutions
Y190 genotype: MATa, ura3-52, his3-200, ade2-101, lys2-801, trpl-901, leu2-3, -112,
gal4\ gal8OA, cyhr 2, , LYS2 :: GAL1vas -HIS3tata-HIS3, URA3::GAL1vas - GAL1 TATA -
lacZ. Yeast two-hybrid experiments were carried out in this S. cerevisiae strain, which
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contains two GAL4-responsive reporter genes, HISS and lacZ. The genes encoding GAL4
and its negative regulator gal80 have been deleted.





L-Adenine hemisulphate salt 100 mg
L-Arginine HC1 200 mg
















dH20 to 500 ml. Autoclave and store at "4°C
The following 10 x dropout solutions were prepared by omitting the appropriate amino acids
in each case: 10 x dropout minus leucine and tryptophan, 10 x dropout minus histidine,
leucine and tryptophan, 10 x dropout minus leucine, 10 x dropout minus tryptophan, 10 x
dropout minus leucine and histidine, 10 x dropout minus tryptophan and histidine. These
solutions were ingredients of the synthetic complete media that were used to select for yeast
transformants containing plasmids carrying prototrophic genes.
Synthetic complete Medium
3.35 g Yeast Nitrogen Base without amino acids (Sigma) was mixed with 10 g agar (Difco).
dH20 was added to 425 ml, followed by 50 ml of the appropriate 1 Ox dropout solution and
the pH adjusted to 5.8. This was autoclaved and allowed to cool to approximately 55°C
before the addition of 25 ml of a sterile 40% solution of glucose. If required, 3-amino-1,2,4-









Adjust to pH 5.8, autoclave, and cool to approximately 55°C. Add glucose to 2% (50 ml of
a sterile 40% stock solution). For agar plates, add 18 g/litre agar (Difco).
10 xTE buffer
0.1 M Tris-HCl, 10 mM EDTA, pH 7.5. Autoclave.
10 x Lithium Acetate (LiAc)
1 M lithium acetate. Adjust to pH 7.5 with dilute acetic acid and autoclave.
50% PEG
50% PEG 3350. Autoclave.
PEG/LiAc solution
1 ml lOx TE
1 ml lOx LiAc
8 ml 50% PEG
dH20 up to 500 ml. Adjust pH to 7.0
Z buffer/X-gal solution
100 ml Z buffer
0.27 ml (3-mercaptoethano 1











The salmon sperm DNA (Sigma type III sodium salt) was dissolved in water to a
concentration of 10 mg/ml and the concentration of NaCl adjusted to 0.1 M. The solution
was extracted once with phenol and once with phenol-chloroform and the DNA sheared by
passing it through a hypodermic needle 12 times. The DNA was precipitated by adding 2
volumes of ice cold ethanol, recovered by centrifugation and then redissolved in water at 10
mg/ml (the OD26o of the solution was measured and the exact concentration calculated). The
DNA was placed in a boiling water bath for 10 minutes and then stored in small aliqouts at -
20°C. Before using the salmon sperm DNA it was boiled for 5 minutes and then quickly
chilled in ice water.
2.26.2 - Yeast Transformation Protocol
The amounts shown are for small scale transformations, those shown in parentheses are for
library scale transformation.
1. 1 ml of YPD was inoculated with several large yeast colonies which were no more than 3
weeks old. The tube was vortexed to disperse clumps.
2. This was transferred to a flask containing 50 ml (150 ml) ofYPD.
3. The flask was incubated overnight at 30°C with shaking at 250 rpm until the culture
reached stationary phase (OD60o >1.5).
4. Sufficient overnight culture was transferred into 300 ml (1L) of YPD to produce an
OD60o of 0.2-0.3.
5. This was incubated at 30 °C with shaking for 3 hours then the cells were centrifuged at
1,000g for 5 minutes at room tempreature.
6. The supernatant was removed and the cells resuspended in 50 ml (500 ml) dH20 before
centrifuging again.
7. The supernatant was discarded and the pellet resuspended in 1.5 ml (8 ml) of freshly
prepared lxTE/LiAc.
8. For each separate tranformation a separate tube was prepared containing 0.1 pg (0.2-1.0
mg) DNA-binding domain construct, 0.1 pg (0.1-0.5 mg) activation domain construct and
0.1 mg (20 mg) sheared salmon sperm DNA.
9. 0.1 ml (8 ml) of the competent yeast cells prepared in step 7 were added to each tube.
10. 0.6 ml (60 ml) sterile PEG/LiAc solution was added and the tubes vortexed to mix.
11. The tubes were incubated at 30 °C with shaking for 30 minutes.
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12. 70 ju.1 (7.0 ml) DMSO was added to each tube and mixed by gentle inversion.
13. The tubes were placed in a 42 °C water bath for 15 minutes to heat shock. The cells
were gently mixed occasionally in the case of library scale transformations.
14. The cells were chilled on ice and then centrifuged for 5 seconds (5 minutes) at 12,000
rpm (1000 x g).
15. The pelleted cells were resuspended in 100 pi (10 ml) lx TE.
16. For small scale transformations, half the cells were plated onto synthetic complete
medium lacking tryptophan and leucine, and half onto synthetic complete medium
containing 25 mM 3-aminotriazole and lacking tryptophan, leucine and histidine. For
library scale transformations, 1 OOjllI of 1:1000, 1:100 and 1:10 dilutions were spread onto
synthetic complete medium lacking tryptophan and leucine. The colonies that grew on
these plates were counted and used to estimate transformation efficiency. The remainder
was spread over sixteen 22cm square plates of synthetic complete medium containing 25
mM 3-aminotriazole and lacking tryptophan, leucine and histidine.
17. The plates were incubated at 30 °C until colonies became visible.
2.26.3 - P-Galactosidase colony-lift filter assay
Fresh colonies were used for the P-Galactosidase assay (i.e. no more than 1 week old and
between 1 and 3 mm in diameter). Z buffer/X-gal solution was prepared as described above
and used to soak clean pieces of Schleicher and Schuell (Fondon, UK) GB003 gel blotting
paper which had been cut to fit inside 8 cm petri dishes. Pieces of Hybond (Amersham
Pharmacia Biotech) N+ nucleic acid transfer membrane of the same size were cut and placed
onto the surfaces of the plates of colonies to be assayed. The membranes were pierced in
three asymmetric positions while still in contact with the colonies in order to orient them
with the agar plates. Using forceps, the membranes were removed from the agar and
tranferred to a liquid nitrogen bath where they was submerged, colony side up, for 10
seconds. They were removed from the liquid nitrogen bath and allowed to thaw at room
temperature (the freeze/thaw treatment permeabilises the yeast cells). The membranes were
placed onto pieces of pre-soaked gel blotting paper and transferred to a 30°C incubator.
They were periodically checked for the appearance of blue colonies until 8 hours had
elapsed. Blue colonies appearing after 8 hours were deemed to be false-positives.
77
2.26.4 - Plasmid purification from transformed yeast colonies
This method is based on that of Hoffman and Winston (1987). 200 pi of plasmid release
buffer (2% Triton X 100 (Sigma), 1% SDS, 0.1 M NaCl, 0.01 M Tris pH 8.0, 0.001 M
EDTA) was put into a 1.5 ml micro fuge tube a 50 pi volume of yeast from a streaked plate
was added. 300 pi glass beads (Sigma), 100 pi phenol and 100 pi chloroform were added.
The tube was vortexed for 2 minutes and then centrifuged at 12,000 rpm at room
temperature for 5 minutes. The supernatant was removed to a new tube and 200 pi of
chloroform was added. The tube was vortexed and centrifuged as before. The supernatant
was removed and 25 pi 5 M NaCl and 1 ml absolute ethanol were added. The tube was
placed at -70°C for 15 minutes and then centrifuged at 12,000 rpm at room temperature for
15 minutes. The pellet ofDNA was washed in 70% ethanol, air dried and resuspended in 25
pi dH20.
2.26.5 - Transformation ofE. coli with plasmid isolated from yeast.
Plasmid DNA preparations from yeast are of low concentration and contain yeast genomic
DNA. For these reasons, E. coli were transformed with these preparations by
electroporation because of the relatively high transformation efficiency that can be achieved.
The HB101 strain carrying the leuB mutation was used so that transformants receiving the
pACTII plasmid (and not the pAS 1 plasmid) could be selected by complementation with the
yeast LEU2 gene.
Electrocompetent HB101 cells were prepared as follows:
1. 5 ml of LB was inoculated with a single HB101 colony and incubated at 37°C, with
shaking, overnight.
2. 1 ml of the overnight culture was transferred to a 500 ml flask containing 100 ml LB
medium. This was incubated at 37 °C until the OD600 reached 0.5 (±0.03).
3. The flask was chilled on ice for 20 minutes and the culture was then centrifuged at 1200
x g for 5 minutes at 4°C.
4. The cells were resuspended in 100 ml of an ice-cold solution of 10% glycerol and left
on ice for 20 minutes.
5. The cells were centrifuged at 1200 x g for 10 minutes at 4°C. The supernatant was
removed and the cells gently resuspended in 10 ml ice-cold 10% glycerol and incubated
on ice for 20 minutes.
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6. The cells were again centrifuged at 1200 x g for 10 minutes at 4°C and resuspended in
400 pi of ice-cold 10% glycerol. At this point the cells were either electroporated or
snap-frozen and stored at ~70°C.
Samples of plasmid DNA isolated from yeast were used to transform 40 pi aliquots of
electrocompetent HB101 cells. After recovery, the cells were washed twice in M9 minimal
medium and plated onto M9 agar medium containing 50 pg/ml ampicillin and a 1 in 10
dilution of 10 x dropout solution minus leucine. The plates were incubated at 37°C
overnight. Plasmid DNA was isolated from Leu+, Ampr HB101 transformants using the
standard mini-prep procedure.
2.27 - Preparation of in vitro translated proteins
To prepare in vitro translated proteins the TnT quick coupled transcription/translation
system was used (Promega). This system provides the "TnT quick master mix", which
combines the reagents for transcription and translation and so allows these processes to be
carried out in a single tube. The mix contains RNA polymerase, nucleotides, salts and a
ribonuclease inhibitor for transcription, and rabbit reticulocyte lysate for translation. To
synthesize proteins, the mix is incubated with a template DNA and a source of radioactive
methionine. Reactions are set up in a 0.5 ml thin-walled microcentrifuge tube by combining
20 pi of the TnT quick master mix with 1 pi 1 mM [35S] methionine (1,000 Ci/mmol at 10
mCi/ml; Amersham Pharmacia Biotech), 1 pg DNA template and nuclease-free water to a
final volume of 25 pi. The components are mixed gently by pipeting and the tube is
incubated at 30°C for 90 minutes. An aliquot of the reaction is analysed on an SDS-
polyacrylamide gel.
2.28 - SDS-polyacrylamide gel electrophoresis
SDS-polyacrylamide gels were used to separate mixtures of proteins and compare migration
of individual polypeptides with the migration of molecular weight standards. A Bio-Rad
Protean II mini gel apparatus was used. The glass plates were assembled in the gel former
and the resolving gel poured. 5 ml of 12% resolving gel contained 1.6 ml of dH20, 2.0 ml of
30% acrylamide mix (Severn Biotech, Kidderminster, UK), 1.3 ml of 1.5 M Tris (pH 8.8),
0.05 ml of 10% SDS, 0.05 ml of freshly prepared 10% ammonium persulfate and 2 pi
79
TEMED (Gibco BRL). Approximately 1 ml of TE-saturated butanol was layered on top of
the resolving gel solution. This was immiscible with the gel solution and so remained on
top causing the gel to set straight and also prevented oxygen from diffusing into the gel and
inhibiting polymerisation. After the resolving gel had set (45 minutes) the butanol was
discarded and the top of the gel washed in water and dried with a paper towel. A comb was
placed above the resolving gel and the stacking gel poured around the comb. 2 ml of
stacking gel contained 1.4 ml of dH20, 0.33 ml of 30% acrylamide mix, 0.25 ml of 1.0M
Tris-HCl (pH 6.8), 0.02 ml of 10% SDS, 0.02 ml of freshly prepared 10% ammonium
persulfate and 2 pi TEMED. The stacking gel was allowed to set for approximately 30
minutes before the comb was removed and the wells rinsed with dH20 to remove any
unpolymerised acrylamide. The gel was mounted in the electrophoresis apparatus and tri-
glycine buffer added to the top and bottom reservoirs. Tris-glycine buffer is made by
diluting a 5x stock solution in dH20. The 5x stock is prepared by dissolving 15.1 g of Tris
base and 94 g of glycine in 900 ml dH20, adding 50 ml of 10% (w/v) electrophoresis-grade
SDS and adjusting the volume to 1000 ml with dH20. Samples are prepared by mixing them
with an equal volume of 2x SDS-loading buffer and heating for 3 minutes in a boiling water
bath. 2x SDS-loading buffer contains 100 mM Tris-HCl (pH 6.8), 100 mM dithiothreitol,
4% SDS, 0.2% bromophenol blue and 20% glycerol. Samples are loaded into the bottom of
the wells. The electrophoresis apparatus is connected to a power supply and a voltage of
200 volts applied to the gel for 55 minutes (mini-gels).
2.29 - Co-immunoprecipitation
The Matchmaker Co-IP kit (Clontech) was used to co-immunoprecipitate in vitro translated
epitope-tagged RPGR and RPGRIP proteins. The T7 promoter and c-myc epitope tag were
introduced upstream of the RPGR cDNA by amplifying the pASl.RPGR insert from the
yeast two-hybrid bait construct by PCR using the DNA-binding domain primers supplied
with the kit (the first underlined portion is the T7 promoter, the translation initiation codon
is in bold and the second underlined portion encodes the c-myc epitope tag):




DNA-BD reverse Co-IP primer
5 '-TACCTGAGAAAGCAACCTGACCTACAGG-3'
The T7 promoter and haemagglutinin (HA) epitope tag were introduced ustream of the
hRPGRIP cDNA by amplifying the pACTII.RPGRIP insert from the yeast two-hybrid prey
construct using the activation domain primers supplied with the kit (the first underlined
portion is the T7 promoter, in bold is the translation initiation codon, the second underlined
portion encodes the HA epitope tag):




AD reverse Co-IP primer
S'-ACTTGCGGGGTrTTTCAGTATCTACGAT-S'
The forward primers anneal to the plasmids at the multiple cloning site, i.e. between the
GAL4 domain-coding sequence and the RPGR/RPGRIP coding sequence. This means that
only the bait/library proteins are translated and not the GAL4 domains.
PCR mixes were made up with the following components:
36.25 pi dH20
5 ju.1 1 Ox Expand HiFidelity PCR buffer (Boehringer Mannheim)
1 pi DNA template (100 ng/pl)
1 pi DNA-BD/AD forward Co-IP primer (10 pM)
1 pi DNA-BD/AD reverse Co-IP primer (10 pM)
5 pi dNTP mix (2 mM each)
0.75 pi Expand HiFidelity Polymerase mix (Boehringer Mannheim).
The reactions were run in a MJ Research PTC-200 Peltier thermal cycler using the
following program: 94°C for 1 minute; 2 cycles of 94°C for 15 seconds, 72°C for 5 minutes;
2 cycles of 94°C for 15 seconds, 70°C for 5 minutes; 21 cycles of 94°C for 15 seconds, 68°C
for 5 minutes; then 68°C for 7 minutes.
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5 pi of the reaction was analysed by electrophoresis on a 1.2% agarose gel containing 1
mg/ml ethidium bromide. The remaining 45 pi was purified by phenol-chloroform
extraction.
The purified PCR products were used with the TnT Quick Coupled
Transcription/Translation System (Promega) to prepare [35S] methionine-labelled proteins
(see section 2.27).
To perform the co-immunoprecipitation, 5 pi in vitro translated bait protein
(RJPGR) was mixed with 5 pi in vitro translated library protein (RPGRIP) in a 1.5 ml
microcentrifuge tube. These were mixed gently with a pipette and incubated at 30°C for 1
hour with occasional mixing. 470 pi co-immunoprecipitation buffer was added (20 mM
Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 5 pg/ml aprotinin, 0.5 mM PMSF, 0.1%
Tween 20) and then 10 pi protein-G agarose beads (a 50% slurry in Tris buffered saline
containing 0.1% Tween 20; Clontech) and 10 pi c-myc monoclonal antibody (mouse IgG,
0.1 pg/pl; Clontech) or 10 pi HA polyclonal antibody (affinity purified rabbit Ig, 0.1 pg/pl;
Clontech). The tube was incubated at 4°C for 2 hours with continuous rocking. The tube
was centrifuged at 14,000 rpm for 1 minute and the supernatant discarded. 0.5 ml Tris
buffered saline containing 0.1% Tween 20 was added (20 mM Tris-HCl pH 7.5, 150 mM
NaCl, 0.1% Tween 20) and the tube agitated gently. The tube was centrifuged again and the
supernatant discarded. The protein-G agarose beads were washed three times in this way.
After the third wash the supernatant was discarded and the beads resuspended in 15 pi SDS-
loading buffer (100 mM Tris-HCl pH 6.8, 100 mM dithiothreitol, 4% SDS, 0.2%
bromophenol blue and 20% glycerol). The samples were eluted and denatured by heating to
80°C for 5 minutes. The tube was placed on ice and then centrifuged brielfy. 10 pi of the
supernatant was loaded onto a sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) minigel. Following electrophoresis the gel was transfered to a tray containing
gel fixation solution (20% methanol, 10% acetic acid) and placed on a rotary shaker for 10
minutes at room temperature. The solution was replaced with fresh solution and the gel
soaked for 30 minutes. The gel was rinsed in dH20 and then soaked in Amplify
Fluorographic Reagent (Amersham Pharmacia Biotech) on a rotary shaker for 20 minutes at
room temperature. The gel was then placed onto pre-wetted Whatman 3MM paper, covered
with Saran wrap and dried for 1 hour at 80°C under constant vacuum in a Bio-Rad model
583 gel dryer. The dried gel was exposed to Biomax X-ray film (Kodak) overnight and the
film developed in a Fuji RGII X-ray film processor.
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2.30 - Mutation screening
Frozen lymphoblastoid cell lines from the three affected individuals (BB13, BB15 and
BB39) were thawed and re-established by Alan Lennon (MRC Human Genetics Unit).
Total RNA was purified from cell pellets and used to amplify RPGRIP cDNA (in two
overlapping fragments) by RT-PCR. Two rounds of PCR using nested or hemi-nested
primers were required to amplify the RPGRIP cDNA using the following oligonucleotides





26Fwd and 19 Rev (first round)
-6Fwd and RG32 Long Rev (second round)
-6Fwd and 19Rev (first round)
-6Fwd and RG32 Long Rev (second round)
-6Fwd and 44Rev (first round)
-6Fwd and 19Rev (second round)
1153 Fwd and Stop+36 (first round)
1153Fwd and Stop+6 (second round).
Sequence changes detected in the patient RPGRIP cDNAs were inspected at the genomic
level by PCR-amplifying and sequencing fragments of genomic DNA in the region of the
changes using the primers detailed in Table 2.2.
Table 2.2: PCR primers used to amplify and sequence RPGRIP genomic DNA in the regions
of variations from wild-type detected in RPGRIP RT-PCR products (primer sequences given
in Table 2.1).
DNA
Primers used to amplify RPGRIP Primer used to sequence genomic PCR
genomic DNA product
869 Fwd and Intron 5 Rev 869 Fwd
BB13 Intron 5 Fwd and 962Rev Intron 5 Fwd
Intron 3 Fwd and 670 Rev Intron 3 Fwd
869 Fwd and Intron 5 Rev 869 Fwd
BB15 Intron 5 Fwd and 962Rev Intron 5 Fwd
Intron 3 Fwd and 670 Rev Intron 3 Fwd
BB39
686 Fwd and Intron 4 Rev; Intron 4 Fwd
and 845 Rev 686Fwd, Intron 4 Rev and Intron-4 Fwd
1048 Fwd and Intron 6 Rev Intron 6 Rev
83
CHAPTER THREE
THE YEAST TWO-HYBRID SYSTEM
3.1 - INTRODUCTION
The yeast two-hybrid system (Fields, and Song, 1989; Chien et 1991) allows the
identification of interacting partners for a gene of interest by exploiting the modular nature of
transcription factors. Two potential interacting proteins are expressed in S. cerevisiae, one of
which contains the protein of interest ("bait", X) fused to the DNA-binding domain (BD) of a
yeast transcription factor such as GAL4, while the other ("prey", Y) is fused to the
corresponding activation domain (AD). Binding of the bait to an interacting partner leads to
the restoration of a functional transcription factor, which activates the GALA upstream
activation sequence (UAS) and downstream reporter genes such as HIS3 and lacZ (Figure
3.1).
GAL4 UAS HIS3/LacZ reporter gene
Figure 3.1: Schematic representation of the yeast two hybrid system. A: A fusion protein
consisting of the GAL4 DNA-binding domain (BD) and protein 'X' occupies the GAL4 UAS.
Protein 'Y' interacts with 'X' and brings the GAL4 activation domain (AD) into contact with BD,
so restoring a functional transcription factor. This leads to transcription of the HIS3 and LacZ
reporter genes. B: Protein 'X' does not interact with protein 'Y', the GAL4 transcription factor
components are kept separate and the reporter genes are not transcribed.
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A variation of this is the yeast one-hybrid system, which allows expression libraries to be
screened for proteins that directly interact with DNA target sequences. Yeast cells are
transfected with 2 plasmids, the first of which consists of the transcription factor activation
domain cDNA fused to the cDNA library insert. The second contains the DNA binding site
under investigation plus the GAL1 promoter in front of the HIS3 gene. Binding of the
protein encoded by the library plasmid to the DNA target sequence under investigation then
leads to the initiation of HIS3 reporter gene expression (Li and Herskowitz, 1993). The
reverse two-hybrid and one-hybrid systems are also modifications of the two-hybrid system,
whereby maintenance of an interaction between two proteins, or between a DNA binding
protein and its target sequence, is deleterious to growth. These are used to identify mutations
or additional molecules that disrupt interactions between two proteins or a DNA-binding
protein and its target sequence (Vidal et al., 1996).
The GAL4 yeast transcriptional activator is composed of two physically separable,
functionally independent domains: a DNA-binding domain and a transcriptional activation
domain (Keegan, Gill and Ptashne, 1986; Hope and Struhl, 1986; Ma, and Ptashne, 1987).
The DNA-binding domain recognises and binds to upstream activating sequences (UAS),
and the transcriptional activation domain interacts with other components of the transcription
machinery required to initiate transcription. In yeast, UASs comprise one type of czs-acting
transcription element. They are recognised by specific transcriptional activators and enhance
transcription from adjacent downstream TATA boxes. An example of this is found in the
control of galactose metabolism, which is controlled by the GAL4 and GAL80 proteins, and
the carbon source in the growth medium (Guthrie and Fink, 1991). When galactose is
present, the GAL4 protein binds to GAL4-responsive elements in the UAS upstream of
several genes involved in galactose metabolism, including GAL1, and activates transcription.
In the absence of galactose, the GAL80 protein binds to GAL4 and blocks transcriptional
activation. In the presence of glucose, transcription of the galactose genes is immediately
repressed (Johnston, Flick and Pexton, 1994). All of the UASs of the 20 known galactose-
responsive genes contain one or more conserved palindromic sequences to which the GAL4
protein binds (Giniger, Varnum, and Ptashne, 1985). These are 17-mers and function in an
additive way, that is, the occupancy of more sites leads to higher levels of transcription
(Giniger, and Ptashne, 1988).
In the yeast two-hybrid system used in this study, two potentially-interacting
proteins are expressed in S. cerevisiae strain Y190 from the pASl and pACTII cloning
vectors. One of the proteins is fused to the GAL4 DNA-binding domain (bait; pASl), and
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the other is fused to the GAL4 transcriptional activation domain (prey; pACTII). The
recombinant hybrid proteins are targeted to the nucleus; for the pASl fusion protein the
nuclear localisation signal is an intrinsic part of the GAL4 DNA-binding domain (Silver,
Keegan, and Ptashne, 1984) whereas the pACTII fusion protein uses the SV40 large T
antigen nuclear localisation signal. If the proteins interact, the DNA-binding domain will be
tethered to the transcriptional activation domain. The GAL4 transcriptional activator will
thus be reconstituted and will activate transcription of the lacZ and HIS3 reporter genes. In
GAL4 yeast two-hybrid systems, the native GAL J UAS or a synthetic UASG 17-mer
consensus sequence provides the binding sites for the GAL4 DNA binding domain. The
lacZ and HIS3 reporter genes of Y190 have been engineered to utilise the GAL J UAS. The
Y190 yeast strain also has deletions of endogenous gal4 and gal80 genes to prevent
interference with two-hybrid system constructs and to prevent glucose repression of reporter
gene activity.
The Y190 HIS3 reporter gene is under the control of the GAL1 UAS and a minimal
promoter containing two TATA boxes from the promoter of the native yeast HIS3 gene.
One of the TATA boxes, referred to as Tc, drives low-level constitutive expression of the
HIS3 gene (Mahadevan, and Struhl, 1990). A positive two-hybrid interaction will induce
high-level expression because of binding to the GAL1 UAS. However, in the absence of an
interaction a significant level of HIS3 expression is promoted by the Tc TATA box. To
overcomes this residual HIS3 expression, cells must be grown in the presence of 3-
aminotriazole (3-AT) a chemical inhibitor of the HIS3 gene product (Durfee et al., 1993).
Expression of the fusion proteins in yeast is driven by the ADH1 promoter.
Expression is high for most of the logarithmic growth phase of the host cells, but is repressed
late in the logarithmic phase by the ethanol that accumulates in the growth medium
(Ammerer, 1983). The pACTII and pGADIO vectors contain a truncated ADH1 promoter,
which is capable only of driving much lower levels of expression (Ruohonen, Aalto, and
Keranen, 1995). In pACTII however, a portion ofDNA from pBR322 coincidentally acts as
a transcriptional enhancer and produces strong constitutive expression (Tomow and
Santangelo, 1990).
3.2 - ALTERNATIVE APPLICATIONS OF THE YEAST TWO-HYBRID SYSTEM
The yeast two-hybrid system can firstly be used to test specific candidate proteins for an
ability to interact with the protein of interest. The candidates may be chosen on the basis of
physiological experiments, biochemical or genetic data, sequence similarity, or other criteria.
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A second approach is to use the yeast two-hybrid system to screen entire cDNA libraries for
interacting proteins. Here, the principal choice concerns the tissue source of the library
being screened (for example, to search for interacting partners for a human retinal protein the
best library would be produced from human retina RNA). Two-hybrid libraries are
constructed in the activation domain plasmid (rather than the DNA binding domain plasmid)
because of the abundance of sequences capable of activating transcription when fused to a
DNA binding domain (Ma, and Ptashne, 1987). In this project, the yeast two-hybrid system
was used both to assess the ability of candidate proteins to interact with RPGR and to screen
cDNA libraries for RPGR-interactors.
3.3 - CANDIDATE RPGR-INTERACTING PROTEINS
At the start of this project, little was known about the function of the RPGR protein. The
only clues as to the cellular role ofRPGR came from expression studies, sequence homology
searches and the nature of the XLRP disease process itself. As described in Chapter 1, the
retina contains a large number of diverse proteins capable of causing a retinitis pigmentosa
phenotype when mutated. On the basis of the clinical phenotype, the RPGR protein could be
involved in many different cellular processes in the retina. Alternatively, it could be a
component of an as yet unidentified pathway. Expression studies have indicated that the
RPGR gene is expressed in all of the tissues examined yet the disease only affects the retina
(Meindl et al., 1996). It is possible that the role ofRPGR in the retina is distinct from other
tissues, and that it interacts with a protein that is retina-specific. In non-retinal tissues, there
may be a related protein that compensates for the mutant RPGR in XLRP patients. This is
speculation however, and the expression pattern tells us little about the function of RPGR.
The most salient feature of the DNA sequence is the RCC1-homologous domain spanning
exons 2 to 10. The candidate proteins that were tested for an ability to interact with RPGR
were chosen on the basis of this homology, and included Ran, ARF1 and Clathrin heavy
chain.
3.3.1 - Ran
Ran (Ras-related nuclear protein) is a small GTPase for which RCC1 acts as a guanine
nucleotide exchange factor (Bischoff and Ponstingl, 1991). The structural similarity between
the RPGR N-terminal domain and RCC1 (Renault et al., 1998) led to the proposal that this
RPGR domain also interacts with Ran.
87
Ran is a 25 kDa protein consisting of .216 amino acids and is a member of the Ras
superfamily of small GTP-binding proteins. It was originally isolated by screening a human
cDNA library for sequences related to the Ras family (Drivas et 1990). Homologues of
human Ran have been identified in mammals, birds, Drosophila, Caenorhabditis elegans,
plants, Plasmodium falciparum, Dicytostelium discoideum, Giardia lamblia,
Schizosaccharomyces pombe and Saccharomyces cervisiae (Bischoff et al., 1996). They are
all located predominantly in the nucleus and share a unique, highly acidic (DEDDDL)
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^ Importin p subunitCargo protein containing anuclear localisation signal
Figure 3.2: A model showing the involvement of Ran and RCC1 in NLS-mediated protein
import. Steps 1 to 9 as follows: 1, formation of an import complex comprising importin a,
importin p and the transport substrate ; 2, docking of the transport complex on the nuclear
pore complex; 3, Ran- and energy-dependent translocation of the complex across the nuclear
pore; 4, Ran-GTP binding to importin p and dissociation of transport complex; 5, export of
importin p/Ran-GTP to the cytosol; 6, Ran-GTP hydrolysis, stimulated by RanBPI and
RanBP2-bound RanGAPI, and consequent dissociation of Ran-GDP from importin p; 7,
Binding of Ran-GTP and CAS to importin a; 8, export of Ran-GTP/CAS/ importin a complex;
9, Ran-GTP hydrolysis, stimulated by RanBPI and RanBP2-bound RanGAPI, and
consequent dissociation of the Ran-GTP/CAS/ importin a complex; 10, Ran-GDP import; and
11, RCC1-dependent regeneration of Ran-GTP from Ran-GDP (Kohler, et al. 1999).
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Ran has been implicated in various nuclear processes, including RNA metabolism, DNA
replication and chromosome condensation and decondensation. However, most of the
experimental data concerns its involvement in the organisation of microtubule structures
during M phase of the cell cycle (reviewed by Kahana and Cleveland, 1999; Desai and
Hyman, 1999; Nishimoto, 1999) and in the nucleocytoplasmic trafficking of proteins and
RNA (reviewed by Moore, 1998; Kahana and Cleveland, 1999; Yoneda et al., 1999), the
latter being the better understood. The distributions of Ran-GTP and Ran-GDP in the cell,
and the compartmentalisation of the GEF and GTPase Activating Protein (GAP) that
generate them, are thought to underlie the directional nature of nuclear transport. RCC1,
which promotes the formation of Ran-GTP, is localised to the nucleus while RanGAP 1 and
Ran-Binding Protein 1, which enhance the GTP hydrolysis activity of Ran, are exclusively
cytoplasmic. Ran is found throughout the cell. Thus, there is an excess of Ran-GTP in the
nucleus and Ran-GDP in the cytoplasm. Typically, Ran-GTP interacts with nuclear export
receptors and guides transport of their cargoes to the cytoplasm and binds to import factors
and causes dissociation of imported transport complexes and Ran-GDP associates with
nuclear import receptors and directs movement into the nucleus (see Kahana and Cleveland,
1999). Figure 3.2 shows a simplified model ofRan-regulated nuclear protein import.
3.3.2 - ARF1
The ADP-ribosylation factor (ARF) family is the most divergent member of the Ras
superfamily and consists of the ARF proteins and the ARF-like proteins (Kahn, 1996). The
ARF proteins are essential components of a number of different vesicular trafficking
pathways in eukaryotic cells and activators of specific forms of phospholipase D. Proteins
were previously designated as ARF if they had the ability to (i) stimulate the ADP-
ribosyltransferase activity of the cholera toxin A subunit and (ii) rescue Saccharomyces
cerevisiae mutants with the double deletion ofARF1 and ARF2 genes (Moss and Vaughan,
1998). The ARF-like proteins are structurally similar to the ARF proteins and were initially
thought to lack these ARF activities, although it has subsequently been shown that, under
suitable conditions, this is not always the case (Hong et al., 1998).
The mammalian ARF proteins are divided into three classes on the basis of sequence
comparison. Class I consists ofARF1-ARF3 and is the best understood category. The Class
I ARFs, which seem to be functionally redundant, regulate the assembly of several types of
vesicle coat found at discrete steps in intracellular membrane transport (Roth, 1999). ARF1
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is necessary for the formation of COP1 vesicles vitro (Rothman and Wieland, 1996) and
certain clathrin-coated vesicles both on endosomes and at the Golgi network (Stamnes
and Rothman, 1993). ARF1, like other members of the Ras superfamily, cycles between
active GTP-bound and inactive GDP-bound forms. The conformational change that is
induced by GDP/GTP exchange is coupled to membrane-binding through the ARF1 N-
myristoyl moiety. Active ARF1-GTP is, thus, bound to intracellular membranes, and
inactive ARF1-GDP is cytosolic (Goldberg 1998) (shown schematically in Figure 3.3).
Exchange ofGDP for GTP (and activation ofARF) is promoted by ARF GEFs, the majority
ofwhich contain the 200 amino acid Sec7 domain (Morinaga, et al., 1997). RPGR lacks this
domain. The functions ofARFs 4 and 5, which make up class II, are not known. ARF6, the
least conserved of the human ARFs, constitutes class IE and has been implicated in the
regulation ofmembrane trafficking and remodelling of the plasma membrane and underlying
cytoskeleton (Roth, 1999).
ARF1 interacts with the protein p532 (Rosa et ah, 1996a; Rosa et ah, 1996b), which
was identified as a candidate RPGR-interactor because, like RPGR, p532 contains domains
that are homologous to RCC1: RCCl-like domain 1 (RLD-1) and RCCl-like domain 2
(RLD-2). RLD1 shares 30% identity with RCC1 and 51% similarity (at the protein level);
RLD2 shares 29% identity with RCC1 and 49% similarity. RLD-2 binds to ARF 1 and RLD-
1 stimulates its guanine nucleotide exchange activity.
Figure 3.3: ARF1-GTP, generated by ARF1-specific GEFs, is the active form and
membrane-bound. Inactive ARF1-GDP is cytosolic and is generated by ARF1-specific GAPs




3.3.3 - Clathrin Heavy Chain
A third candidate interacting protein is the Clathrin heavy chain. This was selected as a
candidate interactor because it was identified in a yeast two-hybrid screen for proteins that
interact with the carboxy-terminal p532 RCCl-like domain (RLD-2) (Rosa and Barbacid,
1997). Clathrins are triskelion structures composed of three non-covalently bound heavy
chains and 3 light chains, and are located on the cytoplasmic face of coated vesicles and
coated pits. These intracellular organelles, of which clathrins constitute a major component,
play a role in endocytosis and Golgi sorting (Robinson et al., 1996).
Clathrin-mediated endocytosis is a means of efficiently retrieving proteins from the
plasma membrane (reviewed by McMahon, 1999). This is important at presynaptic nerve
terminals and in many cellular processes, including nutrient uptake and antigen presentation,
and is a means of virus entry into cells. Three classes of proteins are known to contribute to
the clathrin coat: transmembrane receptors, adaptor protein complexes and clathrin triskelia.
Transmembrane proteins (for example, receptors for extracellular ligands) have, in most
cases, internalisation motifs in the cytoplasmic domain that are recognised by the AP-2
adaptor complex proteins (or AP-1 at the tram-Golgi network), to which they become
bound. This binding is followed by the recruitment of soluble clathrin from the cytoplasm,
which also binds to adaptor complex proteins. The clathrin triskelia polymerise, under the
influence of the adaptor protein complex, to form a cage-like structure that encloses the
membrane vesicle. A lattice of pentagons and hexagons is formed by the polymerised
clathrin and this induces curvature in the cage, so allowing membrane invagination. Another
component of this pathway is the GTPase dynamin, which is required for coated pits to pinch
off from the donor membrane as coated vesicles.
3.4 - TESTING CANDIDATES
Prior to the identification of a mutation hot-spot in RPGR exon ORF15, the majority of
RPGR mutations associated with XLRP were clustered in the RCC1 -like domain, suggesting
that this is a functionally important domain. The yeast two-hybrid bait construct was
therefore made to contain the first 12 exons of RPGR, which includes the whole of this
RCC 1 -like domain.
Human RPGR exons 1-12, encoding amino acids 1 to 502, were amplified as a
single fragment from an adult brain cDNA library. Ran and ARF1 were amplified from a
human testis cDNA library (using the polymerase chain reaction). The primers used to
91
amplify these sequences (RPGRATGNcol, Exonl2BamHI, RanNcol, RanStopBamHI,
ARFlATGNcol, and ARFStopBamHI) had non-annealing 5' ends encoding restriction
endonuclease cleavage sites (see Materials and Methods, page 58). These primer restriction
sites facilitated the subcloning of the PCR products into the yeast two-hybrid vectors as
Ncol/BamRl fragments. The positioning of the restriction sites also ensured that the reading
frame of each subcloned sequence was the same as the vector sequence encoding the GAL4
domain. All constructs were sequenced to ensure that errors had not been incorporated
during the amplification reactions. The clathrin heavy chain construct, in the pGAD-GH
GAL4 activation domain vector (van Aelst et al., 1993), and the p532 RLD2 constmct, in the
pGBT9 GAL4 DNA binding domain vector (Bartel et al., 1993a), were donated by Dr
J.L.Rosa (University of Barcelona). Both of these two-hybrid vectors are compatible with
the pAS2/pACTII system.
Competent Y190 cells were transfected with aliquots of the yeast two-hybrid system
constructs and plated onto SC medium containing 3-AT, and lacking leucine, tryptophan and
histidine. HIS3+ colonies were tested for P-galactosidase activity.
Each of the three candidates was tested for an interaction with RPGR both as a
fusion with the GAL4 DNA-binding domain and with the activation domain. This was done
because certain interactions activate transcription more efficiently in one orientation (in
terms of which protein is fused to which GAL4 moiety) than the other (Fields and
Sternglanz, 1994).
3.4.1 - Positive Controls
The yeast proteins SNF1 and SNF4 are known to interact in the yeast two-hybrid system
(Fields and Song, 1989). SNF1 is a serine-threonine-specific protein kinase, and SNF4 is a
protein that is physically associated with SNF1 and required for its maximal activity. The
genes encoding SNF1 and SNF4 in the pASl and pACTII vectors respectively (obtained
from Mhairi Wallace, MRC Human Genetics Unit, Edinburgh) were transfected into the
Y190 yeast strain as a control for a positive interaction. RPGR is known to interact with the
cyclic GMP phosphodiesterase delta subunit (PDE8) (Linari et al., 1999). PDE8 was
amplified by PCR from a human pancreas cDNA library using the primers PDEdNcol and
PDEdBamHI (see Materials and Methods, page 59). It was cloned into the pACTII vector
and transfected with the RPGR bait plasmid into Y190. The interaction reported by Linari et
al., (1999) was verified here and provided a control for a positive interaction with RPGR.
As another positive control, an aliquot of competent Y190 cells was transfected with yeast
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two-hybrid bait and prey vectors containing the carboxy-terminal p532 RCCl-like domain
and Clathrin heavy chain (CHC) respectively. The resulting transformants functioned as a
positive control for a p532 (RLD2)-CHC interaction. RCC1 was amplified by PCR from a
human testis cDNA library using the RCClATGNcol and RCC1StopBamHI primers (see
Materials and Methods, page 59) and cloned into the pACTII vector. It was transfected into
Y190 with Ran (in the pACTII vector) and served as a positive control for an interaction
involving Ran.
For each positive control, the yeast transformants were plated onto synthetic
complete media lacking leucine, tryptophan and histidine and HIS3+ colonies were assayed
for P-galactosidase activity.
3.4.2 - Negative controls
Aliquots of competent Y190 yeast cells were separately transfected with each of the bait and
prey constructs used in these experiments (pAS 1 RPGRN terminal domam, pGBT9.p532RLD2,
pASl.SNFl, pASLRCCl, pACTII.Ran, pACTII.ARFl, pGAD-GH.Clathrin heavy chain,
pACTII.PDES or pACTII.SNF4) and also with empty two-hybrid vectors (pASl and
pACTII). The yeast were spread onto media selective for the particular plasmid (i.e.
synthetic complete media lacking tryptophan or leucine) and for HIS3 expression (therefore
also lacking histidine). This was carried out to determine whether any of the plasmids in
isolation activated the Y190 reporter genes and provided a series of negative controls for
each of the yeast two-hybrid constructs and for the vector backbones.
3.4.3 - Results
None of the candidate proteins (Ran, ARF1, Clathrin heavy chain) were found to interact
with human RPGR in the yeast two-hybrid system. Only three of the four positive controls
gave positive results: SNF1/SNF4, RPGRN-terminal domain/PDE8 and p532RLD2/Clathrin heavy
chain. Yeast containing the Ran and RCC1 constructs failed to grow on the selective media
and produce HIS3+, LacZ colonies. Each of the negative control transformations described
in section 3.4.2 produced negative results (with no viable yeast cells growing on the selective
media). These results are summarised in Table 3.1.
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Table 3.1: Results of screening candidate RPGR-interactor proteins against the RPGRN"te*mirial
d°main



























p^g ^ j^pQj^N-terminal domain pACTII.Ran Negative
p^g j j^pQj^N-terminal domain pACTII.ARF1 Negative
* c
w u p^g y j^jpQ.j^N-terminal domain pGAD-GH.Clathrin heavy chain Negative
p^g y j^pQj^N-terminal domain pACTII.PDES Positive
pGBT9.p532RLD2 pGAD-GH.Clathrin heavy chain Positive
II pASl.RCCl PACTII.Ran Negative
J? °CU O pASl.SNFl pACTII.SNF4 Positive
3.5 - SCREENING A HUMAN PANCREAS LIBRARY
At the start of this project, yeast two-hybrid libraries of retinal origin were unavailable.
However, RPGR is ubiquitously expressed and a northern blot of human tissues probed with
a radiolabeled 3' RPGR cDNA fragment indicated strong expression in the pancreas, and
undetectable expression in retina, suggesting that interacting partners could be identified in
this tissue. For this reason, a human pancreas cDNA library, cloned into the GAL4 vector
pGAD 10, was purchased from Clontech Laboratories Inc. The pGAD 10 vector is similar to
the pACTII vector and is compatible with the pASl vector with which it was used in the
screens. The two vectors differ in the level of expression of the fusion protein: pACTII
directs high levels of expression, whereas pGADIO directs relatively low levels of
expression. The human pancreas library contains 2 x 106 independent clones. The library
culture supplied by the manufacturer was amplified and used to prepare DNA.
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The RPGR RCC1 -homologous domain in the pAS 1 vector was used to screen the library.
Approximately 3 x 106 clones were screened by transfecting the library and the RPGR bait
into the Y190 yeast strain and plating onto synthetic complete medium lacking histidine,
tryptophan and leucine but containing 25 mM 3-aminotriazole. From these yeast
transformation plates, 115 putative positive colonies were identified on the basis of their
histidine prototrophy. These colonies were tested for LacZ expression using the P-
galacotosidase assay, which reduced the number of putative positive colonies from 115 to 13
(HIS3+, LacZt"). Library plasmids were recovered from the yeast colonies and re-tested for
an interaction with RPGR by transfecting them individually into Y190 along with the RPGR
bait. This time none of the 13 clones displayed histidine prototrophy or P-galactosidase
activity, suggesting that they were all false-positives. Four of the 13 plasmids (31%) were
subsequently found to lack cDNA inserts. The inserts from the remaining nine plasmids
were sequenced and used to search the databases for identical clones. They were found to
correspond to human pancreatic trypsin (accession number M22612), human dipeptidase
(D13138), human chymotrypsinogen (M24400), human islet of Langerhans regenerating
protein (Ml8963), human glypican 3 (AF003529), an EST similar to ribosomal protein S3a
(M84711), two chromosome 7 sequence tagged sites (STS) (G31665 and G20212) and an
uncharacterised EST (AA630545). This unacceptably high rate of false positives suggested
that a change of cDNA library was required.
3.6 - SCREENING A BOVINE RETINA LIBRARY.
A second yeast two-hybrid library was obtained from Dr W. Baehr (Moran Eye Center,
University of Utah Health Center, Salt Lake City). This library had been constructed by
Clontech in the pGADIO vector using bovine retina RNA. The library was amplified and
used to prepare DNA which was then screened in the same way as the human pancreas
library. Approximately 1.28 x 106 cDNA clones were screened with human RPGR in pASl.
300 colonies were selected from the transformation plates on the basis of their histidine
prototrophy and 72 of these putative positives subsequently gave positive results in the P-
galactosidase assay. The library plasmids were isolated from the 72 colonies and re-tested in
individual transfections. Each of the 72 gave a very weak positive result (i.e. few HIS3+
colonies and a faint, slow-developing blue colour upon testing for P-galactosidase activity,
relative to the SNF1/SNF4 positive control). 14 of the 72 plasmids were found to have no
insert (19%). Common sequences were sought among the remaining 58 plasmids by PCR-
amplifying the cDNA inserts (using the pGADlOF and pGADlOR primers) and then cutting
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the products with the restriction endonuclease Alul (which is expected to cut human DNA
once every 0.3 kb (Sambrook, Fritsch and Maniatis, 1989)). None of the 58 plasmid inserts
gave the same restriction pattern, suggesting that they represented different clones. Firstly, it
is unlikely that RPGR interacts with 58 different proteins (although it is possible that they
might be different parts of the same protein). Secondly, the high rate of empty vectors
weakened the argument that they were true positives. Finally, both the empty vectors and
those containing inserts only showed a weak blue colour in the (3-galactosidase assay, so that
there was no qualitative difference between the vectors with and without inserts. No further
work was done on these clones since they also appeared to be false-positives.
3.7 - SCREENING A SECOND BOVINE RETINA LIBRARY - ISOLATION OF
RPGRIP
A second bovine retina yeast two-hybrid library was obtained from Dr C. Sung (Department
of Ophthalmology, Cornell University Medical College). This library contained 2 x 106
independent clones in the pACTII vector and had been used successfully by others (Kumar et
al., 1996).
The library was electroporated into DH10B cells and the transformants amplified
and used to prepare DNA. It was screened using the same human RPGR bait as before and
an estimated 2 x 106 clones were screened, as calculated from the transformation control
plates. 32 colonies were selected from the SC-leu/-trp/-his 3-AT medium on the basis of
their histidine prototrophy. Ten of the 32 colonies gave a strong positive result in the P-
galactosidase assay (a vivid, rapidly-developing blue colour - comparable to the SNF1/SNF4
positive control). Library plasmids were isolated from 8 of the 10 yeast colonies (it was not
possible to recover plasmids from the other 2) and re-tested for their ability to interact with
RPGR. All of the 8 colonies gave positive results although one was much weaker than the
rest (fewer HIS3+ colonies, and a faint blue colour). The inserts from the 7 plasmids that
produced strong positive results were partially sequenced using the pACTinsF primer. One
colony was found to contain multiple plasmids; the other 6 contained single plasmids each
with a cDNA insert corresponding to the same transcript. The insert sizes were estimated by
PCR-amplifying the inserts (using the pACTinsF and pACTinsREV3 primers) and
comparing the products to DNA size markers. Five of the inserts were found to be
approximately 760 bp in length and one was approximately 740 bp. One of the longer clones
was sequenced fully and revealed a 782 bp insert consisting of a 678 bp open reading frame
followed by a 78 bp polyadenine tract 3' to the in-frame stop codon. A potential
96
polyadenylation tract (TATAAA (Graber et al., 1999)) was found 18 bp upstream of the




























Figure 3.4: Sequence of the RPGR-interacting clone isolated from a bovine retina yeast two-
hybrid library. Translation of the open reading frame is shown and the in-frame stop codon
shown in bold. A potential polyadenylation signal is underlined.
One of the positive clones was tested for the ability to activate the Y190 reporter genes in the
absence of a second (bait) plasmid and also for the ability to interact with RCC1, Ran and
SNF1. The results of all these tests were negative, suggesting that the original positive result
was dependent on and specific to RPGR.
A search of the EST databases for sequences similar to the bovine interactor
identified 10 human (r93221, ai964059, ai655818, ai632512, ai05922, aa782963, aw681763,
aa928161, aa476670 and w26173) and 8 mouse (aa204546, c80430, aal54084, ai451895,
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av258740, aw050180, aa208719, avl55762) sequences, all previously uncharacterised,
containing 86% (human) and 76% (mouse) nucleotide identity to the bovine sequence. The
IMAGE EST clone r93221, which showed homology to the 5' end of the bovine interactor,
was obtained from the MRC HGMP resource centre (MRC HGMP RC). The cDNA insert
of this clone was sequenced, which revealed homology to the bovine clone extending as far
as the stop codon. The mouse ESTs corresponded only to the 3' end of the bovine and
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Figure 3.5: CLUSTAL W alignment (Thompson 1994) of the translations of the
human, bovine and (partial) mouse RPGR-interactor sequences (* = single, fully conserved
residue,: = conservation of strong groups, . = conservation of weak groups, blank space =
no consensus).
The open reading frame of the r93221 human EST, from the first ATG triplet to the stop
codon, was PCR-amplified using primers r93221NcoI and r93221BamHI and subcloned into
the pACTII vector. This human construct was treated as a candidate RPGR-interactor using
the yeast two-hybrid system as described above. It was found to interact with human RPGR
but not with RCC1, Ran or SNF1, nor did it activate the Y190 reporter genes in the absence
of a bait construct (Figure 3.6).
This new RPGR-interacting protein was given the name RPGRIP (RPGR-Interacting
Protein). Human RPGRIP (hRPGRIP) was tested for the ability to interact with the C-
terminal portion of RPGR (encoded by exons 13 to 19), PDES and the small GTPase Rabl3.
It was of interest to determine whether RPGRIP interacted with PDE6 because this protein is
known to interact with RPGR (Linari et al.,1999). Rabl3 was tested because this had
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previously been shown to interact with PDE8 (Marzesco 1998). RPGR exons 13 to 19
were PCR amplified as a single fragment from an RPGR cDNA clone derived from an adult
brain cDNA library using the Exonl3NcoI and StopBamHI primers. The fragment was
subcloned into pASl. Rabl3 cDNA was PCR amplified from the pGADIO human pancreas
library using primers Rabl3NcoI and Rabl3BamHI and also subcloned into pASl.
Human RPGRIP did not activate the Y190 reporter genes in the absence of a second





Figure 3.6: A novel protein interacts with the RCC1-like domain of RPGR (RPGRN) in the
yeast two-hybrid system but does not interact with the C-terminal half of RPGR, RCC1 or an
unrelated protein (SNF1). Y190 yeast transformed with bait and prey constructs were plated
onto SC -leu/-trp to confirm transformation and SC-leu/-trp/-his/+3AT to test for interacting
proteins (pASIconstruct/pACTIIconstruct: hIP, human RPGRIP: bIP, bovine RPGRIP:
RPGR"0, RPGR C-terminal domain: RC, RCC1: S1, SNF1: S4, SNF4).
3.8 - TESTING RPGRIP FOR INTERACTION WITH MUTANT RPGR
CONSTRUCTS.
An experiment was carried out to determine whether the interaction between hRPGRIP and
RPGR is disrupted when point mutations associated with xlRP are present in the
coding sequence. Nine RPGR constructs were obtained from Dr. J. Becker (Max Planck
Institut furMolekulare Physiologie, Dortmund) in the pBTMl 16 two hybrid vector (Linari et
al., 1999). The plasmids contained RPGR cDNA from the start of exon 1 to the middle of
exon 10, encoding amino acids 1-392 (the RCCl-like domain of RPGR encompasses amino
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acids 39 to 365 ((Renault et al.,1998)). One of the constructs contained the wild-type
sequence, seven contained XLRP disease-associated mutations (G60V, H98Q,
F130C, G215V, P235S, C250R, and G275S) (Meindl 1996; Roepman et al., 1996) and
one contained a substitution that was found in a patient with X-linked congenital stationary
night blindness (V36F; T. Meitinger, personal communication). The inserts were cut out of
pBTMl 16 (which is used in lexA-based yeast two-hybrid systems) as fragments
and subcloned into pASl. The wild-type construct was also tested for an interaction with
hRPGRIP because the RPGR bait used in the library screen coded for the first 502 amino
acids whereas the constructs obtained from J. Becker coded for the first 392 amino acids.
The wild-type RPGR was found to interact with RPGRIP in the yeast two-hybrid
system but the mutants either showed absent (V36F, G60V, H98Q, F130C, P235S, C250R)
or slightly decreased (G215V, G275S) reporter gene activity (Figure 3.7). These results are
summarised in Table 3.2. All of the disease-causing mutations tested, with the exception of
F130C, alter residues of the RPGR RCCl-like domain that are conserved in vertebrates
(Renault et al, 1998), and are therefore likely to be important for correct folding and function
(shown in Figure 3.8).
Figure 3.7: Y190 yeast transformed with wild-type or mutant RPGR bait (in pAS1) and
RPGRIP prey (in pACTII) constructs were plated onto SC -leu/-trp to confirm transformation
and SC-leu/-trp/-his/+3AT to test for interacting proteins. This showed that RPGRIP interacts
with wild-type RPGR and with the G215V and G275S RPGR mutant proteins but does not
interact with other mutant proteins, including V36F, G60V, H98Q, F130C, P235S or C250R
RPGR. (SC-leu/-trp=synthetic complete medium lacking leucine and tryptophan, SC-leu/-trp/-
his/+3AT= synthetic complete medium containing 25mM 3-aminotriazole, lacking leucine,














Table 3.2: Summary of hRPGRIP interaction screens using wild-type and mutant RPGR and
control sequences in the yeast two-hybrid system.
Bait Prey Interaction
hRPGRIP j^RCC 1 -Like Domain Positive
hRPGRIP RCCl Negative
Negative controls hRPGRIP Ran NegativehRPGRIP SNF1 Negative
hRPGRIP none Negative






Mutants hRPGRIP RPGRf130C NegativehRPGRIP rpgrg215v Positive (weak)
hRPGRIP rpgrp235s Negative
hRPGRIP RPGRC250r Negative
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Figure 3.8: Primary structure alignment of five RCC1 orthologues and RPGR (RCC1-
homologous domain only). The highlighted (green) residues show those that were mutated
in human RPGR yeast two-hybrid constructs tested for an interaction with hRPGRIP. The
arrows indicated the residues that form the propeller blades of the tertiary structure of human
RCC1 (Renault etal., 1998).
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3.9 - CO-IMMUNOPRECIPITATION OF RPGR AND RPGRIP
The proposed interaction between RPGR and RPGRIP was tested by co-
immunoprecipitation of in vitro translated RPGR and RPGRIP proteins. Oligonucleotide
primers were used to amplify the cDNA inserts from pASl.RPGR and pACTII.RPGRIP.
The PCR primers are designed so that the translated products contain epitope tags at one end.
RPGR was tagged with c-myc and RPGRIP with haemagglutinin (HA) epitopes. The
amplified sequences were used in a coupled in vitro transcription/translation reaction to
produce [35S] radiolabeled proteins. The proteins were mixed and immunoprecipitated with
either anti-myc or anti-HA antibody as detailed in Chapter 2 (page 80). Control reactions
were performed by mixing RPGR-myc with HA-tagged and radiolabeled Max protein or
RPGRIP-HA with myc-tagged and radiolabeled lamin protein and immunoprecipitating
with anti-myc and anti-HA respectively. The results of this experiment are shown in Figure
3.9. The four lanes on the right hand side of the autoradiograph show undiluted in vitro
transcription/translation products separated on the same gel to allow identification of the
bands in the four test lanes (shown on the left of the figure). From a mixture ofRPGR-myc
and RPGRIP-HA it was possible to co-immunoprecipitate both proteins using either of the
two antibodies. From a mixture of RPGR-myc and Max-HA only RPGR-myc was
immunoprecipitated with anti-myc. From a mixture of RPGRIP-HA and lamin-myc only
RPGRIP-HA was immunoprecipitated with anti-HA. This suggests that the interaction
between RPGR and RPGRIP is specific and not an artefact of the yeast two-hybrid system.
The bands obtained with anti-c-myc mouse monoclonal antibody (Figure 3.9, lanes 1, 3) are
weaker than those obtained with anti-HA rabbit polyclonal antibody (lanes 2, 4), either
because protein G, which was used to capture the antigen-antibody complexes, binds more
strongly to rabbit than to mouse antibodies, or because the polyclonal antibody binds with








































































Figure 3.9: Co-immunoprecipitation of RPGR and RPGRIP in vitro transcribed/translated
proteins. Lane 1, RPGR-myc plus RPGRIP-HA immunoprecipitated with anti-myc antibody;
lane 2, RPGR-myc plus RPGRIP-HA immunoprecipitated with anti-HA antibody; lane 3,
RPGR-myc plus Max-HA immunoprecipitated with anti-myc antibody; lane 4, RPGRIP-HA
plus lamin-myc immunoprecipitated with anti-HA antibody. The four lanes on the right hand
side of the gel contain undiluted in vitro transcription/translation products for size
comparison with proteins on the left hand side. The position of molecular weight markers
are indicated on the left of the gel (sizes in kDa).
3.10 - DISCUSSION
The yeast two-hybrid system is a widely used method for detecting interacting proteins and
for gaining insights into protein function and pathways (Luban and Goff, 1995). This is an
in vivo method for detecting protein-protein interactions and requires confirmation with one
or more independent methods, but provides a powerful means of screening large numbers of
cDNA clones for interacting products (Fields and Song, 1989; Chien etal., 1991).
The yeast two-hybrid system has a number of advantages over other methods of
detecting interacting proteins. Firstly, the experiments are carried out in vivo. This increases
the likelihood that the proteins under investigation will adopt their native conformations. In
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addition, unlike bacterial systems, some post-translational modifications are made to proteins
expressed in yeast. The yeast two-hybrid system is capable of observing relatively weak
interactions. For example, the interaction between the mammalian RAF protein kinase with
the Ras GTPase protein was detected in the yeast two-hybrid system but not by co-
immunoprecipitation methods (van Aelst et al., 1993). The source of this sensitivity is, in
part, the three-fold amplification of positive signals, i.e. transcriptional, translational, and
enzymatic. It is likely that even a transient interaction can activate transcription to produce a
stable mRNA, which can then be repeatedly translated (Fields and Sternglanz 1994).
Another valuable feature of the system is the presence of the HIS3 reporter gene, encoding
histidine prototrophy, which enables high density plating and stringent selection of yeast
transformants expressing interacting proteins. This allows greater numbers of library clones
to be screened than if colour selection (e.g. LacZ) was alone available. One other advantage
of the yeast two-hybrid system over other methods of purifying interacting proteins is that
the end product of a library screen is a cDNA clone of the interactor, rather than a
polypeptide. Lastly, by fragmenting the interacting cDNA clones it is possible to determine
the limits of the interaction domains.
Not all protein-protein interactions can be detected in the yeast two-hybrid system.
Some proteins are unsuitable as baits because they can activate the reporter genes in the
absence of an interacting partner. In these cases, it is necessary to delete whichever portions
of the protein are responsible for this activity - if this is possible (Bartel et al., 1993b). In
some cases, the presence of the DNA-binding domain or activation domain may interfere
with the correct folding of the fusion protein or occlude the normal site of interaction and so
impair the ability to interact (van Aelst et al., 1993). In this situation it may help to switch
the transcription factor domain from the N-terminal end (the usual position) to the C-
terminal end of the protein under investigation (Beranger et al., 1997). The conditions
within the yeast cell may preclude correct folding or post-translational modification of some
mammalian proteins. In these cases, interactor hunts might fail as a result, conversely some
interactions that are observed in yeast may not occur in the protein's native environment
(Fields and Sternglanz 1994). Similarly, (in the yeast two-hybrid system) it may not be
possible to detect interactions involving extracellular proteins - these often contain
disulphide bonds and/or are glycosylated, and these modifications are not generally
compatible with a nuclear-based system (Fields And Sternglanz 1994). Despite these
limitations, mammalian proteins produced in yeast are more likely to resemble their native
state than those produced in bacterial expression systems (Fields and Sternglanz, 1994).
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The function of the RPGR protein is unknown, although Linari et al. (1999) previously
showed that it interacts with PDE8 by screening an embryonic mouse cDNA library using a
yeast two-hybrid system. This interaction was confirmed by in vitro protein binding (pull¬
down) assays and affinity measurements (KD = 90 nM), which were consistent with a
physiological interaction. In the present study, a second RPGR-interacting protein has been
identified, RPGRIP, by screening a bovine retinal cDNA library with the human RPGR N-
terminal domain in a yeast two-hybrid system. Six out of seven strongly positive clones
were shown to contain fragments of the bovine RPGRIP gene and the interaction was
confirmed with human RPGRIP. The bait construct contained the first 12 exons of RPGR,
including the whole of the RCC1 -like domain. This construct was chosen because the goal
of the experiment was to identify proteins that interact with the RCC 1-like domain, which, at
the time this work was carried out, contained all of the known RP3 mutations (Meindl et al.,
1996). An additional line of evidence for the interaction between RPGR and RPGRIP was
provided by the demonstration of specific co-immunoprecipitation of the complex following
in vitro transcription and translation of the two gene products.
Interpreting the results of the candidate interacting protein screens is problematic
because of the failure of Ran and RCC1 to interact in this system, which was unexpected. It
is not always possible to have positive controls for all constructs. For example, before the
interaction between RPGR and PDE8 was detected there was no positive control for RPGR.
If the Ran-RCCl control had not been included then it would have been concluded that
RPGR does not interact with Ran. Similarly, the conclusion that ARF1 does not interact
with RPGR has to be guarded in the absence of a positive control for ARF1. The negative
results obtained for ARF1 and Ran are supported by the absence of detectable GEF activity
for RPGR in the presence of Ran or ARF1 (F.Manson, unpublished results). Linari et al.
(1999) reported a similar result for Ran, which also tends to support the results from these
experiments.
Why did Ran and RCC 1 not interact in this system? Both proteins are present in the
nucleus in humans. It may be that the presence of the GAL4 domain in the RCC1 hybrid
prevented the RCC1 protein from adopting its complex seven-bladed propeller structure
(Renault et al., 1998). The C-terminus and a region close to the N-terminus of RCC 1 come
together to form the first blade of the propeller. The GAL4 domain is attached to the N-
terminus of RCC1 and it is possible that this prevents correct structural organisation of
RCC1. Attachment of the GAL4 domain to the C-terminus would be even more likely to
disrupt the three-dimensional structure, as this is directly involved in forming the first
structural repeat of RCC 1. Ran and RCC 1 are known to interact: they were isolated as a 1:1
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complex from HeLa cell nuclei upon chelation of Mg2+ ions (Bischoff et al., 1990). This
complex is stable in the presence of 2 mM Mg2+ and the absence of GTP or GDP but
completely dissociates in the presence of GTP or GDP and Mg2+ (Bischoff and Ponstingl
1991). Of course, RCC1 must interact with Ran in the cell in order to stimulate guanine
nucleotide dissociation and Ran has been observed in a ternary complex with RCC1 and
guanine nucleotide, indicating that these two factors do not compete for the same binding
site on Ran (Klebe et al., 1995). Klebe et al. (1995) proposed a scheme for guanine
nucleotide exchange whereby RCC1 binds to Ran-GDP, GDP dissociates (leaving the binary
Ran-RCCl complex), GTP binds to Ran-RCCl and RCC1 dissociates from Ran-GTP. In
this scheme the Ran-RCC 1 interaction would, therefore, be a transient one and possibly too
short-lived to allow detection in the yeast two hybrid system. Klebe et al. (1995) also
reported the affinities of the Ran-GTP/RCCl and Ran-GDP/RCCl interactions as being
relatively low, at 18 pM and 13 pM respectively, compared with the 90 nM RPGR-PDE8
interaction.
It is also possible that over-expression ofRan and RCC 1 is harmful to yeast cells. In
mammalian cells, over-expression of Ran prolongs the duration of S-phase and leads to
reduced cell proliferation and decreased total cell numbers (Milano and Strayer, 1998).
Over-expression of the yeast RCC1 homologue piml causes cells to arrest with
postmitotically condensed chromosomes, an unreplicated genome and a wide medial septum
(Matynia et al., 1998). However, previous examples have shown both Ran and other
exchange factors can be overexpressed without problems in the yeast two-hybrid system.
For example, Schurmann et al. (1999) used ADP-ribosylation factor-related protein (ARP) as
bait and identified the ARF-specific guanine nucleotide exchange factor Cytohesin as an
interacting partner in a two-hybrid library screen. Ran was used as bait to identify the
Xenopus Ran-binding protein 1 (Nicolas et al., 1997), and, in Arabidopsis, a mutant form of
Ran, which remains in the GTP-bound form, was used to identify the Arabidopsis Ran-
binding protein 1. A number of human Ran mutants are known to be locked in the GTP-
bound form due to an absence of GTPase activity including Ran G19V (Bischoff et al.,
1994), Ran Q69L and Ran L45E (Lounsbury et al., 1996). The T24N Ran mutant is known
to have an approximately 100-fold higher affinity for RCC 1 than wild-type Ran (Lounsbury
et al., 1996). Although this would have been a preferable alternative to wild-type Ran in this
test, the wild-type sequence was appropriate in the first instance. Time constraints prevented
the construction of such mutants for screening in the yeast two-hybrid system.
p532 was initially localised to the Golgi complex by Rosa et al. (1996). This
localisation, and the presence of two RCC 1-like domains in the p532 sequence, led the
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authors to investigate p532 binding to small GTPases associated with the Golgi complex.
ARF1, Rab3a, and Rab5 were all tested using co-immunoprecipitation methods but only
ARF1 bound to p532-RLD2. It was for this reason that ARF1 was considered a candidate
RPGR-interactor. RLD-1 was found to act as a GEF for the ARF1, Rab 3A and Rab5
proteins. To only ARF1, however, was p532 able to both bind (RLD2) and show GEF
activity (RLD1), suggesting a physiological role.
Screening two different two-hybrid libraries in pGADIO yielded no confirmed
positive clones and a large number of false positive results. The first screen identified 13
putative positive clones (HIS3+, LacZ7") all of which turned out to be false positives. One-
third of these clones lacked cDNA inserts, while the remainder contained a variety of clones
that would be expected to be abundant in a pancreatic library and therefore represent false
positives.
The identification of false positives is a known hazard of the yeast two-hybrid
system. These are frequently the result of a library plasmid encoding a protein involved in
transcription. A list of yeast two-hybrid false-positives reported by various workers can be
found at the web site http://www.fccc.edu/research/labs/golemis/intro.html. Screening the
bovine retina library in pGADIO also failed to produce any true positives. This time the
number of putative positive clones as determined by histidine prototrophy was larger (300),
and the number displaying both HIS3 and LacZ expression was much larger (72). However,
all of these clones again appeared to be false positives when treated as candidate interactors
and 14 of them (19%) lacked inserts. One possibility is that some feature of the pGADIO
vector backbone is responsible for inappropriate activation of the reporter genes. The
product of pGADIO consists of the insert protein fused to amino acids 768 to 881 ofGAL4,
the same as in pACTII. According to the vector manufacturers, pGADIO is perfectly
compatible with pASl and the only significant difference between pGADIO and pACTII is
that the latter drives much higher expression of the fusion protein in yeast. An excess of
activation domain hybrids over DNA-binding domain hybrids is desirable. This ensures that
more of the DNA-binding domain hybrids that are occupying UASs are likely to associate
with activation domain hybrids and activate reporter gene expression (Fields and Sternglanz,
1994). If the lower expression of the pGADIO hybrids leads to an excess of DNA-binding
domain plasmids then a lowering of reporter gene expression is expected, but this does not
explain the large number of false positives observed.
It is not clear why PDE6 was not detected on two-hybrid screening of the bovine
retina library, since it is known to be strongly expressed in this tissue (Florio, Prusti, and
Beavo, 1996) and the interaction has been repeatedly confirmed by direct screening. The
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absence of PDE8 from the positive clones described in section 3.7 can be compared with the
results of other groups attempting to isolate RPGR-interacting proteins. Eight out of 40
clones isolated by Linari et al. (1999) in a yeast two-hybrid screen of a mouse embryo cDNA
library encoded the PDE delta subunit. The authors do not state how many clones were
screened in total, or how many the library contained. Elong et al. (2000) screened 1 x 106
clones from a mouse retina library containing 1 x 106 clones in total. Out of six positive
clones, one encoded PDES and five encoded mRPGRIP. Roepman et al. (2000) screened 6 x
106 bovine retina clones in the yeast two-hybrid system in an attempt to identify RPGR-
interacting proteins and isolated six RPGR1P clones but no PDES clones.
Possible reasons why PDES was not detected in this study include differences in the
RPGR "bait", a species difference, and the exhaustiveness of library screening. Linari et al.
(1999) used an RPGR bait containing amino acids 1-392, whereas here a bait consisting of
amino acids 1-502 was used (the RLD consists of residues 39-365). It seems unlikely that
this difference would account for the failure to identify PDES. A second possibility is a
species difference, since the RPGR-PDE8 interaction was detected by screening a mouse
library with human RPGR, whereas a bovine library was used in this study. This is also an
unlikely explanation however, since human, mouse and bovine PDES are unusually well
conserved, with 98% of residues identical at the amino acid level between the three species.
Only 3 conservative substitutions out of 150 residues separate these species and only 1
substitution occurs between bovine and human (compared with 2 between bovine and
mouse; see Figure 1.15, page 46). This leaves the third possibility, namely a failure to
exhaustively screen the library. An estimated 2 x 106 clones were screened and prior to
amplification the library contained 2 x 106 independent clones (Kumar et al., 1996).
Amplifiying the library may have led to the underrepresentation of some clones. The
probability of detecting a specific clone in a cDNA library can be estimated using the
method described in Hartl and Jones (1988). The number of clones required to be screened
(n) in order to achieve a probability (P) of detecting a specific clone (which accounts for a
fraction (f) of the total number of clones in the library) is given by:
n = In (1-P) / In (1-f)
Thus, if there was a single PDES clone in the bovine retina library, and assuming the library
contained 2 x 106 clones in total, the number of clones required to be screened in order to
obtain a 90% probability of detecting the PDES clone is:
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In (1-0.9) / In (1-5 x 10"7) = 4,605,169
If the fraction of PDE8 clones is increased to 10 in 2 x 106 clones, the number of clones that
have to be screened to detect PDE8 is reduced accordingly (to In (1-0.9) + In (1-5 x 10"6) =
460,516). In the same way, to increase the probability of finding a clone larger numbers of
clones must be screened. Table 3.3 shows how the probability of detecting PDE8 by
screening 2 x 106 clones changes according to the proportion of PDES clones in the bovine
retina cDNA library.
Table 3.3: Estimates of the probability (P) of detecting PDES in the bovine retina yeast two-
hybrid library (consisting of 2 x 106 unamplified clones) according to the method described in
Hartl and Jones (1998). Through screening 2 x 106 clones, the probability of detecting PDES
increases according to its abundance (see text).
Number of PDES clones in
library
Probability of detection (P)
by screening 2 x 106 clones
1 in2x 106 0.632
2 in 2 x 106 0.865
3 in 2 x 106 0.950
4 in 2 x 106 0.982
5 in 2 x 106 0.993
10 in 2 x 106 >0.999
Although PDES is reported to be abundantly expressed in the retina (Florio, Prusti, and
Beavo, 1996), amplification of the library may have led to this transcript being under-
represented. It remains a possibility that further screening would identify PDES. If this was
the reason for the absence of PDES among the positives then it follows that there may be
additional RPGR-interacting proteins in the library that were not identified for the same
reason.
Further confirmation of the specificity of the RPGR-RPGRIP interaction was
obtained when six out of eight XLRP disease-associated RPGR mutations (V36F, G60V,
H98Q, F130C, P235S and C250R but not G215V or G275S) were shown to abolish the
interaction in yeast two-hybrid experiments. These mutations all affected conserved residues






















































Figure 3.10: CLUSTAL W alignment (Thompson et al., 1994) of human, canine, mouse,
bovine and Takifugu rubripes RPGR polypeptide sequences from hRPGR residue 1 to 285.
Positions of the substitutions investigated in the yeast two-hybrid system (section 3.8) are
highlighted (yellow) (* = single, fully conserved residue,: = conservation of strong groups,
= conservation of weak groups, blank space = no consensus).
The V36F substitution was found in a single patient with X-linked congenital stationary
night blindness (T. Meitinger, personal communication). On the alignment of RCC1
homologues (Figure 3.8) the valine at this position in RPGR is conserved only in the
Schizosaccharomyces pombe piml protein. At this position in PRP20 (Saccharomyces
cerevisiae) there is an alanine residue and in the other species shown in the alignment
(human, hamster and Drosophila) there is a gap. Alanine and valine are both small amino
acids with aliphatic, non-polar side chains, suggesting that they could substitute for one
another in different species. An alignment of RPGR protein sequences from Homo sapiens,
Canis familiaris, Mus muscuius, Bos taurus and Takifugu rubripes is shown in Figure 3.10
and summarised (with respect to the residues at hRPGR positions 36, 60, 98, 130, 215, 235,
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250 and 275) in Table 3.4. This shows that there is an aliphatic, non-polar side chain-bearing
amino acid (valine or isoleucine) at this position in each of the mammalian sequences. The
presence of phenylalanine at this position in RPGR abolishes the interaction with RPGRIP,
which it does not for PDE8 (Linari et al., 1999). This amino acid has an aromatic side chain
and may not be expected to substitute for valine at a position essential for the RPGR-
RPGRIP interaction. The fact that this change has no effect on the RPGR-PDE8 interaction
suggests that different parts or residues of the protein may be involved in binding to PDE8
and RPGRIP. The seven remaining mutations (G60V, H98Q, F130C, G215V, P235S,
C250R and G275S) were found in XLRP patients. The glycine at position 60 is conserved in
the RCC1 protein of all species examined, while in RPGR the only species which deviates is
Bos taurus (serine). The substitution of a glycine for a valine is not a radical one, suggesting
that the residue is important for RPGR in terms of the interaction with RPGR. The histidine
at hRPGR position 98 is 100% conserved in all of the RCC1 homologues and all of the
mammalian RPGR homologues, indicating that it may be an critical residue. The
replacement of the basic histidine with the amidic glutamine abolished the interaction with
RPGRIP. The phenylalanine at position hRPGR 130 is conserved in canine and murine
RPGR but is substituted for a serine in bovine and a lysine in Takifugu rubripes. The
aligned RCC1 sequences (Figure 3.8) have a gap at this position, with the exception of
PRP20 (Saccharomyces cerevisiae), which has a leucine residue. This residue is thus well
conserved but restricted to RPGR and the presence of the small, sulphur-containing cysteine,
in place of the aromatic phenylalanine, disrupted the interaction with RPGRIP. In RCC1, the
glycine at hRPGR position 215 is 100% conserved across the species examined. The
murine, human and canine RPGR proteins all have a glycine here, while there is a valine in
bovine and glutamine in Takifugu rubripes. The substitution of a glycine for a valine failed
to disrupt the interaction with RPGRIP, but did prevent binding to PDE8 (Linari et al.,
1999). Both of these amino acids are small, non-polar residues but the fact that the same
alteration at position 60 produced a different result suggests that position 215 is less critical
for the RPGRIP interaction. Changing the imino-acid proline at position 235 to a hydroxyl-
containing serine also abolished the interaction with RPGRIP, although it failed to
completely prevent the interaction with PDE8 (Linari et al., 1999). The proline at this
position is conserved in RCC1 in all species examined and in human, canine and murine
RPGR. Human, canine and murine RPGR contain a cysteine at position 250 (bovine RPGR
has a methionine here, and Takifugu rubripes a glutamate) as do all the RCC1 proteins
examined except BJ1 (Drosophila), which has a threonine. Substituting this cysteine in
RPGR for an arginine prevented binding to RPGRIP. The glycine at hRPGR position 275 is
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well conserved among the RPGR homologues - all but Takifugu rubripes (alanine) have
glycine - but less so in RCC1. RPGR and PRP20 (Saccharomyces cerevisiae) have the same
residue here while piml (Schizosaccharomyces cerevisiae) contains an arginine, BJI
(Drosophila) a lysine, and hamster and human RCC1 a histidine. Changing this glycine to a
serine abolished the RPGR-PDE8 interaction but did not affect RPGR binding to RPGRIP.
Table 3.4: Comparison of RPGR amino acids residues at specific positions in five species.
Residues were altered at these positions, as indicated in the 'Mutants' row, and tested for
interaction with RPGRIP in the yeast two hybrid system. Positions refer to the human RPGR
sequence. See sections 3.8 (Testing RPGRIP for interaction with mutant RPGR constructs)
and 3.10 (Discussion).
Position 36 60 98 130 215 235 250 275
Mutation+ F V Q C V S R S
Human RPGR V G H F G P C G
Canine RPGR V G H F G P C G
Mouse RPGR I G H F G P C G
Bovine RPGR I S H S V I M G
Takifugu rubripes* T G A K E M E A
Mutation abolishes
interaction?
Yes Yes Yes Yes No Yes Yes No
* retinitis pigmentosa GTPase regulator-like protein, +all except V36F were found in XLRP
patients. V36F was found in a patient with CSNB.
In summary, the XLRP-associated G215V and G275S substitutions did not prevent RPGRIP
binding but did prevent the interaction with PDE8, and the V36F change, which is not
associated with XLRP, disrupted RPGRIP binding only. Although these results are purely
qualitative, they suggest that different RPGR sub-domains within the RLD are likely to be
involved in the interactions with RPGRIP and PDE8 and that the latter may be more
important for full expression of the XLRP disease. Useful future experiments would be (i) a
semi-quantitative P-galactosidase assay to give a measure of the interaction between RPGR
and the G215V and G275S mutants and (ii) attempts to map these sub-domains.
Following the identification of interacting partners, it is necessary to verify that
binding is reproducible using independent techniques and not an artefact of the yeast two-
hybrid system. The technique used here involved the in vitro co-immunoprecipitation of in
vitro transcribed and translated epitope-tagged RPGR and RPGRIP. This showed that the
interaction between RPGR and RPGRIP is specific and reproducible in vitro and strongly
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supports the yeast two-hybrid in vivo evidence for binding. This is one of several commonly
used methods to test yeast two-hybrid data. Alternatives include the co-immunoprecipitation
of native proteins from tissue or cell extracts, co-immunoprecipitation of recombinant
proteins from transfected cell-lines, affinity chromatographic techniques and 'pull-down'
assays.
Co-immunoprecipitation of the proteins from an appropriate tissue extract (e.g.
retina in the case of retinal proteins) is the ideal method because the proteins are in their
normal environment and native state and a positive result strengthens the argument that the
interaction occurs in vivo. In this, antibodies against one or both of the two interacting
proteins are used to purify the complex from a tissue lysate. The antibodies are removed
from the mixture using protein A or G and separated from the bound proteins, which are
analysed by SDS-PAGE. The technique requires that antibodies be raised against the
interacting partners and can be difficult to perform successfully if the proteins are of too low
abundance for detection or antibodies are low affinity. In addition, the source tissue itself
may not be easy to obtain, as is the case with human retina. A variation of this technique is
to use, as a source of the binding complex, cell lines derived from the tissue in which the
interaction is expected to occur. These cells can be grown in the presence of radioactive
amino acids (for example [35S] methionine) in order to produce radiolabelled proteins which
can be more readily detected using autoradiographic methods. Alternately, the cell lines can
be transfected with expression vectors encoding the interacting proteins. In this way, large
amounts of the polypeptides can be obtained for co-immunoprecipitation.
Another method of verifying two-hybrid interactions involves affinity
chromatography. One of the proteins is expressed containing a tag at the amino- or
carboxyl-terminus (for example, a string of six histidine residues) by means of which it can
be fixed to a chromatographic column (containing, in order to bind His6-tagged proteins,
nickel nitrilotriacetic acid). The column is then used to fractionate a cellular extract and, if
binding is reproducible in this system, the interacting protein will bind to the column. The
bound proteins are eluted and analysed by SDS-PAGE.
In the 'pull-down' assay (Durfee et al., 1993), one protein is typically expressed
fused to a glutathione ^-transferase moiety (GST). This is incubated with either a tissue
extract or the untagged potential interacting protein and glutathione-Sepharose. The GST
moiety binds to the glutathione, thereby attaching the bound interacting proteins to the
sepharose, which is sedimented by centrifugation. The proteins are removed from the
glutathione-sepharose and analysed by SDS-PAGE.
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These techniques differ in the method of capturing the interaction complex (i.e. through
antibodies recognising the proteins directly, antibodies recognising epitope tags or affinity
methods) and in whether a complex native or simple in vitro mixture is used as the protein
source. None of them, however, can give direct evidence that an interaction occurs within
living cells. The strongest evidence for this comes from the yeast two-hybrid system itself.
The methods being discussed here merely offer secondary, independent evidence that the
proteins physically interact. The co-immunoprecitation method used to verify the RPGR-
RPGRIP interaction was successful in this and shows that binding is specific and





The aims of this work were (i) to isolate the full-length human RPGRIP cDNA, (ii) to
determine the chromosomal location of the RPGRIP gene, (iii) to describe the genomic
structure of RPGRIP and (iv) to investigate RPGRIP expression in a range of tissues.
Finally, (v) the deduced RPGRIP amino acid sequence was analysed in silico using a panel
of peptide analysis programs.
4.2 - ISOLATION OF THE FULL-LENGTH HUMAN RPGRIP cDNA
Alignment of the 10 human and 8 mouse RPGRIP ESTs shows that they are clustered,
predominantly at the 3' end of the bovine sequence. None of these ESTs provided any
additional 5' sequence. The positions of the human ESTs relative to the bovine clone and to
each other are shown in Figure 4.1.









Figure 4.1: Extent of the human RPGRIP ESTs (green) relative to the bovine clone (orange)
and to each other. The numbers indicate the size and relative extents of the sequences,
from 1, at the start of the most 5' sequence (the bovine clone), to 945, at the end of the most
3' sequence (EST aa476670).
It was important to discover if the 5' and 3' ends of the human cDNA represented the true
limits of the RPGRIP transcript. The second triplet in the bovine clone is an initiation codon
and this is preserved in the human open reading frame, suggesting that it may be the start of
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the RPGRIP transcript. However, sequencing the whole of the cDNA insert of clone r93221
revealed that the open reading frame continues in a 5' direction beyond the first ATG triplet
for 28 bp and that there are no stop codons between the vector polylinker and the first ATG.
Additional 5' sequence was therefore sought using the 5' rapid amplification of cDNA ends
(RACE) technique (see below).
At the 3' end of the aligned sequences, the stop codons of the human, bovine and




This suggests that they have been evolutionarily conserved and represent the 3' termini of
the open reading frames. 3' RACE experiments were carried out to investigate whether
additional 3' exons could be detected.
4.2.1 - 5' Primer extension reactions
Initial attempts to obtain extra upstream cDNA sequence by 5' RACE, using primers
complementary to the coding strand, were unsuccessful. This technique was performed
using a variety of human RNA samples for first strand cDNA synthesis (including retina
poly (A)' RNA), and a number of different PCR primers and protocols. Commercial
adaptor-ligated cDNA libraries were also used for human retina, testis and foetal liver, again
without success.
To examine the sequence around the 5' end of the human r93221 clone at the
genomic level, another primer extension technique was employed. This was analogous to
the RACE method, differing only in that the PCR template DNA is genomic rather than
cDNA (Siebert et al., 1995). Five pools of genomic DNA were obtained (Clontech,
Basingstoke) that had each been separately digested with restriction endonucleases (EcoRV,
Seal, Dral, PvwII, and Sspl) and the resulting linear fragments ligated to adaptors at each
end. From these samples, it was possible to selectively amplify lengths of genomic DNA
using a gene-specific primer and a primer specific for the adaptor DNA. Non-specific
amplification from the adaptor primers was prevented by the adaptors having retracted 3'
ends that terminate in an amine group. The retracted 3' end eliminated the adaptor primer
target (until the extension from the specific primer had extended to the end of the other
strand of the adaptor) and the amine group at the free 3' end of the adaptor end blocked 3'
extension of this strand and creation of an adaptor primer target site (Figure 4.2). The use of
... ATTTGTTTTC ATGAAGGAAC AAGTGCTATT ...
... ATTTGTGTTC CTGATGGAAC AAGTGCTAGT ...
... ATCTGTTTTC ATGAAAGTAC AAGTTCTACT ...
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five distinct genomic DNA samples (each digested with a different endonuclease) increased
the likelihood of amplifying a fragment containing the 5' end of RPGR1P. Genomic
fragments containing the sequence at the 5' end of EST r93221 were amplified in this way.
For the first round of PCR, the API adaptor-specific oligonucleotide supplied with the kit
was used with 19REV, which is specific for RPGRIP. The second round of amplification
was achieved using nested primers: AP2 (adaptor-specific) and 4REV (specific for
RPGRIP). Specific products were obtained from two of the five templates. These were
'TA' cloned (see section 2.11.4, page 57) and sequenced using M13F and M13R primers.
The sequence obtained from these clones extended the open reading frame in a 5' direction
by 146 bp (i.e. 146 bp separated the 5' end of the EST r93221 insert from the nearest
upstream stop codon).
No binding site for AP1 until extension of 19REV; amine group

















Figure 4.2: Schematic representations of the primer extension technique whereby linear
fragments of RPGRIP genomic DNA were amplified by PCR. Grey bars indicate genomic
DNA, red bars indicate adaptor sequences. The first round of amplification was primed
with the adaptor-specific AP1 and RPGRIP-specific 19 REV oligonucleotides and the
second round was primed with the nested adaptor-specific AP2 and RPGRIP-specific
4REV primers.
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4.2.2 - 5' RACE
RPGRIP cDNA adaptor
42a 44REV
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Figure 4.3: Schematic representations of the 5' and 3' RACE technique. Red bars indicate
RPGRIP cDNA, blue bars indicate adaptor sequences. The first rounds of PCR-
amplification were primed with the adapter-specific AP1 and RPGR IP-specific 44 REV (5')
and AP1 and RPGRIP-specific 414 FWD (3') oligonucleotides. The second rounds were
primed with the nested adapter-specific AP2 and RPGRIP-specific RG32 long REV (5') and
AP2 and RPGRIP-specific 544 FWD.
The new 5' sequence was used to design an oligonucleotide PCR primer, RG321ongREV,
which was used for a 5' RACE experiment (shown schematically in Figure 4.3) using human
retina and testis cDNA pools (Clontech, Basingstoke). The first round of amplification was
primed with the API adaptor primer and the Rspecific44REV primer. The second
round of amplification was carried out using nested primers: the AP2 adaptor primer and
RG321ongREV. The result of this experiment is shown in Figure 4.4.
The specific (though poorly-defined) products in lanes 1 and 4 (indicated by arrows
in Figure 4.4) were excised from the gel and purified. The testis product was re-amplified by
PCR and sequenced; attempts to re-amplify the retina product were unsuccessful, possibly
because of the difficulty in excising a clean band from the agarose gel. The extra 5'
sequence obtained from the testis cDNA extended the open reading frame to 1758 bp. The
nucleotide context of the first ATG triplet conforms well to the Kozak consensus (Kozak,
1987) as shown in Table 4.1.
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Figure 4.4: Photograph of an agarose gel
containing the products of the second round
of 5' RACE from retina and testis cDNA
(Lane M = marker (sizes in bp), lanes 1 and
4 = products of the PCR primed with both
the adaptor- and gene-specific primers,
lanes 2 and 5 = adaptor primer only, lanes 3
and 6 = gene specific primer only. The white
arrows show the bands that were excised.
Table 4.1: The hRPGRIP presumed 5' noncoding sequence from position -9 to position +4
compared with the consensus determined by Kozak (1987). The numbers indicate the
percentage of transcripts that have the residue shown in that position.
Position: -9 -8 -7 -6 -5 -4 -3 -2 -1 +1 +2 +3 +4
Consensus: g33 C39 C37 g44 c39 c53 a61/g36 c49 C55 a T g g46
hRPGRIP: a23 <-pl9 »y20 g C c a g13 C a T g C'6
Oligonucleotide PCR primers were designed to anneal to the 5' RACE product (760 delREV
and 494 REV, Table 2.1, page 59) and these were used for additional 5' RACE experiments
using human retina cDNA (Clontech, Basingstoke). A transcript was identified which starts
12 bp downstream from the start of the testis transcript but no additional 5' coding sequence
was obtained. Like the testis 5' RACE product, the retina transcript contains in-frame stop
codons upstream of the proposed translation initiation codon, consistent with it containing
the first exon.
A BLAST search of the human EST database for sequences similar to the 5' RACE
product identified a single EST (accession number w28191) with strong sequence homology
(94% identical; e value (the number of different alignments with equal or better scores
expected to occur in a search by chance) = 2 xlO"17). The EST contains RPGRIP sequence
from nucleotides 408 to 474 and comes from a random primed human retina cDNA library.
4.2.2 - 3' RACE
The 3' end of hRPGRIP was amplified from a testis oligo (dT)-primed cDNA pool
(Clontech, Basingstoke). The RPGRIP-specific oligonucleotides 414FWD and adaptor
primer AP1 were used for the first round of amplification and the nested primers 544FWD
and AP2 for the second round (see Figure 4.3). A transcript was identified extending 84 bp
beyond the end of the open reading frame. The product was sequenced and found to contain
Retina Testis
M 1 2 3 4 5 6
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the same in-frame stop codon and no additional 3' coding sequence. 3' RACE experiments
using retina cDNA (Clontech, Basingstoke) also failed to detect any additional 3' transcribed
sequence. Neither of the two most commonly used hexameric polyadenylation signals
(AATAAA and ATTAAA) is present at the 3' end of the testis RACE product or the ESTs.
However, 17 bp and 31 bp upstream from the 3' end of the RACE product are two hexamers
that differ from the canonical AATAAA by a single nucleotide: TATAAA and AGTAAA
respectively. These, according to Graber et al. (1999), are the fifth (TATAAA) and fourth
(AGTAAA) most commonly used hexameric polyadenylation signals. Of the two,
TATAAA but not AGTAAA is conserved in human, bovine and mouse RPGRIP. An
alignment of these three sequences in the region of the termination codon and the potential





















Figure 4.5: CLUSTAL W alignment (Thompson et al., 1994) of human, bovine and mouse
RPGRIP 3' sequences. The conserved termination codon is boxed (green), as is a
conserved potential polyadenylation signal (red) and a potential polyadenylation signal
present in human RPGRIP only (pink). Blue letters indicate conserved nucleotides in these
positions, black letters represent non-conserved nucleotides.
4.3 - GENOMIC STRUCTURE OF hRPGRIP
Prior to the release of 196 kb of chromosome 14 genomic sequence containing hRPGRIP
(see below), much of the genomic structure was determined by sequencing PCR products
generated using genomic DNA and different combinations of RPGRIP cDNA-specific
primers. Fourteen intron/exon boundaries were established in this way using the following
combinations of PCR primers (the sequences ofwhich are given in Table 2.1, page 59): 430
FWD and 494 REV to determine the exon 2/intron 2 and intron 2/exon 3 boundaries, 801
FWD and Long REV to determine the exon 8/intron 8, intron 8/exon 9, exon 9/intron 9 and
intron 9/ exon 10 boundaries, 139 FWD and 183 REV to determine the exon 11 /intron 11
and intron 11/exon 12 boundaries, 419 FWD and 522 REV to determine the exon 12/intron
12 and intron 12/exon 13 boundaries, 414 FWD and 544 REV to determine the exon
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13/intron 13 and intron 13/exon 14 boundaries, 521 FWD and 761 REV to determine the



















494 REV Long REV 183 REV 522 REV 544 REV 761 REV
Figure 4.6: Generation of PCR products used to determine fourteen RPGRIP intron/exon
boundaries (open boxes = exonic RPGRIP, line = intronic RPGRIP, arrows of same colour
show forward and reverse PCR primers used to amplify segments of the gene).
The remaining boundaries were obtained, towards the end of this project, following the
database appearance of 196 kb of genomic sequence from a chromosome 14 contig
(accession number AL135744). The open reading frame that was assembled from the 5'
RACE product and the r93221 clone is divided into 12 exons (although see below). The
boundaries conform to the GT/AG rule (Mount, 1982) with the exception of the splice donor
site at the end of exon 4. The sequence at the exon 4/intron 4 junction was repeatedly
checked and confirmed as C T G g_c a a g t (the exonic sequence is in upper case letters; the
intronic sequence is in lower case letters). It is rare to observe a GC instead of the conserved
GT present at most splice donor sites but other examples of functional splice sites with this
sequence have been reported (Senapathy, Shapiro and Harris, 1990). The exon/intron
boundaries and intron sizes are shown in Table 4.2 (page 124).
The HGMP RC NIX panel of bioinformatics programs (http://www.hgmp.mrc.ac.
uk/Registered/Webapp/nix/) was applied to the 196 kb genomic sequence containing
RPGRIP (AL135744). The GENSCAN exon-recognition program (Burge and Karlin, 1998)
predicted the presence of three previously undetected exons in the middle of intron 4 and
twelve exons upstream of exon 1 that were absent from 5' RACE products. The splice sites
and exon and intron sizes of the twelve upstream GENSCAN-predicted exons are given in
Table 4.3 (page 125) and their sequences are given in Table 4.4 (page 126). The relative
positions of these GENSCAN-predicted exons (numbered -12 to -1 and 5 to 7; blue) and the
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Figure 4.7: Exons predicted by GENSCAN analysis of the chromosome 14 genomic
sequence (AL135744) containing RPGRIP. Previously-identified exons are shown
in red and additional exons are shown in blue. Horizontal green arrows indicate the
positions of GENSCAN-predicted exon-specific PCR primers; the horizontal yellow arrow
indicates the target site for the RPGRIP exon 10-specific PCR primer RG32longREV.
Vertical arrows indicate the positions of GrailEXP-predicted CpG islands.
As a component of the NIX analysis, the chromosome 14 sequence (AL135744) was
examined using the GrailEXP program (version 2.0; Hyatt et 2000) in an attempt to
identify CpG islands (see page 151). Six potential CpG islands were identified (see Figure
4.7): (1) 699 bp ofDNA located 111 bp downstream of GENSCAN-predicted exon -10 and
encompassing the whole of exon -9, (2) 357 bp of DNA located 6,638 bp downstream of
GENSCAN-predicted exon -9 and 11,447 bp upstream of GENSCAN-predicted exon -8, (3)
259 bp encompassing most of GENSCAN-predicted exon -6 (beginning 12 bp upstream of
the start of the predicted exon and ending 27 bp upstream of the end of it), (4) 265 bp located
672 bp upstream of exon 3, (5) 288 bp located 1,613 bp upstream of exon 12 and (6) 1061 bp
located 31,605 bp downstream of the terminal exon (exon 15). TATA, GC and CAAT boxes
were not found in the immediate vicinity of RPGRIP exon 1, or any of the GENSCAN-
predicted exons.
Attempts were made to PCR-amplify the GENSCAN-predicted exons from human
retina-derived cDNA using primers designed to anneal to these exons (Genscan exon 1-12
and 17-19,) and a primer specific for a previously identified RPGRIP exon (RG321ongREV).
The annealing site locations of the GENSCAN-predicted exon-specific primers (green) and
RG321ongREV (yellow) are shown schematically in Figure 4.7 and their sequences are given
in Table 2.1 (page 59). The 3 exons predicted to lie in intron 4 (GENSCAN-predicted exons
5 to 7) were detected and maintained the open reading frame (ORF) of the RPGRIP
transcript, but the 12 upstream exons (GENSCAN-predicted exons -12 to -1, which are also
in a continuous ORF with the rest of RPGRIP) were not detected (Figure 4.8). This
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indicated that RPGR1P consists of 15 exons: the twelve previously identified exons (exons 1-
4 and 8-15) and the three GENSCAN-predicted exons downstream of exon 4 (exons 5-7).
Table 4.2: Genomic structure of the human RPGRIP gene. Exonic sequence is in upper
case letter, genomic sequence in lower case. The atypical splice donor site at the exon-
intron junction at the end of exon 4 is underlined.
Exon Sequence at intron-exon junction Intron













































































Table 4.3: Genomic structure of the hypothetical portion of hRPGRIP predicted using the
GENSCAN program (Burge and Karlin, 1998) to lie upstream of exon 1. Attempts to amplify
these exons from human retina cDNA were unsuccessful. Exonic sequence is in upper case
letter, genomic sequence in lower case.
Exon Sequence at intron-exon junction Intron






























































Table 4.4: The 12 exons predicted using the GENSCAN program (Burge and Karlin, 1998)
to lie upstream of the first detected RPGRIP exon. Attempts to amplify these exons from































M -12-11 -10 -9 -8 -7 -6 -5 -4 -3-2-15 6 7
Figure 4.8: Amplification of RPGRIP fragments containing GENSCAN-predicted exons from
human retina cDNA. M= marker lane (sizes in bp). Lanes -12 to -1 = products of PCR
reactions primed with oligonucleotides specific for GENSCAN-predicted exons -12 to -1
(upstream of RPGRIP exon 1) and a primer specific for a previously identified RPGRIP exon
(RG32longREV); lanes 5 to 7 = products of PCR reactions primed with oligonucleotides
specific for GENSCAN-predicted exons 5 to 7 (located downstream of exon 4) and
RG32longREV. The 1389 bp product in the '5' lane includes exons 8-10 and GENSCAN-
predicted exons 5-7. The 870 bp product in the '6' lane includes exons 8-10 and
GENSCAN-predicted exons 6-7. The 572 bp product in the '7' lane includes exons 8-10 and
GENSCAN-predicted exon 7.
The precise boundaries of the three additional exons (exons 5-7) were determined by
sequencing across them at the cDNA level. To achieve this, the 1389 bp lane '5' band
shown in Figure 4.8 was sequenced as was a PCR product generated from human retina
cDNA using an exon 4-specific forward primer (638 FWD long, Table 2.1, page 59) and an
exon 5-specific reverse primer (?4/5 junction REV, Table 2.1, page 59). The boundaries
were found to coincide with the GENSCAN prediction. Examination of these exons at the
genomic level (using the AL135744 chromosome 14 sequence submission) revealed these
exons to have canonical splice sites (shown in Table 4.3). It is interesting to note that these
are the three exons immediately 3' to the non-canonical splice site at the exon 4/intron 4
junction splice site and are absent from PCR-amplified RPGRIP transcripts.
Interestingly, PCR-amplification ofRPGRIP from human testis cDNA using primers
in the 5' and 3' untranslated regions (UTR) (-26F and Stop +36, Table 2.1, page 59)
produced 2 bands: one of the expected size of 1862 bp and a larger but much less abundant
band of approximately 2350 bp (Figure 4.9). This estimated 488 bp of additional sequence is
large enough to include either exon 5 (453 bp) or exons 6 and 7 together (495 bp). However,
repeated attempts to purify and 'TA' clone DNA from the larger band were unsuccessful.
The extra exons lengthen the cDNA from 1,946 bp to 2,894 bp and the open reading
frame from 1,758 bp to 2,706 bp, predicting a protein of 902 amino acids and 97 kD. The
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Figure 4.9: RPGRIP amplified by
PCR from testis cDNA using primers
in the 5' and 3' UTRs produced 2
products of different sizes (this
photo shows the slightly (51 bp)
smaller products of a second round
of amplification using nested primers
(-6 Fwd and stop+6). M= marker
(sizes in bp).
full-length hRPGRIP cDNA with intron/exon boundaries is shown in Figure 4.11. The
sequence was submitted to GenBank and assigned the accession number AF260257. The
RPGRIP gene covers 33,495 bp of genomic DNA and consists of 15 exons. The average
exon size is 188 bp (range = 85 - 453). The average intron size is 2199 bp (range = 161 -
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Figure 4.10: Schematic representation of the genomic structure of hRPGRIP. The











































































































































T E D L F S * 902
2881 AGCTTGCTATAACA 2894
Figure 4.11: cDNA and predicted amino acid sequence of the RPGRIP gene (Acc. no.
AF260257). The translation initiation codon is boxed and in-frame upstream stop codons are
double underlined. The stop codon at the 3' end of the sequence is in bold and two potential
polyadenylation signals are shown in red. Predicted coiled-coil (green) and C2 domains
(yellow) are highlighted (see section 4.6.1) and the three alternatively spliced exons (exons
5-7) are underlined. Exon-intron boundaries are shown.
4.4 - CHROMOSOMAL MAPPING OF hRPGRIP
Four separate lines of evidence were used to determine the chromosomal location of the
hRPGRIP gene. These were (i) screening a monochromosomal somatic cell hybrid DNA
panel, (ii) radiation hybrid mapping, (iii) the identification of an STS containing the RPGRIP
sequence and (iv) the identification of a GenBank sequence submission containing
hRPGRIP.
4.4.1 - Screening a monochromosomal somatic cell hybrid DNA panel
A panel of human monochromosomal somatic cell hybrid DNAs was obtained from the
MRC HGMP Resource Centre (Kelsell, et al.,1995).This was screened by PCR using the
RPGRIP-specific 419FWD and 522REV primers to determine the chromosomal location of
RPGRIP. The human chromosome 14-containing hybrid sample was found to provide a
template for amplification of RPGRIP while none of the other panel samples, including the
rodent control, produced fragments of the correct size. This result is shown in Figure 4.12.
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The chromosome 14 sample consists of chromosome 14 DNA plus part of chromosome 16,
most likely to be 16pl3.1-16q22.1 (HGMP RC, product information leaflet). The negative
result obtained with chromosome 16 DNA indicated that RPGR1P is located on chromosome
14.
Figure 4.12: Screening a mono-
chromosomal somatic cell hybrid DNA
panel. (M=Marker lane (sizes in bp),
14=human chromosome 14 DNA,
15=human chromosome 15 DNA,
Hu=total human genomic DNA,
Mo=total mouse genomic DNA,
Ha=total hamster genomic DNA, 0=no
DNA.) Hybrids containing all other
human chromosomes were negative.
4.4.2 - Identification of an STS containing RPGRIP sequence
A BLAST search of the STS database for sequences with homology to RPGRIP identified
STS:hl4al407 (accession number G35988). This contains 320 bp of RPGRIP genomic
sequence (covering the intron 12 - exon 13 boundary) which had been localised to
chromosomal region 14ql 1.1 by Dear et al. (1998).
The location of hi4a1407 was determined during the generation of a high density
(100 kb resolution) STS map of the chromosome 14. The method used to do this is called
"HAPPY mapping" and is an in vitro technique similar in principle to radiation hybrid
mapping that replaces radiation hybrids with samples of pure genomic DNA (Dear et al.,
1998). Genomic DNA is broken into a pool of fragments by shearing or irradiation and 96
samples are taken from it, each containing less than one whole genome: this constitutes the
mapping panel. The more closely linked two markers are, the more likely they are to localise
to the same DNA fragment. The mapping panel is screened by PCR in order to determine
which STS markers are present in each of the 96 samples. The results of this are used to
generate a map, with distances between markers estimated from the frequency with which
they co-segregate.
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4.4.3 - Radiation Hybrid mapping
In order to determine a more precise chromosomal location for RPGR1P, a PCR analysis was
performed on the HGMP-RC subset of the Genebridge 4 radiation hybrid panel (Gyapay et
al., 1996). The PCR primers used were the same as for screening the monochromosomal
somatic cell hybrid DNA panel. The results were submitted to the Whitehead Institute and
indicated that RPGR1P is located between markers D14S275 and D14S264 with a LOD
score of 2.03 relative to the next most likely placement (6.94 centiRays from D14S264) in
14ql 1.
4.4.4 - GenBank submission
The location of RPGRIP was independently confirmed as being
196 kb sequence submission (accession number AL135744)
chromosome (BAC) clone containing human chromosome 14
hRPGRIP gene sequence appeared in the GenBank database.
4.5 - EXPRESSION OF RPGRIP
To assess the expression of RPGRIP in various tissues, northern blots were probed, reverse
transcriptase-PCR (RT-PCR) experiments were carried out, and in situ hybridisation of
labelled RPGRIP cDNA to embryonic mouse sections was performed.
4.5.1 - Northern blots
Three northern blots were probed using radiolabeled RPGRIP cDNA to determine the size
and tissue distribution ofRPGRIP transcripts.
on chromosome 14 when a
from a bacterial artificial
DNA including the entire
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4.5.l.i - Northern blot 1
A commercial human multiple tissue northern blot (MTN2, Clontech, Basingstoke) was
probed with a 713 bp 32P-labelled RPGRIP fragment corresponding to RPGRIP nucleotides
2135 to 2847 (from the middle of exon 10 to the end of exon 15, see section 2.22, page 69).
Two different transcripts were detected in the testis lane: a strong band of 2.0 kb and a
weaker band of 3.1 kb, but no signal was detected in lanes containing spleen, thymus,
prostate, ovary, small intestine, colon or peripheral leukocyte (Figure 4.13A). The same blot
hybridised to a G3PDH control probe (section 2.22) is shown in Figure 4.13B. Strong
G3PDH bands were detected in all lanes.





Figure 4.13: A commercial human multiple tissue northern blot (MTN2, Clontech) was
probed with (A) a radiolabeled 3' RPGRIP probe and (B) a G3PDH probe. A strong band of
2.0 kb and a weak band of 3.1 kb were detected in testis only. Sp = spleen, Th = thymus, Pr
= prostate, Ts = testis, Ov = ovary, S.I. = small intestine, Co = colon, P.B.L. = peripheral
blood leukocyte. Sizes are in kilobases.
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4.5.1.ii - Northern blot 2
A second commercial human multiple tissue northern blot (MTN, Clontech, Basingstoke)
was probed with a 2759 bp 32P-labelled RPGRIP fragment corresponding to RPGRIP
nucleotides 80 to 2838 (encompassing exons 1 to 15, see section 2.22, page 69). A very
weak 6.2 kb band was identified in the lane containing skeletal muscle RNA but no signal
was obtained in other tissues, including pancreas, kidney, liver, lung, placenta, brain and
heart (Figure 4.14A). Figure 4.14B shows that this blot also hybridised to a G3PDH control
probe. Strong G3PDH bands were detected in skeletal muscle and heart but only weak bands
in pancreas, kidney, liver, lung, placenta and brain.
Pa Ki Sk Li Lu PI Br He
Figure 4.14: A commercial human multiple tissue northern blot (MTN, Clontech) was
probed with (A) a radiolabeled 3' RPGRIP probe and (B) a G3PDH probe. A weak
band of 6.2 kb was detected in skeletal muscle only. Pa = pancreas, Ki = kidney, Sk =
skeletal muscle, Li = liver, Lu = lung, PI = placenta, Br = brain, He = heart. Sizes are in
kilobases.
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4.5.1.iii - Northern blot 3
A northern blot was prepared using poly (A)+ RNA purified from a range of human tissue
samples including retina. Upon hybridisation to a 595 nucleotide radiolabeled RPGRIP
probe corresponding to RPGRIP nucleotides 2206 to 2800 (from exon 11 to the end of exon
15, see section 2.22, page 69), a very faint signal was detected in the retina lane but no signal
was seen in thymus, spleen, lung, liver, kidney, heart or brain. There appeared to be two
bands, one of approximately 6.25 kb, and one of approximately 5 kb (Figure 4.15A). The
blot was probed with 32P-labelled P-actin (obtained by radiolabelling a commercial fi-actin
probe; Clontech, Basingstoke) and a strong band of the correct size was seen in retina only.
Weak bands were seen in thymus, spleen, lung, heart and brain and no signal was detected in
liver or kidney RNA (Figure 4.15B).







Figure 4.15: A Northern blot prepared using poly (A)+ RNA purified from a range of human
tissue samples was probed with (A) a radiolabeled 3' RPGRIP probe and (B) a p-actin
probe. Two very faint bands, of 6.25 kb and 5.0 kb were detected in retina only. Th = thymus,
Sp = spleen, Re = retina, Lu = lung, Li = liver, Ki = kidney, He = heart, Br = brain. Sizes are in
kilobases.
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Blots 2 and 3 failed to provide convincing results and it can be seen from the control
probings (P-actin in the case of northern blot 3, G3PDH for northern blot 2) that they contain
unequal loadings ofRNA. On blot 2, a commercial product, there appears to be much more
RNA in the skeletal muscle and heart lanes than the others and a very faint band was visible
only in the skeletal muscle lane after probing with RPGR1P. Blot 3 contains much more
RNA in the retina lane and, again, faint bands could be seen here only. From the control
probing of northern blot 3 it appears that the spleen, liver and kidney lanes contain barely
detectable amounts of RNA. The results from blots 2 and 3 suggest that with equal and




Figure 4.16: Amplification of bovine RPGRIP (A) and G3PDH (B) by RT—PCR from RNA
isolated from a variety of tissues (AC, adrenal cortex; AM, adrenal medulla; He, heart; Ki,
kidney; Li, liver; Lu, lung; Sk, skeletal muscle; Ov, ovary; Pa, pancreas; Re, retina; Te,
testis). A band of the expected size (487 bp) was amplified from all tissues. The low signal
from the pancreatic sample appears to result from poor quality RNA.
In order to carry out a more sensitive screen for low level RPGRIP expression, samples of
human and bovine total RNA were used to amplify RPGRIP by RT-PCR. Bovine total RNA
was obtained from Dr R. Vervoort (MRC Human Genetics Unit, Edinburgh.). These RNA
samples were purified from tissues collected within 30 minutes of death and immediately
homogenised in Trizol reagent (Gibco BRL) on ice. Samples were kept as Trizol
homogenates at -70°C until they were used for RNA purification. The samples were treated
in this way in order to protect the RNA from RNase degradation (Chomczynski and Sacchi,
1987). One round of RT-PCR-amplification (35 cycles) primed with bovine RPGRIP
primers Bov FWD and Bov REV (Table 2.1, page 59) was sufficient to produce a band of
the correct size from the majority of the samples (all except pancreas RNA, from which it
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was only possible to produce a G3PDH product of very low abundance). Figure 4.16A
shows the products of this reaction separated in an agarose gel. Figure 4.16B shows the
results of a control reaction in which the same samples were used to amplify bovine G3PDH




exon 12 (549 bp)
B
•+G3PDH
Figure 4.17: Amplification of human RPGRIP (A) and G3PDH (B) by RT-PCR using RNA
from a variety of tissues (Ad, adrenal; Br, brain; He, heart; Ki, kidney; Li, liver; Lu, lung; Re,
retina; Sp, spleen; Te, testis). A band of the expected size (742 bp) was amplified from
retina and testis only. An additional smaller band (549 bp) was also amplified from testis.
This band was sequenced and found to lack exon 12.
Human total RNA samples were obtained from previously frozen tissues collected from
approximately 24 hours-old cadavers. Using the 1048 FWD and 544 REV oligonucleotide
primers, which anneal to exons 9 and 14 respectively, RPGRIP transcripts were amplified
from human retina and testis RNA after one 35-cycle round of amplification (Figure 4.17A).
It was not possible to amplify RPGRIP from adrenal, brain, heart, kidney, liver, lung or
spleen RNAs. A single product of the correct size (742 bp) was amplified from testis and
retina RNA and an additional smaller product (549 bp) was amplified from retina RNA. The
additional retina product (the lower retina band in Figure 4.17A) was sequenced and found to
lack exon 12. The G3PDH positive control (amplified using the G3PDHF and G3PDHR
PCR primers) is shown in Figure 4.17B. It was also possible to amplify RPGRIP exons 1 to
4 and 8 to 15 from human lymphoblastoid cell line derived total RNA (no attempt was made
to amplify exons 5, 6 and 7) in the course of attempts to screen ARRP patients for RPGRIP
mutations (see section 4.7, page 149). Specific products were only obtained following a
second round of amplification using nested primers.
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4.5.3 - Tissue in situ hybridisation
Sense and antisense DIG-labelled mouse RPGRIP riboprobes were prepared by cutting the
aa204546 IMAGE EST clone with restriction endonucleases and incubating with T7 and T3
RNA polymerases respectively (see section 2.23). These were used, with the help of Judy
Fletcher (MRC Human Genetics Unit, Edinburgh), in a tissue in situ hybridisation
experiment with 12.5 and 15 day-old mouse embryo sections. No signal was detectable after
a single experiment and unfortunately, due to time constraints, this was not repeated.
4.5.4 - RPGRIP ESTs
One other method of assessing RPGRIP expression was to determine the tissue source of
RPGRIP ESTs identified in database searches. A large number of cDNA libraries have been
sequenced and the ESTs deposited in databases, making this a valuable means of assessing
gene expression. For example, since the commencement of the Washington University-
Merck human EST project (Hillier et al., 1996), 631,372 ESTs have been sequenced
(http://genome.wustl.edu/est/esthmpg.html). RPGRIP ESTs came from a limited range of
human tissues, namely foetal liver/spleen (r93221), retina (w28191, w26173), testis
(ai015922, aa782963), mixed foetal lung, testis and B-cell (aa928161, aw081763) and
pooled germ cell tumour (ai964059, ai655818, ai632512) (Table 4.5). r93221 was the only
RPGRIP EST present in a library that did not have retina or testis origins (foetal
liver/spleen). This indicates that RPGRIP is poorly represented in the EST databases,
possibly as a result of a narrow range of expression, and, based on the number of clones from
expressing tissues, the level of expression appears to be low.





Mixed foetal lung, testis and b-cell aa928161, aw081763
Pooled germ cell tumour ai964059, ai655818, ai632512
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4.6 - AMINO ACID SEQUENCE ANALYSIS
4.6.1 - Prediction of coiled-coil and C2-domains
The deduced RPGRIP amino acid sequence was analysed using the HGMP-RC PIX
assembly of bioinformatics programs (http://menu.hgmp.mrc.ac.uk/menu-bin/Pix) in an
attempt to identify possible secondary or tertiary structural features. Such features were
found by the Coils (Lupas, Van Dyke, and Stock, 1991), PROSITE (Hofmann et al., 1999)
and SOSUI (Hirokawa, Boon-Chieng and Mitaku, 1998) programs but the majority of the
programs run during the PIX analysis failed to produce significant results for the RPGRIP
sequence. These latter included prediction of subcellular localisation (Psort (Nakai and
Horton, 1999)), BLAST searches against domain databases (SBASE (Murvai et al., 2000),
PRODOM (Corpet, Gouzy and Kahn, 1999), searches against motif and domain databases
(Pfam (Bateman et al., 2000), PRINTS (Atwood et al., 2000), BLOCKS (Henikoff and
Henikoff, 1991)), transmembrane predictions (Tmpred (Hofmann and Stoffel, 1993), Tmap
(Persson and Argos, 1994), DAS (von Heijne, 1992), Phd (Rost and Sander, 1993)) and
signal peptide predictions (Sigcleave (von Heijne, 1986)).
RPGRIP was predicted by the Coils program (Lupas, Van Dyke, and Stock, 1991) to
have two coiled-coil domains at the N-terminus, the first encompassing residues 14 to 78,
and the second encompassing residues 150 to 200 (Figures 4.11). Analysis using the
PROSITE protein motif and domain database (Hofmann et al., 1999) revealed the presence
of four potential N-glycosylation sites, one potential cyclic adenosine monophosphate-
(cAMP) and cGMP-dependent protein kinase phosphorylation site, nine potential protein
kinase C phosphorylation sites, fourteen potential casein kinase II phosphorylation sites, two
potential tyrosine kinase phosphorylation sites, four potential N-myristoylation sites and
three potential amidation sites in the RPGRIP protein (Figure 4.18 and Table 4.6). RPGRIP
is predicted to be a soluble protein by the SOSUI system, which analyses proteins according
to the physicochemical properties of the amino acid sequence (Hirokawa, Boon-Chieng and
Mitaku, 1998). The molecular weight of the 902 amino acid RPGRIP translation was
predicted to be 97 kDa and that of the 586 amino acid translation ofRPGRIP minus exons 5
to 7 was predicted to be 67 kDa. Their isoelectric points were predicted to be 4.99 and 4.93
respectively.
The RPGRIP (902 amino acid) sequence was also analysed using the Simple
Modular Architecture Research Tool (SMART) internet-based database and research tool
(Schultz et al., 1998; Schultz et al., 2000). This predicted two calcium- and phospholipid-
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binding C2-domains, encompassing residues 416-532 and 611-716 (Figures 4.11). Figure
4.18 shows a schematic drawing of the RPGRIP transcript, highlighting the positions of the
predicted coiled-coil and C2-domains in the primary sequence.
Table 4.6: Results of a search of the PROSITE database for potential motifs present in the
902 residue RPGRIP protein.
Protein Motifs Position in RPGRIP
N-glycosylation sites 515-518; 523-526; 532-535; 652-655
cAMP- and cGMP-dependent protein
kinase phosphorylation site
115-118
protein kinase C phosphorylation sites 314-316; 517-519; 566-568; 598-600; 619-621;723-725; 731-733; 777-779; 855-857
casein kinase II phosphorylation sites
102-105; 127-130; 131-134;161-164;273-276;
446-449; 448-451; 475-478; 570-573; 571-574;
712-715; 770-773; 855-858; 868-871
tyrosine kinase phosphorylation sites 836-844; 837-844
N-myristoylation sites 193-198; 397-402; 499-504; 594-599; 703-708;
amidation sites 397-400; 623-626; 803-806
I II I
♦ •
1 14 78 150 200
II coil


















Y potential protein kinase C
phosphorylation sites
I potential casein kinase II
phosphorylation sites
♦ potential cAMP- and cGMP-
dependent protein kinase
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^ potential N-myristoylation sites
*{c potential tyrosine kinase
phosphorylation sites
V potential amidation site
¥ nntfintial N-nlvnnsvlation sit
Figure 4.18: Schematic representations of the transcript with (upper) and without
(lower) exons 5-7 (shaded). The two predicted coiled-coil encoding regions are shown in
purple and the predicted C2-domains are in yellow. The C-terminal 225 amino acids (labelled
the "RPGR-interacting domain") were shown to interact with RPGR. The arrows show the
position of the non-canonical splice site at the exon 4/exon 5 junction. Numbers indicate
amino acid positions. Above the transcripts are shown the positions of potential protein
motifs identified as a result of a PROSITE analysis (Hofmann etal., 1999).
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4.6.2 - Database searches for sequences with homology to RPGRIP
The available databases were used to search for proteins with homology to the translation of
the full-length RPGRIP cDNA (encoded by exons 1-15). A number of sequences were
identified from species including Homo sapiens, Caenorhabditis elegans, Rattus norvegicus,
Xenopus laevis, Mus musculus, Schizosaccharomyces pombe and others (Table 4.7). The
amino acid sequence encoded by the twelve upstream GENSCAN-predicted exons was then
added to pRPGRIP and the resulting sequence was also used in BLAST database searches
(Table 4.7). This extra sequence was also investigated as a single, separate polypeptide but
there appeared to be no significant homologies. The majority of the sequences detected in
database searches contained homology to RPGRIP in the region of the predicted coiled-coil
domains (residues 14 to 78 and 150 to 200). To determine whether these predicted domains
were masking any other (albeit weaker) homologies, residues 1 -200 were removed from the
RPGRIP sequence and more searches were performed (Table 4.7). The only sequences with
homology to RPGRIP (minus the coiled-coil domains) were KIAA1005 protein {Homo
sapiens) and 'weak similarity to myosin~cDNA' {Caenorhabditis elegans). The higher e
values of the next most similar sequences indicate the lower significance of the subsequent
hits.
KLAA1005 protein {Homo sapiens) and weak similarity to myosin~cDNA
{Caenorhabditis elegans) were the two most significant matches on all three BLAST
searches (with e values of lxlO"135 and 5xl0"13 respectively). KIAA1005 is an
uncharacterised human protein of 1,055 amino acids, which is 34% identical and 53%
similar to human RPGRIP. It was identified during a project to deduce the coding sequence
of previously unidentified human genes by sequencing a number of clones isolated from
human brain cDNA libraries (Nagase et al., 1999). The low e value of the
RPGRIP/KIAA1005 alignment suggests a much greater significance than for the
(uncharacterised) weak similarity to myosin~cDNA, which is 22% identical and 39% similar
to human RPGRIP. An alignment ofRPGRIP and KIAA1005 is shown in figure 4.19.
The next eight sequences most similar to the 902 amino acid RPGRIP sequence
(containing the predicted coiled-coil domains but lacking the upstream GENSCAN-predicted
exons) were analysed using the Coils (coiled-coil prediction) program (Lupas, Van Dyke,
and Stock, 1991). They were all found to contain domains predicted to adopt coiled-coil
formations. The regions of homology coincide closely with the predicted RPGRIP coiled-
coil domains and the BLAST search using the RPGRIP sequence without the coiled-coil
domains failed to identify these proteins. These eight sequences consisted of three myosin
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Table 4.7: Results of BLAST searches for sequences similar to RPGRIP (Horn. Reg. =
homologous region, Ids = percentage of identical residues, +ves = percentage of similar
residues, e value = the number of different alignments with equal or better scores expected
to occur in a search by chance).








A. RPGRIP sequence (amino acids 1-902, equivalent to exons 1-15)
1. KIAA1005 protein (AB023222, Homo sapiens) 35-900 34 53 lxl 0-135 484
2. Weak similarity to myosin~cDNA (Z46791,
Caenorhabditis elegans)
50-555 22 39 5xl0"13 78
3. Hypothetical 130.5 kDa protein (C09G5.8,
Caenorhabditis elegans)
50-398 21 37 lxlO"7 60















5. Myosin of the dilute-myosin-V family (U60416,
Rattus norvegicus)
49-226 24 47 0.002 46
6. Lamin A (S02358, Xenopus laevis) 34-195 26 47 0.004 45
7. Lamin B2 (X54098, Mus musculus) 34-199 23 46 0.004 45
8. Myosin-3 isoform, heavy chain (Z98762,
Schizosaccharomyces pombe)
38-202 26 45 0.006 44
9. Hookl protein (AF044923, Homo sapiens) 44-192 28 47 0.006 44
10. Myosin-II; Myp2p (AF029788,
Schizosaccharomyces pombe)
38-202 26 45 0.006 44
B. RPGRIP sequence including the 12 upstream GENSCANpredicted exons (amino acids 1-1431)
1. KIAA 1005 protein (AB023222, Homo sapiens) 355-1429 33 52 lxl 0-159 562
2. Weak similarity to myosin-cDNA (Z46791,
Caenorhabditis elegans)
348-1084 22 39 3xl0'16 89
3. Hookl protein (AF044923, Homo sapiens) 362-721 23 37 3xl0'8 62
















5. Integrin analogue gene /Intracellular transport




















7. Unknown protein (AC011665, Arabidopsis
thaliana)
367-710 20 42 4x10~7 59
8. Unnamed protein product (AK025690, Homo
sapiens)
410-721; 414-




9. Similar to nuclear matrix constituent protein 1
(AC007357, Arabidopsis thaliana)
404-747; 389-




10. Paramyosin (S04027, Caenorhabditis elegans)
417-779; 367-




C. RPGRIP sequence minus the coiled-coil domains (amino acids 201-902)
1. KIAA1005 protein (AB023222, Homo sapiens) 205-900 34 53 lxlO"113 408
2. Weak similarity to myosin~cDNA (Z46791,
Caenorhabditis elegans)
269-555 25 42 8xl0"8 60
3. Unknown (AF115283, Leptospira interrogans) 653-786 29 47 0.008 43
4. Hypothetical 130.5 kDa protein (C09G5.8,
Caenorhabditis elegans)
269-398 26 42 0.015 43
5. Nlj21 (AF000402, Lotusjaponicus) 674-845 23 42 0.096 40
6. Hypothetical protein L2719.04 (AL117324,
Leishmania major)
239-332 28 44 0.16 39
proteins (from Rattus norvegicus and Schizosaccharomyces pombe), two proteins of
unknown function (hypothetical 130.5 kDa protein of Caenorhabditis elegans and 364K
Golgi complex-associated protein of Rattus norvegicus), two lamins (lamin A, Xenopus
laevis and lamin B2, Mus musculus) and human Hookl protein. Lamins are members of the
intermediate filament protein family that make up the fibrous lattice lying beneath the inner
nuclear membrane (Stick 1992). Three types of mammalian lamins exist, A, B and C.
Lamin B2 was identified as the second major B-type lamin after lamin B1 (Hoger et al.,
1990). The relatively high e value for the lamin A and B2 alignments (0.004) indicates that
these matches are less likely to be significant than KIA10055. Hookl encodes a human
homologue of the Drosophila Hook gene involved in endocytic trafficking, so-called because
flies with hook mutations display a characteristic hooked-bristle phenotype (Kramer and
Phistry, 1999). Hook mutations have a detrimental effect on the accumulation of soluble and
transmembrane ligands into multivesicular bodies.
The e value for Hookl is relatively high when aligned with the 902-amino acid
RPGREP protein (0.006) but this diminishes (to 3xl0"8) with the addition of the 529-amino
acid translation of the additional upstream GENSCAN predicted exons. The homology of
Hookl to the former polypeptide (the 902 amino acid RPGRIP sequence) encompassed the
predicted coiled-coil domains. This region was extended towards the N-terminus in the case
of the 1431-residue protein (the coiled-coil domains occupy amino acids 543-607 and 679-
729 of the 1431 residue RPGRIP sequence that includes the translation of the GENSCAN-
predicted exons). Among the remaining hits with the highest score/lowest e value for this
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RPGRIP - - -MLDSSDSSSQPHWSNELIAEQLQQQVSQLQDQLDAELEDKRKVLLELSREKAQNEDL
KIAA1005 NYDKLYDSAFSAAHEEQWKLKEQQLKVQIAQLETALKSDLTDKTEILDRLKTERDQNEKL
* * * .
_ _ . * :**: *::**: . *: ***.*
RPGRIP KLEVT NILQKHKQEVELLQNAATISQPPDRQSEPATHPAVLQENTQIEPS
KIAA1005 VQENRELQLQYLEQKQQLDELKKRIKLYNQENDINADELSEALLLIKAQKEQKNGDLSFL
* * * : . . * *:::
RPGRIP -EPKNQEEKKLSQVLNELQVSHAETTLELEKTRDMLILQRKINVCYQEELEAMMTKADND
KIAA1005 VKVDSEINKDLERSMRELQATHAETVQELEKTRNMLIMQHKINKDYQMEVEAVTRKMENL
• . • * •>***>.****> **************** * ★ * • * * • * • *
RPGRIP NRDHKEKLERLTRLLDLKNNRIKQLEGILRSHDLPTSEQLKDVAYGTRPLSLCLETLPAH
KIAA1005 QQDYELKVEQYVHLLDIRAARIHKLE - -AQLKDIAYGTKQYKFKPEIMPDD
* * : ; * * ****.****. . * . *
RPGRIP GDEDKVDISLLHQGENLFELHIHQAFLTSAALAQAGDTQPTTFCTYSFYDFETHCTPLSV
KIAA1005 SVDEFDETIHLERGENLFEIHINKVTFSSEVLQASGDKEPVTFCTYAFYDFELQTTPWR
. . . *.*★****.**..# . **.
RPGRIP GPQPLYDFTSQYVMETDSLFLHYLQEASARLDIHQAMASEHSTLAAGWICFDRVLETVEK
KIAA1005 GLHPEYNFTSQYLVHVNDLFLQYIQKNTITLEVHQAYSTEYETIAACQLKFHEILEKSGR
* .* _***.*.*. . *..*** ..*.*.** . .
RPGRIP VHGLATLIGAGGEE- -FGVLEYWMRLRFPIKPSLQACNKRKKAQVYLSTDVLGGRKAQEE
KIAA1005 IFCTASLIGTKGDIPNFGTVEYWFRLRVPMDQAIRLYRERAKALGYITSNFKGPEHMQSL
*.***. *. ... ** *.
RPGRIP EFRSESWEPQ NELWIEITKCCGLRSRWLGTQPSPYAVYRFFTFSDHDTAI
KIAA1005 SQQAPKTAQLSSTDSTDGNLNELHITIRCCNHLQSRASHLQPHPYWYKFFDFADHDTAI





★*.**.* * *. *** . *** .**** * . *.*. ***. **.
RPGRIP NESIKGDFNLTDPAEKPNGSIQVQLDWKFPYIPPESFLKPEAQTKGKDTKDSSKISSEEE
KIAA1005 DRCISGIFELTDHQKHPAGTIHVILKWKFAYLPPSGSITTEDLG NFIRSEE-
:..*.* *;*** *:*:* *<***>*.**>> . * ***
RPGRIP KASFPSQDQMASPEVPIEAGQYRSKRKPPHGGERKEKEHQWSYSRRKHGKRIGVQGKNR
KIAA1005 PEWQRLPPASSVSTLVLAPRPKPRQRLTPVDKKVSFVDIMPHQS
*. * #* ::
RPGRIP MEYLSLNILNGNTPQQVNYTEWKFSETNSFIGDGFKNQHEEEEMTLSHSALKQKEPLHPV
KIAA1005 DVSQEGSVDEVKENTEKMQQGKDDVSLLSEGQLAEQSLASSEDETEITEDLEPE
:: : .: *.. : . * * . *
RPGRIP NDKESSEQGSEVSEAQTTDSDDVIVPPMSQKYPKADSEKMCIEIVSLAFYPEAEVMSDEN
KIAA1005 VEEDMS ASDSDDCIIPGPISKNIKQPSEKIRIEIIALSLN-DSQVTMDDT
• • . * ••*****•* * ★ ***• ***..*•• ...* *.
RPGRIP IKQVYVEYKFYDLPLSETETPVSLRKPRAGEEIHFHFSKVIDLDPQEQQGRRRFLFDMLN
KIAA1005 IQRLFVECRFYSLP--AEETPVSLPKPKSGQWVYYNYSNVIYVDKENNKAKRDILKAILQ
*....** .** ** ****** **..*• .....*.** .* .... .* .* .*.
RPGRIP GQDPDQGHLKFTWSDPLDEEK-KECEEVGYAYLQLWQILESGRDILEQELDIVSPEDLA
KIAA1005 KQEMPNRSLRFTWSDPPEDEQDLECEDIGVAHVDLADMFQEGRDLIEQNIDVFDARADG
*. . *.******* ..*. ***..* *...* .... ***..**..*.
RPGRIP TPIGRLKVSLQAAAVLHAIYKEMTEDLFS
KIAA1005 EGIGKLRVTVEALHALQSVYKQYRDDLEA
**.*.*...* *...**. .** .
Figure 4.19: CLUSTAL W alignment (Thompson et al., 1994) of the human RPGRIP and
KIAA1005 proteins (* = single, fully conserved residue,: = conservation of strong groups, =
conservation of weak groups, blank space = no consensus).
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larger hypothetical sequence were integrin homolog (Saccharomyces cerevisiae),
intracellular transport protein USOl (Saccharomyces cerevisiae), cingulin (.Xenopus laevis),
unknown protein {Arabidopsis thaliana), unnamed protein product (.Homo sapiens) and
nuclear matrix constituent protein 1 (Arabidopsis thaliana). Integrin homolog and uso 1 are
homologous proteins. Uso 1 has been proposed to be a component of the cytoskeleton with a
role in the transport of proteins from the ER to downstream secretory compartments
(Nakajima et al., 1991). It was identified from a Saccharomyces cerevisiae mutant strain
blocked in the protein secretion pathway. At the C-terminal end of the 1,790 amino acid
Usol protein is an alpha-helical structure of 1,100 residues similar to the coiled-coil region
found in the cytoskeleton-related proteins (Nakajima et al., 1991). Cingulin is a
phosphoprotein found on the cytoplasmic face of epithelial tight junctions (Cordenonsi et al.,
1999). It forms coiled-coil parallel dimers and interacts with a number of proteins including
myosin. It has been proposed to form a connection between the tight junction submembrane
plaque domain and the actomyosin cytoskeleton. Nuclear matrix constituent protein 1
(NMCP1) was identified from carrot cells (Daucus carota) as a constituent of higher plant
structures architecturally homologous to the nuclear lamina of vertebrates (Masuda et al.,
1997). The primary structure of NMCP1 is similar to myosin, tropomyosin, and some
intermediate filament proteins (of which lamins A and B are examples - see Table 4.7). Its
function is largely undetermined.
4.6.3 - Bovine and mouse RPGRIP
The RPGRIP amino acid sequences reported by Roepman et al. (2000) and Hong et al.
(2000) were compared to the RPGRIP sequence described here. Hong et al. (2000)
submitted a 1331 residue murine RPGRIP sequence to GenBank (accession number
AY008297) and Roepman et al. (2000) submitted several sequences from bovine and
human, the longest being a 1221 residue bovine sequence (accession number AAG10247).
The longest human sequence reported by Roepman et al. (2000) (accession number
AAG10246) contained 762 residues, 140 amino acids shorter than the 902 residue sequence
described here. Neither Hong et al. (2000) nor Roepman et al. (2000) provide any
information regarding the genomic structure of RPGRIP in human, bovine or mouse.
Compared to the hRPGRIP sequence shown in Figure 4.11, the bovine sequence contained
an additional 336 amino acids at the amino terminal end and the murine sequence an
additional 345 amino acids. The 529 amino acids encoded by the (undetected) 12 upstream
GENSCAN-predicted exons (exons -12 to -1) were added to the 902 encoded by the detected
exons (exons 1 to 15) and the resulting 1431 aa sequence was compared to the 1221 aa
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bovine and 1331 aa murine sequences. Residues 1 to 183 of this predicted hRPGRIP were
found to have no equivalent in the bovine and murine proteins but the remaining sequence
(residues 184 to 1431) was found to be similar to both over their entire lengths (the
hypothetical human protein was 73% identical and 81% similar to the bovine and 59%
identical and 68% similar to the mouse). These three sequences are shown in alignment in
Figure 4.20. Although none of the 12 upstream GENSCAN-predicted exons appeared to be
transcribed in retina (Figure 4.8), the close similarity of the deduced amino acid sequence
encoded by exons -8 to -1 to bovine and mouse RPGRIP sequences suggests that they may in
fact be part of the human RPGRIP gene. The initiation codon of the mouse sequence
coincides with a methionine codon in the hypothetical human sequence. It is possible that
this is the initiation codon of an RPGRIP transcript. The DNA surrounding this codon in
comparison with the consensus sequence for initiation of translation (Kozak 1987) is shown
in Table 4.8.
Table 4.8: The sequence around a putative translation start site of the hypothetical
hRPGRIP sequence compared with the consensus determined by Kozak (1987). The
numbers indicate the percentage of transcripts that have the residue shown in that position.
Position: -9 -8 -7 -6 -5 -4 -3 -2 -1 +1 +2 +3 +4
Consensus: g33 c39 c37 G44 c39 c53 a61/g36 c49 c55 a T g g46
hRPGRIP: a23 c a23 g a18 g15 a yl 1 c a T g -yl5
There are two obvious gaps in the hypothetical human RPGRIP sequence which are absent
from the bovine and mouse. The first of these is an 8 residue gap in the region encoded by
the 3' end of exon -3. By adding the 4 nucleotides of genomic sequence immediately
downstream of exon -3 and 20 from immediately upstream of exon -2 (see Table 4.3), it is
possible to fill this gap and obtain canonical splice sites. This produces the following amino
acid sequence (additional sequence in red):
-3 -2
bovine . .T E V Q A A Y E T L L H K N Q G I.
human . .T E V Q E V S T F L L T Q N Q G I.
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Figure 4.20 (previous 2 pages): CLUSTAL W alignment (Thompson et al., 1994) of bovine,
mouse and hypothetical human (hum pred) RPGRIP amino acid sequences. The human
sequence is a translation of the gene predicted by analysing the human chromosome 14
genomic sequence (accession number AL135744) with the GENSCAN program (Burge and
Karlin 1998). The numbers and lines correspond to human exons. Shaded letters indicate
the residues encoded by DNA corresponding to the target sites of the PCR primers used to
test for the presence of these exons (section 4.3). * = single, fully conserved residue,: =
conservation of strong groups, . = conservation of weak groups, blank space = no
consensus.
The second gap is in the region encoded by the 5' end of exon -1. The addition to exon -1 of
6 nucleotides of chromosome 14 genomic sequence from immediately upstream of exon -1
fills the gap and again provides a canonical splice acceptor site. These extra nucleotides
would translate into phenylalanine and glutamine, identical to the mouse and bovine residues
at these positions. This 1259 amino acid hypothetical human sequence (including the
additional residues to fill the aforementioned gaps) was analysed using the Compute pI/Mw
tool (Wilkins et al., 1998) and predicted to have a molecular weight of 144 kDa and an
isoelectric point of 5.47.
4.7 - SCREENING RPGRIP FOR MUTATIONS IN ARRP PATIENTS
Bruford (1996) attempted to find ARRP loci in the Sardinian population by studying 11
south-central Sardinian ARRP families, consisting of 28 affected and 44 unaffected
individuals. This was done by screening the whole genome for linkage with 195
microsatellite markers. No linkage was detected to ARRP in the entire set of families (no
lod scores > 3), although heterogeneity analysis (HOMOG program) showed suggestive
linkage (P=0.065) in a subset of 5 families to chromosomal region 14qll. Examination of
additional microsatellite markers in one of these families suggested that an ARRP gene may
lie distal to marker D14S275. The location of the RPGRIP gene was estimated by radiation
hybrid mapping using the Genebridge 4 panel (Gyapay et al., 1996; see section 4.4.3, page
131) and was placed proximal to D14S275, between D14S264 and D14S275 on the
framework of markers, in chromosomal region 14qll. RPGRIP was placed 6.94 cR-6ooo
from the closest marker, D14S264, and the lod score of 2.03 means that this position is 107
times more likely to be the true position than the next most likely placement. Although
Bruford concluded that linkage had been detected to markers distal to D14S275, the
coincidence of finding RPGRIP localised to chromosome 14ql 1, and the comparatively low
radiation hybrid score that placed it proximal to D14S275 (in addition to the possibility that
the maker order is incorrect), led us to believe that it would be unwise to dismiss RPGRIP as
149
a candidate RP gene. Consequently, the screening of RPGRIP for mutations in Sardinian
ARRP patients was begun.
A single individual was screened from three of the five Sardinian ARRP families
that were identified as linked to 14q. Time constraints prevented investigation of the other
two families. RPGRIP was amplified from RNA rather than directly from genomic DNA
because, at the time this work was carried out, the complete structure of the RPGRIP gene
had not yet been determined. In addition, this was prior to the identification of exons 5-7, so
these were not screened. Frozen lymphoblastoid cell lines from the three affected
individuals (BB13 from the ARRP4 pedigree, BB15 from ARRP1, and BB39 from
ARRP 12) were thawed and re-established by Alan Lennon (MRC Human Genetics Unit).
Total RNA was purified from cell pellets and used to amplify RPGRIP cDNA by RT-PCR as
outlined in section 2.30 (page 82). A number of sequence variations from wild-type
RPGRIP were found in the cDNAs from each patient. These were then re-examined by
sequencing RPGRIP PCR products containing the corresponding genomic DNA fragments
(section 2.30, page 81). At the genomic level, the sequence of RPGRIP in these three
patients (coding regions and splice sites) was identical to the wild-type RPGRIP cDNA.
This indicated that the changes seen at the cDNA level were likely to have resulted from
reverse-transcriptase errors rather than mutations.
4,8 - DISCUSSION
The first aim of the experiments presented in this chapter was to isolate the full length
RPGRIP cDNA. Primer extension methods were used to obtain a 2894 bp RPGRIP cDNA.
Initial attempts to extend the RPGRIP cDNA (obtained from human EST r93221) using 5'
RACE were unsuccessful so primer extension methods were applied to a library of adaptor-
ligated linear genomic DNA fragments. In this way, the RPGRIP open reading frame was
extended by 146 bp in the 5' direction. This new sequence was then extended at the cDNA
level in human retina and testis 5' RACE reactions. The retina and testis 5' RACE products
both contain in-frame stop codons upstream of the putative initiation codon. This would
suggest that the exons starting these transcripts are complete at the 5' end. The sequence
surrounding the presumed initiation codon conforms well to the consensus identified by
Kozak (1987), reinforcing the argument that this codon is used to start translation in vivo. A
TATA box has not been identified upstream of the first methionine triplet. The promoters of
many genes lack such elements (Novina and Ror, 1996; Audic and Claverie, 1998) including
many of the so-called 'housekeeping' genes (Azizkhan et al., 1993). GC and CAAT boxes
were also absent from the sequence immediately upstream of exon 1. These elements were
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not found in the sequence upstream of GENSCAN-predicted exon -8. Further work is
necessary to determine the promoter ofRPGRIP.
CpG islands are segments of DNA closely associated with all housekeeping genes
and many tissue-specific genes which are enriched in the CpG dinucleotide (reviewed by
Kundu and Rao, 1999). They are defined as sequences over 200 bp in length (usually 1-2
kb) which contain at least 50% dGTP/dCTP with a CpG content greater than 0.6 of that
expected on the basis of the dGTP/dCTP content of the surrounding DNA (Gardiner-Garden
and Frommer, 1987). If ubiquitous RPGRIP expression had been detected, suggesting a
housekeeping gene, positive identification of a CpG island may have helped to locate the 5'
end of the gene. However, from the expression studies carried out it would appear that
human RPGRIP is not a housekeeping gene. Although CpG islands are also found in some
tissue-specific genes, none were predicted to be located close to RPGRIP exons 1 to 15.
Potential CpG islands (of 699, 357, 259, 265, 288 and 1061 bp) were identified in close
approximation with GENSCAN-predicted exons -9 and -6 following a GrailEXP (Hyatt et
al., 2000) analysis of the chromosome 14 genomic sequence containing RPGRIP.
3' RACE experiments carried out using testis cDNA identified a transcript extending
84 bp downstream from the open reading frame. Most of the ESTs identified in BLAST
searches for sequences with homology to RPGRIP are from the 3' end of the cDNA and
include the stop codon (the 903rd codon of RPGRIP). None of the ESTs or the 3' RACE
product contain either of the two most common polyadenylation signals, AATAAA and
ATTAAA (Graber et al., 1999). The nearest AATAAA is found 5 kb 3' to the end of the
RPGRIP open reading frame but the 3.1 kb transcript size seen in testis (Figure 4.13) is too
small to include such a long 3' UTR. In the absence of a strong polyadenylation signal
(AATAAA or ATTAAA) (Sheets et al., 1990) it is likely that cleavage and polyadenylation
of the mRNA transcripts may be directed by variant polyadenylation signals. Sheets et al.
(1990) analysed 296 ESTs in silico and calculated the frequency of alternative residues at
each position within the polyadenylation hexamers, as shown below.
A A T A A A
A 98 86 0.8 98 95 96
T 0.8 12 98 0.5 3.4 1.5
G 1.1 1.9 0.4 1.5 0 0.7
C 0.4 0.7 0.8 0.4 1.5 2.3
Graber et al., (1999) looked at a much larger number of 3'-ESTs (4,427) and found that 35%
of them did not have AATAAA or ATTAAA. The hexamers TATAAA and AGTAAA are
found close to the 3' end of most RPGRIP transcripts (RACE products and ESTs) (see
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Figure 4.10). According to Sheets et al. (1990), the polyadenylation signal is typically
located 15-25 nucleotides upstream of the polyadenylation site. The last adenosine residue
of the AGTAAA hexamer is 31 bp from the end of the RPGR1P transcripts and the presumed
site of polyadenylation; the last adenosine residue of the TATAAA hexamer is 17 bp from
the end of the transcripts. Graber et al (1999) estimated that TATAAA is the fourth most
common of 18 single-base-substitution variants of AATAAA in 3'-ESTs that do not contain
AATAAA. The variants seen more frequently than TATAAA are (in order of frequency)
ATTAAA, AAAAAA and AGTAAA. Sheets et al. (1990) assessed the effects of point
mutations in the AATAAA polyadenylation signal on the efficiency of polyadenylation in
vitro. When the polyadenylation signal was AGTAAA, the efficiency of polyadenylation
was 29% (± 8.1%) that of AATAAA. When the polyadenylation signal was TATAAA the
efficiency of polyadenylation was 17% (± 3%) that of AATAAA. Thus, AGTAAA would
appear to be a more efficient polyadenylation signal, at least in vitro, although TATAAA is
closer to the supposed polyadenylation site. Both are relatively common variants of
AATAAA (Graber et al., 1999) and either could be acting as the polyadenylation signal,
suggesting that the 3' end of the identified RPGRIP sequence does represent the correct 3'
end.
Eight out of the nine human ESTs located at the 3' end of RPGRIP (ai964059,
ai655818, ai632512, ai05922, aa782963, aw681763, aa928161 and w26173) terminate 81-83
bp downstream of the termination codon. These ESTs were oligo (dT)-primed, indicating (if
the polyadenylation signal is located 15-25 nucleotides upstream of the polyadenylation site)
that the polyadenylation signal is likely to be 57 - 67 bp downstream of the stop codon (the
first position of the TATAAA hexamer is 59 bp downstream of the stop codon and the
AGTAAA hexamer is 45 bp downstream). The presence of in-frame stop codons in these
ESTs (at the position shown in Figure 4.10) also indicates that this is the likely 3' end of the
coding sequence. The remaining EST (aa476670) is also oligo (dT)-primed but ends 315 bp
3' to the end of the termination codon. Immediately 3' to the end of this EST is an A-rich
region (17/20), suggesting that an extended transcript has false-primed within this region.
In addition, probing the first northern blot (MTN2) revealed the presence of two
transcripts in testis, of 3.1 kb and 2.0 kb. These sizes are close to the full length RPGRIP
cDNA (i.e. including exons 5-7) and the smaller transcript (lacking exons 5-7), at 2.89 and
1.95 kb respectively. Estimates of transcript sizes from northern blots must be treated as
rough indicators only (since they are made by comparing fragment movements with those of
a limited number of standards), so the possibility of additional small 5' exons not revealed
by RACE cannot be excluded.
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A second goal of these experiments was to determine the genomic structure ofRPGRIP and
was facilitated by the appearance of chromosome 14 sequence in genomic sequence
databases. This submission also enabled exon-finding analyses to be carried out, using the
HGMP RC NIX collection of bioinformatic programs. The GENSCAN analysis (Burge and
Karlin, 1998) predicted the existence of fifteen additional exons within the RPGRIP gene:
twelve upstream of the first exon, and three between the fourth and fifth detected exons. The
latter three exons were found to be transcribed in human retina but the twelve 5' predicted
exons were not detected. The existence of additional exons had been proposed (i) on the
basis of northern blot data (two bands were observed in testis (MTN2, Figure 4.13, page
133): a smaller band of 2.0 kb, roughly the size of the presumed full length RPGRIP cDNA,
and a larger band of 3.1 kb) and (ii) the presence of an approximately 488 bp larger but less
abundant band accompanying the expected 1862 bp product of a PCR primed in the 5' and
3' UTRs ofRPGRIP (Figure 4.9)
It remains a possibility that the undetected 12 upstream exons (exons -12 to -1) are
transcribed into an isoform that lacks exon 10 (containing the RG321ongREV target
sequence), or that a transcript containing these exons was not abundant in the retina cDNA
which was used in the attempt to amplify these exons. Alternatively, the reactions carried
out to amplify RPGRIP cDNA between the predicted exons and exon 10 may have failed due
to the size limitations of RT-PCR. Comparison of a translation of the 12 upstream
GENSCAN-predicted exons with recently reported bovine (Roepman et al., 2000) and
mouse (Hong et al., 2000) RPGRIP proteins indicates that it is likely that exons -8 to -1
contribute to the RPGRIP gene. Further cDNA work using alternative primers and different
tissue cDNAs is needed to conclusively include or exclude the presence of these predicted
exons.
A third goal was to identify the chromosomal location of the RPGRIP gene.
Screening a human monochromosomal somatic cell hybrid DNA panel (Kelsell, et al., 1995)
initially placed RPGRIP on chromosome 14. This was confirmed after completion ofmuch
of this work when the human chromosome 14 genomic sequence containing RPGRIP
appeared in the genome databases. The gene was also localised to chromosome 14 on two
human gene maps that had been constructed using analogous techniques: a radiation hybrid
map and the chromosome 14 HAPPY map (Dear et al., 1998). These were both produced by
fragmenting the genome (by irradiation or shearing), and then estimating the order and
distances between separate loci on the basis of the frequency of cosegregation: the closer two
loci are in the genome the more frequently they will have been retained on the same
fragment.
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The location of the RPGRIP gene was determined by radiation hybrid mapping using
the Genebridge 4 panel (Gyapay et al., 1996). In this way it was placed on the framework of
markers in-between D14S264 and D14S275 in chromosomal region 14qll. This places
RPGRIP proximal to D14S275. The gene was placed 6.94 centiRays-6ooo (cR) from the
closest marker, D14S264, with a LOD score of 2.03 relative to the next most likely
placement. A LOD score of 2.03 means that this position is 107 times more likely to be the
true position than the next most likely placement. The breakage distance of 6.94 cR
translates into a physical distance of 1443.52 kb on the Genebridge 4 radiation hybrid map of
chromosome 14, where 1 cR equates to 208 kb.
Identification of an STS (hi 4a 1407) containing 320 bp ofRPGRIP sequence located
the gene on the HAPPY map, a framework of 1003 markers covering the whole of
chromosome 14 (Dear et al., 1998). In addition to the STSs generated by Dear et al. (1998),
the chromosome 14 HAPPY map contains a number of markers which are present on the
radiation hybrid and genetic maps to facilitate cross-referencing between maps.
STS:hl4al407 is located on the chromosome 14 HAPPY map between markers D14S72 and
D14S275. D14S72 and D14S264 are both proximal to D14S275, so the placement of
RPGRIP in this interval is in agreement with the radiation hybrid data.
A further goal of these experiments was to evaluate the expression of RPGRIP in a
variety of human and bovine tissues. Expression was detected in retina and testis only in
human tissues but was seen to be more widespread in bovine (although this may reflect the
rapidity with which bovine tissues were harvested after death and the consequent likelihood
that RNAs are undegraded). Three northern blots containing human poly (A)+ RNA were
probed in an attempt to determine the size, number and tissue distribution of RPGRIP
transcripts. Only one of these gave a strong positive result when two testis transcripts were
detected (northern blot 1), one of 2.0 kb and a less abundant one of 3.1 kb. No signals were
detected on this blot in spleen, thymus, prostate, ovary, small intestine, colon or peripheral
leukocyte. A faint band of 6.2 kb was detected in the skeletal muscle lane of the second
northern blot (northern blot 2) and two weak bands of 5 kb and 6.25 kb were observed in the
retina lane of the third northern blot (northern blot 3). These were presumed to be non¬
specific, although addition of the twelve upstream GENSCAN-predicted exons to the 2894
bp RPGRIP sequence would produce a transcript of 4483 bp, and a 1.7 kb 5' untranslated
region could raise this to 6.2 kb. Alternative splicing was evident in RPGRIP (transcripts
lacking exons 5-7 and 12 were isolated) so it remains a possibility that some of the
GENSCAN-predicted exons are part of the RPGRIP gene but are not transcribed in the
tissues used for cDNA analysis. The retina that was used to prepare the retinal RNA on this
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northern blot was obtained from a different source to the other tissues and the much stronger
P-actin signal in retina compared with the other tissues may reflect this. All of the RNA
samples used to prepare the third blot were purified from tissue samples that had been
collected an average of 24 hours after death. This is sufficient time for RNase-mediated
degradation of the RNA to occur. No retina-containing northern filters (or RNAs) are
available commercially. With the ready availability of fresh bovine RNA, hybridising an
RPGR1P probe to a bovine northern blot would be a valuable future experiment.
RPGRIP expression is readily detectable in human and bovine retina using more
sensitive RT-PCR analyses. Expression was evident in all bovine tissues examined with the
exception of pancreas, although this RNA sample also failed to produce a strong G3PDH
control signal. From a range of human total RNA samples, RPGRIP was only detectable in
retina and testis (two bands were amplified from retina RNA; one lacked exon 12, the other
was intact). In both the human and the bovine RT-PCR experiments, two separate reactions
were used to generate the RPGRIP/bRPGRIP and G3PDH products. These reactions utilised
gene specific primers during the reverse transcriptase step (rather than oligo (dT) primers to
generate a cDNA pool from which specific transcripts could be subsequently amplified).
The difference between human and bovine tissues may reflect a genuine species difference
or a difference in mRNA quality: human retina RNA could only be obtained 24 hours post¬
mortem compared with less than 30 minutes for bovine tissues. Alternatively, the bovine
RT-PCR products may represent illegitimate transcription products (Chelly et al., 1989) or a
processed pseudogene. The latter possibility could be confirmed or excluded by sequencing
the bovine RT-PCR products. Human RPGRIP transcripts were also amplified from human
lymphoblastoid cell line derived total RNA. However, two rounds of PCR using nested
primers were required in order to obtain visible bands, so increasing the risk of detecting
illegitimate transcription products. Consequently, any conclusion that RPGRIP is normally
expressed in lymphoblastoid cellsmust be treated with caution.
The large number of sequences deposited in public EST databases (for example
3,288,343 human ESTs in dbEST (http://www.ncbi.nlm.nih.gov/dbEST/) from several
thousand separate libraries) provides a means of assessing the range of expression of a gene.
RPGRIP ESTs came from: retina; foetal liver and spleen; testis; mixed foetal lung, testis and
B-cell; and pooled germ cell tumour libraries (see Table 4.5). The absence ofRPGRIP ESTs
from adult libraries without a retina or testis component suggests that RPGRIP expression in
adults may be limited to retina and testis. In addition, the low number of ESTs in the
databases may indicate low expression ofRPGRIP.
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Bioinformatic analyses of the primary structure can potentially generate functional
information about a novel protein. Structure predictions using peptide analysis programs
suggested that RPGRIP is a soluble protein containing two coiled-coil domains
(encompassing residues 14 to 78 and 150 to 200) and two C2-domains (residues 416-532 and
611-716). The coiled-coil was first identified as the major structural component of a large
group of fibrous proteins that include keratin, myosin and fibrinogen (Pauling and Corey,
1953; Crick 1953). Coiled-coils consist of a number of a-helices, generally between two
and four, wound into a superhelix (Cohen and Parry, 1986). The constituent a-helices may
be arranged in parallel or antiparallel. At the amino acid level, coiled-coils are made up of 7-
residue repeats. If the positions in these heptad repeats are labelled a to g, then the side
chains of the residues at positions a and d are generally non-polar/hydrophobic and form the
helix interface (Figure 4.21A), and b, c, e, f and g are polar/hydrophilic and make up the
solvent-exposed part of the coiled-coil (Lupas 1996; Figure 4.2IB). Positions e and g are
frequently occupied by charged residues (Beck et al., 1997). The a and d residues form a
non-polar band running along the surface and inclined around the axis of each a-helix
(Cohen and Parry, 1986; Figure 4.21C). These non-polar side chains are packed in the core
of the bundle of a-helices in a distinctive manner, known as 'knobs-into-holes', to stabilise
the coiled-coil (Figure 4.21A). This consists of a side chain from one helix (knob)
positioned in a space bordered by four side chains of the opposing helix (hole), immediately
to the side of the equivalent side chain from the opposing helix (Lupas, 1996).
Coiled-coils have a numbers of different functions including the provision of spacers
to separate the bacterial cell wall from the outer membrane, providing a scaffold for
regulatory complexes (tropomyosin), forming a defensive surface for pathogens
(Staphylococci M proteins), forming the so-called antiparallel 'thumbs' and 'arms' in several
DNA and RNA processing enzymes that move, guide or grip the reaction substrates (e.g.
DNA polymerase I), contributing to the cytoskeleton (intermediate filaments), and forming
molecular levers (myosin) and stalks (kinesin, influenza haemagglutinin), and producing
mechanically rigid structures such as blood clots (fibrin) or hair (keratin) (reviewed by
Lupas, 1996). Coiled-coils have also been found in protein segments identified by deletion
analysis as being responsible for oligomerization (Jasin et al., 1984). This is only a few of
many examples to illustrate the fact that coiled-coils are present in a diverse array of
proteins. Further study will be required to determine the function of this organised tertiary
structural feature in RPGRIP.
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Figure 4.21: Models showing how two alpha helices interact to form a coiled-coil (Lumb and
Kim, 1995). The primary sequence of the constituent helices consists of a repeat unit of
seven residues, labelled a to g(Aand B). The a and d residues tend to have non-polar/
hydrophobic side chains and form the interface between the two helices (A). The b, c, e, f
and g residues generally have polar/hydrophilic side chains and make up the solvent-
exposed part of the coiled-coil (B). The packing of the a and d non-polar side chains in the
core of the a-helical bundle, known as 'knobs-into-holes', stabilises the coiled-coil. This
consists of a side chain from one helix (knob) positioned in a space bordered by four side
chains of the opposing helix (hole), immediately to the side of the equivalent side chain from
the opposing helix (A). The a and d residues form a non-polar band running along the
surface and inclined around the axis of each a-helix (represented by red stripes in C).
C2-domains are independently folding calcium- and phospholipid-binding domains
of approximately 130 amino acids. The majority of proteins with C2-domains play roles in
signal transduction, such as those involved in protein phosphorylation (e.g. protein kinase C
(PKC) (Coussens et al.,1986; Knopf et al.,1986), ubiquitin ligation (e.g. Nedd4 (Plant
1997)), the activation of GTPases (e.g. Ras-GAP (Trahey et al., 1988)) and the generation of
lipid second messengers (e.g. cytoplasmic phospholipase A2 (cPLA2) (Clark et 1991),
phospholipase Cs (PLCs; Rhee et al., 1989), and phosphatidylinositol 3-kinases (Hiles et al.,
1992)). They are also involved in membrane trafficking, as with rabphilin-3 (Shirataki et al.,
1993), synaptotagmins (Perin et al., 1990; Perin et al., 1991), RIM (Wang et al., 1997) and
Muncl3 (Brose et al., 1995)) proteins.
The notion that C2-domains may bind calcium ions followed from the observation
that C2-domain-containing PKC isoforms were regulated by Ca2+ whereas isoforms without
C2-domains were not (Nishizuka, 1988). For many C2-domains, phospholipid binding is
regulated by calcium and, for this reason, they are sometimes referred to as calcium-
dependent lipid binding domains (reviewed by Rizo and Sudhof, 1998).
Most of the information about C2-domains has come from the study of
synaptotagmin 1, cPLA2, PKC, and inositol phospholipid-specific phospholipase C delta 1
subunit (PLC81). Synaptotagmin is one of at least twelve transmembrane proteins that
contain two C2-domains (the C2A- and C2B-domains) and plays a role in membrane
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trafficking. It is found on synaptic vesicles and is required for the rapid Ca2+-dependent
element of the release of neurotransmitters (Geppert et 1994; Brose 1992). A
mechanism involving Ca2+ binding to both of the two synaptotagmin C2-domains is thought
to function as the chief calcium sensor in the exocytosis of synaptic vesicles. The C2-
domains in cPLA2, PKC and PLC51 are thought to function by effecting the Ca2+-dependent



























Figure 4.22: Schematic representations of the two defined C2-domain topologies. The
arrows represent b-strands and are numbered according to their appearance in the primary
sequence. At the top of the C2-domains the three calcium-binding loops are labelled loops 1-
3.
In isolation, the synaptotagmin I C2A-domain was found to display autonomous folding and
Ca2+-dependent phospholipid binding (Davletov and Siidhof 1993). The domain was shown
to bind all negatively charged phospholipids as well as syntaxin (Li 1995). The
cPLA2 (Nalefski et al., 1994; Nalefski et al., 1997), PKCp (Shao et al., 1996) and Nedd4
(Plant et al., 1997) C2-domains also bind phospholipids in a Ca2+-dependent manner,
although cPLA2 binds to neutral phospholipids (Daveltov and Siidhof 1993; Nalefski et al.,
1998) and PKCp does not exhibit Ca2+-dependent syntaxin 1 binding. These facts reflect
the functional diversity among C2-domains. Further to this, some Ca2+-regulated C2-domains
simultaneously associate with other molecules independent of Ca2+ (e.g. synaptotagmin C2B-
domain interacts with AP-2 (Zhang et al., 1994), inositol polyphosphates (Fukuda et al.,
1994), p-SNAP (Schiavo et al., 1995) and Ca2+ channels (Sheng et al., 1997)). Finally, the
observation that a number of synaptotagmins seem to lack Ca2+ binding suggests that a
number ofC2-domains may be Ca2+-independent (see Rizo and Sudhof, 1998).
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The first studied structure of a C2-domain was the C2A-domain of synaptotagmin I (Sutton et
al., 1995). X-ray diffraction analysis showed this to consist of two closely apposed four-
stranded P-sheets, with four loops at the bottom and three at the top connecting the eight
strands (Figure 4.22). This conformation is referred to as topology I. The three-dimensional
structure of the C2-domain of PLC61 strongly resembles that of the synaptotagmin C2A
domain but the arrangement of the strands is very different (Essen et al., 1996). This is a
circular variation of topology I and is referred to as topology II (Figure 4.22). The PKC3
and cPLA2 C2-domain crystal structures were studied and found to be similar to those of the
synaptotagmin I and PLC61 C2-domains and found to display topologies I and II respectively
(Perisic et al., 1998). Binding sites for multiple (two or three) calcium ions are contained in
the top loops of C2-domains. These are formed for the most part by aspartate side chains,
which serve as bidentate ligands for the Ca2+ ions. It appears that Ca2+-dependent C2-
domains have evolved to cluster multiple Ca2 ions within a small volume. Unsatisfied
coordination sites on the Ca2" ions are able to mediate interactions with molecular targets
(see Rizo and Siidhof, 1998). Comparison of the RPGRIP C2-domain with those of other
proteins suggests that it is likely to be a Ca2+-binding domain (C. Ponting, personal
communication).
Shao et al., (1996) showed that calcium binding causes rotation of some side chains
but induces no significant conformational change in synaptotagmin 1 C2A-domain. This led
to questions as to how Ca2+ regulates C2-domain function. In the case of synaptotagmin 1
C2A-domain, calcium binding leads to a significant change in the electrostatic potential of
the protein (Shao et al., 1996). It has been proposed that such changes may, in some cases,
lead to target binding, including (for the synaptotagmin 1 C2A-domain at least) phospholipid
binding (Daveltov and Siidhof 1993). However, work carried out on PKCP has shown that
lipid binding to C2-domains is probably not entirely electrostatic (Edwards and Newton
1997), although what other factors influence this remain unknown.
Information about the potential function of a novel protein can also be gained by
identifying homology with previously characterised sequences. BLAST searches were
carried out in order to identify sequences with homology to RPGRIP. The sequence that was
identified with the lowest e value (equivalent to the highest significance) was the
uncharacterised human protein KLA1005. 'Weak similarity to myosin' had the next lowest e
value and the subsequent sequences had much higher e values. This was the case for each of
the three RPGRIP sequences that were used for database searching: (i) the 902 residue
protein, (ii) the 1431 residue combination of the 902 amino acid RPGRIP and the 529 amino
acids encoded by the GENSCAN-predicted exons and (iii) the 702 residue RPGRIP
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sequence lacking the predicted coiled-coil domains. The e values are more significant for
the top 10 matches with the 1431 residue RPGRIP sequence than with the other two query
sequences. In the absence of experimental evidence as to which, if any, of the upstream
GENSCAN-predicted exons are used or spliced, the in silico results obtained with the 1431
residue sequence should be treated with caution. However, the regions of homology with
these sequences do not extend beyond the predicted first residue of the hypothetical 1259
amino acid RPGRIP protein identified as the likely orthologue ofmurine RPGRIP (described
in section 4.6.3). Most of these homologous proteins are uncharacterised but three of them,
hookl protein, integrin homolog and intracellular transport protein USOl, are thought to
play roles in intracellular transport, and two, paramyosin and "weak similarity to myosin",
are potential motor proteins, suggesting the possibility of a similar role for RPGRIP.
Another aim of this chapter was to screen RPGRIP for mutations in RP patients.
Bruford (1996) detected suggestive linkage to chromosome 14ql 1 in a subset of five out of
eleven Sardinian ARRP families by typing and analysing 195 microsatellite markers. The
RPGRIP gene was localised by radiation hybrid mapping to chromosome 14ql 1, close to the
D14S275 marker Bruford identified as being linked to Sardinian ARRP. The RPGRIP gene
was therefore screened for mutations in three of the five linked families but none were found.
RPGRIP was amplified from RNA/cDNA and checked by genomic sequencing. The full
genomic structure was obtained at a later stage (see section 4.3, page 121), after which exons
5, 6 and 7 were identified. Time constraints prevented these exons from being screened for
mutations in the three ARRP families, and prevented the screening of RPGRIP in the other
two linked families. This will need to be carried out in the future. If this fails to identify
any mutations, and in the absence of other pedigrees linked to chromosomal region 14q 11, a
suitable approach would be to screen a large number of ARRP families in an attempt to
detect RPGRIP mutations, which might be rare because ARRP is a very heterogeneous
disorder with at least thirteen mapped or identified loci (see section 1.6, page 11).
In summary, a 2894 bp RPGRIP cDNA was isolated, which may be the full-length
human transcript, and a smaller 1946 bp transcript, which lacks exons 5 to 7. The predicted
products would yield proteins of 586 and 902 amino acids respectively, with molecular
masses of 67 kD and 97 kD. The RPGRIP gene was localised to the long arm of
chromosome 14 in band 14qll, between markers D14S264 and D14S275 and found to be
expressed in retina and testis. The more widely expressed bovine homologue was detected
in all except one of the tissues examined. Two potential coiled-coil and two C2-domains
were identified by in silico analysis of the RPGRIP protein sequence. These are likely to be




The principal aim of this project was to isolate proteins that interact with RPGR, the RP3
gene product. Using the yeast two-hybrid system, a previously uncharacterised sequence has
been identified that encodes RPGR Interacting Protein (RPGRIP). Fifteen exons were
shown to contribute to the RPGRIP gene, translating to a protein of 902 amino acids and 97
kDa. The bovine orthologue of RPGRIP (Roepman et al., 2000) was reported at the same
time as this work (Boylan and Wright, 2000) and the mouse orthologue was reported some
time later (Hong et al., 2000a). Comparison of the human RPGRIP protein with the bovine
and mouse orthologues, indicates that additional upstream exons are likely to contain
RPGRIP coding sequence. A GENSCAN analysis (Burge and Karlin, 1998) of human
chromosome 14 genomic DNA identified 12 exons upstream of the presumed first exon of
RPGRIP but these were not detected in human retina cDNA. RPGRIP is expressed in
human testis (revealed by northern blot and RT-PCR) and retina (RT-PCR) but more widely
in bovine tissues. The gene is located on chromosome 14qll and preliminary screening
RPGRIP in Sardinian ARRP patients, previously shown to be linked to this region, failed to
identify any mutations. In silico analysis of RPGRIP revealed the presence of two potential
coiled-coil domains, two potential calcium/phospholipid-binding C2-domains and homology
with characterised and uncharacterised proteins, including several with roles in intracellular
trafficking.
The three research papers that reported the isolation ofRPGRIP (Boylan and Wright,
2000; Hong et al., 2000a; Roepman et al., 2000) each presented the results of screening
bovine or mouse retina expression libraries in the yeast two-hybrid system. Hong et al.
(2000a) screened a mouse retina library using residues 39 to 460 of the mouse RPGR protein
(mRPGR) as bait. They screened 1 x 106 library sequences and identified five mRPGRIP
clones and one PDE8 clone, the latter replicating the result of Linari et al. (1999). The
interaction between mRPGRIP and mRPGR was confirmed using a GST pull-down assay.
Roepman et al. (2000) screened 1.85 X 106 independent bovine retina clones using residues
1 to 402 of human RPGR as bait. They identified six bovine RPGRIP clones and verified
the interaction using a GST pull-down assay and co-immunoprecipitation of bRPGR and
bRPGRIP from bovine retinal extracts using anti-RPGR and anti-RPGRIP antibodies.
By hybridising northern blots containing RNA purified from murine tissues to
mRPGRIP probes, Hong et al. (2000a) detected a 10 kb doublet in retina and a 3 kb band in
testis but no bands in brain, heart or liver, nor in retinal tissue from the rd mouse. Roepman
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et al. (2000) probed bovine northern blots with bRPGRIP and observed a band of 0.8 kb in
retina, brain, RPE, kidney, liver and spleen and retina-specific transcripts of 4.5 kb and 7.5
kb. RT-PCR experiments using bovine RNA samples revealed RPGRIP expression in heart,
brain, spleen and retina but not liver, lung, skeletal muscle, placenta or kidney. Both groups
also assessed RPGRIP expression in a variety of tissues by probing western blots with anti-
RPGRIP antibodies. Hong et al. (2000a), using a polyclonal antibody that binds mRPGRTP
residues 991-1331 (including the RPGR-binding domain), detected a 210 kDa polypeptide in
the retina of wild-type and RPGR knockout mice but not in wild-type brain, heart, lung,
muscle, testis, kidney or spleen. Roepman et al. (2000) used a polyclonal antibody against
the RPGR-interacting domain of bRPGRIP (encompassing residues 842-1232) to probe
western blots containing bovine proteins. They observed a 175 kDa retina-specific band; a
100 kDa band in retina, brain, skeletal muscle and lung; a 97 kDa band in spleen, kidney and
lung and a 48 kDa band in retina, brain and skeletal muscle. This indicates either alternative
splicing ofRPGRIP in bovine tissues or differential protein degradation (possibly as a result
of the extraction process). The results of expression studies described in the three reports are
summarised in Table 5.1. The 2894 bp human RPGRIP sequence shown in figure 4.11
translates to a 902 amino acid protein with a predicted molecular weight of 97 kDa. This is
likely to be homologous to either the 97 kDa isoform or the 100 kDa isoform observed by
Roepman et al. (2000). The 1259 amino acid human protein identified in section 4.6.3 as
being the probable human orthologue of bovine and mouse RPGRIP has a predicted
molecular weight of 144 kDa. A protein encoded by a transcript containing exons 1 to 15
and GENSCAN-predicted exons -12 to -1 would have a molecular weight of 163 kDa. With
significant post-translational modification, either the 144 kDa or 163 kDa hypothetical
human proteins may be homologues of the 175 kDa bovine peptide observed by Roepman et
al. (2000) or the 210 kDa mouse peptide observed by Hong et al. (2000a).
The antibody work of both groups extended to investigating the subcellular
localisation of RPGRIP. Hong et al. (2000) carried out immunostaining of murine retinal
sections and detected RPGRIP at the junction between photoreceptor inner and outer
segments (staining was identical in wild-type and RPGR knockout mice). Immunostaining
of mechanically disrupted photoreceptors revealed the localisation of mRPGRIP to the
connecting cilium, with small amounts in the basal body. Similar results were obtained
using cone-dense squirrel retinas, although the epitopes recognised by the anti-mRPGRIP
antibody were not definitively shown to be present in this animal. Immunogold labelling
showed mRPGRIP to be localised to the external side of the cilia microtubule doublets but
not to the basal body. Hong et al. (2000b) had previously localised mRPGR to the photorec-
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Table 5.1: RPGRIP expression was detected in a variety of mouse, human and bovine
tissues by Hong et al. (2000a), Roepman et al. (2000) and Boylan and Wright (2000). Blank
boxes indicate that RPGRIP expression was not investigated in these tissues.
(Hum./Bov./Mur. north = sizes in kilobases of bands detected in human/bovine/mouse
northern blots, Hum./Bov./Mur. RT = results of screening for RPGRIP transcripts by RT-
PCR, Hum./Bov./Mur. west = sizes in kiloDaltons of proteins detected on western blots. S.I.


















Brain X 0.8 100, 48 X X
Colon X
Heart X / X X
Kidney X 0.8 / 97 X
Liver X 0.8 / X
Lung X / 100, 97 X













Spleen X X 0.8 97 X
Testis 2.0,3.1 / / 3 X
Thymus X
eptor cilium using an antibody against the C-terminal 250 amino acids of mRPGR. By
performing cell fractionation and extraction experiments on mouse photoreceptor inner and
outer segments, Hong et al. (2000a) detected RPGRIP exclusively in a detergent-insoluble
fraction that was enriched for the ciliary axoneme (the central fibrillar core of the cilium,
consisting of 9 pairs of microtubules). In COS cells, recombinant mouse RPGRIP was
observed to have a punctate and filamentous distribution and formed homo-dimeric or homo-
oligomeric complexes. It did not co-localise with microtubules. These results led Hong et
al. (2000a) to propose that RPGRIP is a structural component of the ciliary axoneme and that
RPGR indirectly associates with the cilium via RPGRIP binding. Roepman et al. (2000)
observed RPGRIP and RPGR (using the anti-RPGRIP antibody mentioned earlier and an
antibody against residues 96-116 ofRPGR) co-localising in the rod outer segments of bovine
and human photoreceptors. No signals were detected in cone photoreceptors. They also
reported a degree of staining at the junction between the rod inner and outer segments,
suggestive of a ciliary localisation. Similar to Hong et al. (2000a), Roepman reported that a
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transfected heterologous N-terminal RPGRIP polypeptide formed a visible and self-
aggregated higher order complex. Roepman et al. (2000) also investigated the effects of
XLRP mutations on hRPGRIP binding in the yeast two-hybrid system. The F130C, Q236X
and 468:RNQIICX mutations abolished RPGRIP binding at 30°C and G275S decreased
RPGRIP binding. A human RPGRIP fragment encompassing residues 579 to 762 (equivalent
to residues 719 to 902 of the RPGRIP shown in figure 4.11) was identified as the minimal
RPGR-binding domain by deletion mutational analysis. By radiation hybrid mapping,
Roepman et al. (2000) mapped human RPGRIP to a locus defined by marker D14S932 in
chromosomal region 14ql 1.
It is not clear what the function of RPGRIP is in the retina. However, from the data
contained in the three reports (Boylan and Wright 2000; Hong et al, 2000a; Roepman et al,
2000) it is possible to speculate as to the roles of RPGRIP and RPGR and suggest
experiments that would help to define them. Neither Hong et al. (2000a) nor Roepman et al.
(2000) competed for antibody binding with peptide in order to exclude non-specific
immunostaining. However, both detected RPGRIP in the photoreceptor cilium, which
connects the inner and outer segments. The observation of RPGRIP transcripts in human
testis and retina (sections 4.5.l.i, page 132, and 4.5.2, page 136) hinted at a ciliary
localisation for RPGRIP as the spermatozoan flagellum is analogous to the photoreceptor
cilium. The literature contains numerous examples of sperm and ciliary abnormalities
accompanying retinitis pigmentosa (although some have questioned this phenomenon (Lee et
al., 1983; Szczesny, 1995)), including thinning of cilia (in XLRP, ADRP and ARRP;
Szczesny, 1995), immotile cilia syndrome (often coupled with infertility due to impaired
sperm velocity and motility; Ohga et al., 1991; van Dorp et al., 1992), abnormal structure
and reduced sperm docosahexaenoic acid content (Connor et al., 1997), abnormal nasal cilia
(in ADRP, ARRP and Usher's syndrome; Arden and Fox, 1979) and abnormal ciliary
axonemes (in XLRP; Hunter et al., 1988) and at least one kindred with reported ciliary
abnormalities is known to carry an RPGR mutation (Dry et al., 1999).
The inner and outer segments are two morphologically and functionally distinct
compartments of photoreceptor cells. Outer segment proteins are synthesised within the
inner segments and the cilium must support their transport distally and prevent their
retrograde diffusion (Spencer et al., 1988). The functions of this organelle are yet to be
comprehensively described but Wolfrum and Schmitt (2000) recently showed that after
synthesis in the inner segment, rhodopsin, which accounts for up to 85% of outer segment
protein (Molday, 1998), is transported through the connecting cilium prior to incorporation
into the outer segment disc membranes. Rod outer segments are renewed continually and the
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rate of addition of new membrane has been estimated at up to 3 pm2/min (Besharse, 1986).
RPE cells, which process the phagocytosed fragments of outer segments, are among the most
phagocytically active cells in the human body (see section 1.3, page 6), reflecting this huge
turnover of photoreceptor material. The connecting cilium is clearly a vital component of
protein transport in photoreceptors. RPGR was previously localised to the connecting cilium
and RPGR knockout mice displayed mis-localisation of blue and green cone opsins to the
inner segment, perinuclear and synaptic regions, as well as showing reduced outer segment
rhodopsin content, suggesting aberrant opsin trafficking (Hong et al., 2000b). Moreover, the
in silico analysis of RPGRIP presented in section 4.6.2 (page 141) revealed that RPGRIP is
homologous to several proteins involved in intracellular transport (hookl protein, integrin
homolog and intracellular transport protein USOl). Therefore, the observations that
RPGRIP interacts with RPGR and localises to the connecting cilium are compatible with the
notion that it plays a role in intracellular trafficking between the inner and outer segments.
Vesicle-mediated intracellular protein transport is regulated by a complex molecular
machinery involving an assortment of membrane-bound and soluble factors (see Guo et al.,
2000). Nascent proteins are directed to their final destination in transport vesicles after
entering the endoplasmic reticulum lumen and traversing the Golgi complex for post-
translational processing. Each step of vesicular transport consists of three stages: budding of
the vesicle from donor membranes, targeting to new compartments and fusion of the vesicle
with acceptor membranes (Rothman, 1994). The SNARE hypothesis (Rothman, 1994)
proposes that at all stages of vesicular transport, vesicle and target membranes have one or
more SNAP-receptor proteins (called v-SNAREs and t-SNAREs, respectively) that act as
unique address markers. A vesicle covered in v-SNAREs will only fuse with a target
membrane if it is displaying the cognate t-SNARE. The cytosolic W-ethylmaleimide
sensitive factor' (NSF) ATPase (Block et al., 1988) binds to SNAREs through its interaction
with soluble NSF attachment proteins (SNAPs, which interact with the membrane-bound
SNARE proteins) to form a complex known as the '20S particle'. The ATPase activity of
NSF subsequently causes the disassembly of the 20S particle and fusion of vesicle and target
membranes (Sollner et al., 1993). Most SNAREs are type II membrane proteins with short
luminal or extracellular domains and large cytosolic domains. The cytosolic domains are
proposed to mediate the SNAP-SNARE interaction and contain coiled-coils (Sollner and
Rothman, 1996). Synaptotagmin, a well characterised C2-domain containing protein, is an
example of a v-SNARE (Siidhof, 1995) and it is possible that RPGRIP, another C2-
domain/coiled-coil-containing protein is a v-SNARE also. Once fusion has occurred, v-
SNAREs must be recycled back to the original donor compartment to preserve membrane
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identity (Ferro-Novick and Jahn, 1994). It is not known how this is brought about but it is
thought that v-SNAREs are inactive until they engage in an association with a specific Rab
GTPase (Machamer, 1996). Transport of secretory vesicles is blocked by non-hydrolysable
analogues of GTP (Rothman, 1994) and Rab proteins are known to be required for the
assembly of SNARE complexes (Sollner and Rothman, 1996).
Rab proteins are Ras-related small GTPases that serve to regulate the movement of
intracellular transport vesicles. Different Rab proteins regulate vesicular trafficking within
distinct subcellular compartments (Novick and Brennwald, 1993) by switching between
GDP- and GTP-bound forms (Zerial and Stenmark, 1993). A model has emerged describing
the role Rab proteins play in regulating vesicular transport. In this, Rab-GDP is maintained
in a complex with a guanine nucleotide dissociation inhibitor (GDI) protein in the cytosol.
Donor membrane-associated Rab guanine nucleotide exchange factor (GEF) catalyses the
exchange of GDP for GTP and subsequent dissociation of the GDI. This causes the
unmasking of the Rab geranylgeranyl group, through which the GTPase becomes bound to
the vesicle budding site on the membrane. The vesicle then buds from the donor membrane
and moves through the cytoplasm to the target membrane. The vesicle-bound Rab-GTP is
thought to mediate fusion with the target membrane by interacting with effector molecules
present on the acceptor membrane. After GTP hydrolysis, which may be necessary for
fusion or may occur after fusion, Rab-GDP re-establishes contact with GDI, dissociates from
the target membrane and returns to the donor membrane (Novick and Zerial, 1997; Pfeffer,
1994; Nuoffer and Balch, 1994).
The accurate transport of newly-synthesised rhodopsin is essential for the
maintenance of viable rod photoreceptors. Sorting of rhodopsin into specific post-Golgi
membranes at the trans-Golgi network (TGN) involves the five C-terminal amino acids of
the protein (Deretic et al., 1998). Mutations affecting these five residues cause particularly
severe forms of ADRP (Berson et al., 1991; Sandberg et al., 1995) and, in transgenic
animals, defective delivery of rhodopsin to the rod outer segments (Li et al., 1996; Sung et
al., 1994). Work has been done to characterise the factors regulating the intracellular
transport of newly synthesised rhodopsin, particularly in frog photoreceptors (Deretic, 1998).
In these cells, rhodopsin is synthesised on rough endoplasmic reticulum and then transported
to the Golgi for processing. Post-Golgi vesicles bearing rhodopsin form at the trans-Golgi
network, where they are separated from the vesicles that transport synaptophysin (an
abundant synaptic vesicle protein) to the photoreceptor synapse (Deretic and Papermaster,
1995). Rabs 1, 6 and 8 have all been implicated in the trafficking of rhodopsin between the
inner and outer segments. The locations within the retina of these proteins and the specific
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effects of mutations in the genes encoding them help to interpret their functions. In
transgenic dominant-negative Drosophila Rabl mutants, the rough ER lumina became
swollen, and the accumulation of immature rhodopsin and dissembly of Golgi bodies were
noted (Satoh et al., 1997). This suggests that Rabl is required for the transport of newly
synthesised proteins from the ER to the Golgi apparatus. Rab3 is found on rhodopsin-
bearing post-Golgi vesicles, Golgi membranes and synaptic vesicles but appears to function
in synaptic vesicle fusion rather than rhodopsin transport (Deretic and Papermaster, 1995).
Expression of a GTPase-defective mammalian Rab6 protein led to a reduction in protein
transport from the cis/medial to late Golgi compartments (Martinez et al., 1994). In
Drosophila, over-expression of a GTPase-defective Rab6 mutant led to reduced steady-state
rhodopsin levels and prevented the maturation of this protein beyond an immature 40 kDa
form (Shetty et al., 1998). Post-translational modification of rhodopsin occurs in the cis- or
medial-Golgi, so these experiments indicated that Rab6, in Drosophila at least, is involved in
trafficking the nascent protein between the ER and Golgi. Rab6 has been detected on Golgi
(Goud et al., 1990), TGN (Antony et al., 1992; Jones et al., 1992) and post-Golgi
membranes (Jasmin et al., 1992) and in rod outer segments (Deretic and Papermaster, 1993).
Depletion of Rab8 in developing hippocampal neuronal cells using anti-sense
oligonucleotides led to a block in the morphological maturation of the cells and the
inhibition ofmembrane traffic (Huber et al., 1995). Rab8 is found on post-Golgi (Huber et
al., 1993a) and plasma membranes (Huber et al., 1993b). In frog photoreceptors, Rab8 was
localised to rod outer segments and to the base of the cilium where rhodopsin-bearing post-
Golgi vesicles accumulate prior to their delivery to the outer segments (Deretic et al., 1995).
These localisations are shown schematically in Figure 5.1A.
The presence of an RCC1-homologous domain within the RPGR protein gave rise to
speculation that it may act as a GEF for a small GTPase, since RCC1 performs this function
on Ran. Choroideremia (see section 1.6.2.iii, page 19) is a similar disorder to RP and is
caused by mutations in the REP1 gene (Cremers et al., 1990), which encodes subunit A of the
Rab geranylgeranlytransferase enzyme (homologous to Rab GTP dissociation inhibitor). The
resemblance of choroideremia to RP and the fact that the targets of the REP1 gene product
are the Rab GTPases, have led others to speculate that RPGR may act as the GEF for a Rab
protein (Roepman et al., 1996). It is possible that RPGR acts as the GEF for one of the Rab
proteins found in the distal photoreceptor, such as Rab8, which is found in the connecting
cilium (Deretic et al., 1995). RPGRIP, which has been detected in the connecting cilium
(Hong et al., 2000a; Roepman et al., 2000), and is possibly a structural component, may
recruit RPGR to this compartment in order to play a role in the delivery of vesicles containing
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rhodopsin, or other photoreceptor proteins, through the connecting cilium to the outer
segment. GEFs appear to be required for vesicle budding in Rab GTPase-mediated vesicular
transport (Rothman, 1994), i.e. the first of the three steps in movement of vesicles between
compartments (budding, targeting, fusion). Because Rab6 and Rab8 have both been found in
photoreceptor outer segments and connecting cilia (Deretic and Papermaster, 1993; Deretic









Figure 5.1: A. Photoreceptor compartments localisations to of Rab GTPases involved in
post-Golgi trafficking of rhodopsin (Deretic and Papermaster, 1995) and potential
localisation of RPGRIP (Roepman et al., 2000; Hong et al., 2000a) and RPGR (Hong et al.,
2000b). Rab8 and Rab6 are both found in outer segments, connecting cilia and on post-
Golgi vesicles. ROS = rod outer segment, RIS = rod inner segment. B. Model of vesicular
transport according to the SNARE hypothesis (Rothman, 1994; Deretic and Papermaster,
1995). (1) Protein vesicles bud from donor membranes. Inactive Rab-GDP binds to
membrane-bound GEF (possibly RPGR) and Rab-GTP is formed. Rab-GTP binds to vesicle
budding site, which also recruits v-SNARE membrane protein (possibly RPGRIP). Vesicle
buds from the donor membrane and moves through cytoplasm to target membrane. (2) The
v-SNARE recognises t-SNARE and this recognition initiates GTP hydrolysis, catalysed by
acceptor membrane-associated Rab GTPase activating protein (GAP). Membrane fusion
involves the 20S particle (NSF and SNAP proteins). (3) Inactive Rab-GDP is removed from
the membrane by the Rab dissociation inhibitor (GDI) and recycled back to the donor
compartment.
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A potential RPGR/Rab interaction could be tested in the yeast two-hybrid system. However,
the yeast two-hybrid system is not typically successful in showing GEF/GTPase interactions
so direct testing of wild-type Rab and RPGR proteins is unlikely to give a positive result (De
Toledo et al., 2000). Two approaches may overcome this. The first would be to use
dominant-negative Rab mutants (predominantly GDP-bound) in order to stabilise the
Rab/GEF interaction. Other dominant-negative GTPases are known to bind to GEFs more
readily, for example, the T24N Ran mutant is known to have an approximately 100-fold
higher affinity for RCC1 than wild-type Ran (Lounsbury et al., 1996). The second approach
would be to use the yeast exchange assay, a modification of the yeast two-hybrid system,
which was shown by de Toledo et al. (2000) to be useful for testing the specificity of newly
identified GEF proteins. In this technique, three proteins are expressed in yeast two-hybrid
host strains: a GTPase protein fused to the GAL4 DNA-binding domain, a GTPase effector
protein fused to the GAL4 activation domain and the putative GEF protein. The specific Rab
GTPase effector protein would be analogous to one of the Ran-binding proteins in the
Ran/RCCl system (Coutavas et al., 1993) and its presence in the yeast nucleus makes the
GTPase/GEF interaction much more readily detectable. The technique was used to identify a
novel RhoA exchange factor using a Rho kinase effector and could be used to test candidate
GTPases or screen yeast two-hybrid libraries. RPGR could also be tested for GTP/GDP
exchange activity directly using GEF assays (Rosa and Barbacid, 1997). RPGR has been
investigated in this way using a number of small GTPases but, to date, no GEF activity has
been detected (Dr. F. Manson, personal communication).
Another potential future experiment would be a yeast two-hybrid library screen using
RPGRIP as bait. The bovine retina library that isolated RPGRIP in the screen for RPGR-
interacting proteins is a resource that could be used to characterise this novel protein. If
RPGRIP is involved in intracellular trafficking then two-hybrid library screens may identify
other proteins involved in this process. As Hong et al. (2000a) have suggested, RPGRIP may
contribute to the structure of ciliary axonemes. If this is the case, then it is feasible for RPGR
both to interact with a small GTPase involved in protein trafficking and to bind to RPGRIP.
This is supported by the fact that Rab proteins are known to be intimately associated with
cytoskeletal proteins and to regulate transport along microtubules (Somsel Rodman and
Wandinger-Ness, 2000). Investigation of Rab8 and its yeast orthologue Sec4p, for example,
have indicated that interactions with actin play a role in vesicle docking and fusion (Finger et
al., 1998; Guo et al., 1999; Peranen et al., 1996). In addition, Deretic et al. (1995) speculated
that Rab8 may mediate the attachment of rhodopsin vesicles to microfilament bundles prior
to incorporation into rod outer segment membranes.
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The C2- and coiled-coil domains are likely to be important for the correct functioning
of RPGRIP and should be investigated independently. These domains could be investigated
in the yeast two-hybrid system in order to isolate interacting proteins that may participate in
an RPGR/RPGRIP complex. The coiled-coil domains may mediate homo-oligomerisation, or
interact with other retinal/photoreceptor proteins. The C2-domain may bind Ca2+, or bind
phospholipids in a Ca2+-dependent manner - activities which are not amenable to replication
in the yeast two-hybrid system. However, the RPGRIP C2-domains could be investigated for
Ca2 -dependent phospholipid binding using the method of Davletov and Siidhof, (1993). In
this experiment, recombinant GST-tagged RPGRIP C2-domains would be attached to
glutathione-agarose beads and incubated with radiolabelled liposomes (made from
phosphatidylcholine mixed with phosphatidylserine, phosphatidylethanolamine or
phosphatidylinositol, after labelling with l,2-dipalmitoyl,L-3-phosphatidyl[N-wer/z>7-
3H]choline). The degree of phospholipid binding in the presence of Ca2" can be compared
with binding in its absence by liquid scintillation counting of the collected agarose beads.
Alternatively, the C2-domains may mediate an interaction with other proteins and the yeast
two-hybrid system could be used to investigate this.
The RPGR plaid domain is commonly mutated in XLRP patients and is likely to be
present in retinal RPGR isoforms that also contain the RPGRIP-interacting/RCC 1-
homologous domain (Vervoort et al., 2000). Screening of cDNA libraries in the yeast two-
hybrid system for proteins interacting with the RPGR plaid domain would help to ascertain
its role. Another use of the yeast two-hybrid system would be to define the minimal
RPGRIP-interacting domain ofRPGR in order to delineate its functional components.
The localisation of RPGR to the connecting cilium was achieved using an antibody
against the C-terminal 250 amino acids of mRPGR (Hong et al., 2000b). Vervoort et al.
(2000) showed that RP3 mutations are predominantly located in the novel terminal exon
ORF15 of RPGR. The protein encoded by a transcript containing this exon would not
contain the epitopes recognised by the antibody used by Hong et al. (2000b). A useful future
experiment would be to determine whether the subcellular localisation of the exon ORF15-
encoded protein differs from that described by Hong et al. (2000b). The question of whether
RPGRIP recruits RPGR to the connecting cilium, as Hong et al. (2000a) propose, could be
investigated by immunostaining retinal tissue from an animal model of RP3 containing an
RPGR mutation that abolishes binding to RPGRIP (e.g. G60V, H98Q, F130C, P235S,
C250R). A fourteen-amino-acid peptide (equivalent to RPGRIP residues 796-809:
DLDPQEQQGRRRFL) was synthesised and used to raise antibodies in two rabbits by
Severn Biotech Ltd (Kidderminster, Worcester, UK) with a view to carrying out
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immunohistochemical experiments. Unfortunately, there was insufficient time for antibody
work to be carried out.
Human RPGRIP transcripts were detectable in only a very limited range of tissues
(testis and retina), contrasting with apparently ubiquitous expression in bovine tissues. This
may reflect the increased likelihood that human transcripts were degraded, since tissues were
collected some time after death. The apparent differences in RPGRIP expression between
bovine and human may also be due to RT-PCR amplification of illegitimate transcripts
(Chelly et al., 1989). If all transcripts are subject to RNase-degradation, the delayed
extraction of human RNA would reduce the number of illegitimate transcripts in these
tissues compared with bovine. Alternatively, bovine RPGRIP may be widely expressed and
this is supported by the observation of Roepman et al. (2000) of a ubiquitous bovine
transcript of 0.8 kb in addition to retina-specific transcripts. If fresh human samples could be
obtained (especially difficult with retinas, which only rarely become available) then
expression studies could be carried out with greater confidence. The absence of exons 5-7
from PCR-amplified RPGRIP transcripts, and of exon 12 from an RT-PCR-amplified retina
transcript suggests alternative splicing patterns. Further cDNA analysis would help to
characterise additional RPGRIP isoforms. Other retinal or tissue-specific exons or
transcripts may throw light on potential RPGRIP functions. For example, the absence of
specific RPGRIP exons in a transcript could remove one of the protein domains and affect its
activity (e.g. exons 1, 2 and 4 encode the putative coiled-coils and exons 1,9, 10 and 11
encode the putative C2-domains). It would be a relatively straightforward task to check for
the presence of each exon in mRNA transcripts from a range of tissues. None of the twelve
GENSCAN-predicted exons were detected in human retina cDNA but comparison of human
RPGR with the bovine and mouse orthologues strongly suggests that at least five of these
(GENSCAN predicted exons -8 to -12) contribute to RPGRIP. An exhaustive, systematic
cDNA analysis would determine which, if any, of these predicted exons are genuine, and in
what tissues they are expressed.
The functions of RPGR in extra-ocular tissues are of interest since they may
elucidate its functions in the retina. The ubiquitous nature of RPGR expression (Meindl et
al, 1996) reflects that of PDE8, the first RPGR-interacting protein to be identified (Linari et
al., 1999). Mutations in the PDEa and P subunits, but not the 6 subunit, have been found in
association with retinal degenerations, suggesting that PDE5 has a more general role outside
the eye. The C-termini of RPGR isoforms encoded by exon 19-containing transcripts have a
consensus isoprenylation site with the motif [CaaX] (where a is an aliphatic amino acid and
X is leucine) preceded by a string of basic residues, as found in geranylgeranylated proteins
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(Brown and Goldstein, 1993). This potentially enables RPGR to become anchored to
membranes. It is conceivable therefore that PDE8 solubilises membrane-bound RPGR in the
same way as it solubilises the PDE holoenzyme (Florio, Prusti, and Beavo, 1996). It is also
possible that this is predominantly an extra-ocular process. Vervoort et al. (2000) have
showed that the mutationally important part of RPGR, the plaid domain, is encoded by the
terminal exon ORF15. Isoforms containing this domain will lack the isoprenylation motif
and will not be membrane-bound in this tissue unless through interaction with other proteins.
It may be possible to test the idea that PDE8 solubilises membrane-bound RPGR in a
heterologous expression system. Yan et al. (1998) showed that, in transfected COS cells,
mouse RPGR is isoprenylated and localised to the Golgi complex. It would be interesting to
express the isoprenylated isoform of RPGR and note whether the addition of a PDE8
expression construct led to the solubilisation/removal of RPGR from the Golgi complex.
The interaction with PDE8 may, however, be important for the normal function of RPGR in
the retina and, in support of this, Linari et al. showed that a number of RP3 mutations disrupt
RPGR/PDE8 binding. Moreover, PDE8 is known to bind to several small GTPases
including Rabl3 (Marzesco et al., 1998), Rho6, Arl3 and Arll84 (Linari et al., 1999). This
again links RPGR (indirectly, through its interaction with PDE8) with small GTPases and,
potentially, with protein or vesicle transport.
Finally, an RPGRIP-deficient animal would be a valuable asset for investigating the
subcellular localisation of RPGR, vesicular trafficking and photoreceptor function, etc. It
would also be interesting to observe whether the animal displays any retinal disease. No
mutations were found in RPGR1P during the preliminary screening of Sardinian ARRP
patients (section 4.7, page 149) although screening of a large panel of RP patients may lead
to the identification of RPGRIP mutations in association with retinal disease. A recent
ARVO abstract details the screening of RPGRIP in unrelated patients with Leber's
congenital amaurosis (McGee et al., 2001). Four null alleles were identified in the 3 out of
57 (5.3%) patients: one was homozygous for the mutation Lys342(l-bp del A), one was
homozygous for Gln893(l-bp ins T) and one was a compound heterozygote with the
mutations Aspll76(l-bp del T) and Trp65Ter. The numbers refer to a 1259 amino acid
protein that the authors describe as the full length RPGRIP and which is presumably
identical to the 1259 residue protein described in section 4.6.3 (page 145) and shown in
Figure 4.20 (page 147). These mutations all lead to truncated proteins (shown schematically
in Figure 5.2) and this may be reflected in the severe phenotype. The mutations all remove
at least one of the predicted internal domains from RPGRIP with the exception of
Asp 1176(1-bp del T). However, the region of RPGRIP that was shown to mediate the
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interaction with RPGR is removed by this mutation, indicating that disruption of the
interaction may be sufficient to cause retinal disease. It is possible that RPGRIP missense
mutations that have a less dramatic effect on the protein might be found in recessive RP
patients. Additional genes are mutated in LCA (see section 1.6.1.iv, page 15) and the figure
of 5% of patients with RPGRIP mutations compares with 7-16% with RPE65 mutations,
approximately 6% with GUCYD mutations, approximately 3% with CRX mutations and
approximately 10% with AIPL1 mutations (all figures from RetNet, the Retinal Information
Network http://www.sph.uth.tmc.edu/RetNet/).
Coiled coil domains C2-domains
Tro65Ter —
Lvs342( 1 -bo del A) 1,1,1
Figure 5.2: Schematic representation of truncated RPGRIP proteins resulting from null
mutations found in LCA patients (McGee et 2001). Grey lines indicate primary
sequence of RPGRIP, red lines indicate the positions of the potential coiled coil domains,
blue lines indicate the positions of the potential C2-domains.
In summary, a new protein, called RPGRIP, has been identified as an interacting partner for
the retinal protein RPGR. RPGR is mutated in up to 11% of all retinitis pigmentosa patients
(Vervoort et al.,2000) and the first comprehensive screening for RPGRIP mutations
revealed genetic lesions in 5.3% of Leber's congenital amaurosis patients (McGee et al.,
2001). These results indicate that RPGR and the novel RPGRIP described here are
fundamentally important for normal retinal function and that their further characterisation
will aid the understanding of this tissue.
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A novel protein, called RPGRIP, has been identified as interacting with the RPGR protein, which is mutated in
a severe form of human retinal degeneration, X-linked retinitis pigmentosa (RP3 type). The bovine RPGRIP
was identified initially by screening for RPGR-interacting proteins with a bovine retina cDNA library using the
yeast two-hybrid system. The specificity of the interaction was confirmed by co-immunoprecipitation of in
vitro translated protein and using RPGR mutants. The human RPGRIP gene was isolated and shown to be
expressed in retina and testis. Human RPGRIP spans a genomic interval of 34 kb, and consists of 15 exons,
some of which are alternatively spliced. It was mapped using monochromosomal and radiation hybrid cell
lines to chromosomal region 14q11. The function of RPGRIP is unknown; it shows no homology to proteins
of known function, although it is predicted to form two coiled-coil domains at the N-terminus. RPGRIP is a
strong candidate gene for causing human retinal degeneration.
INTRODUCTION
Retinitis pigmentosa (RP) is a heterogeneous group of inher¬
ited retinal degenerations which affects l in 4000 of the
general population (1,2). Over 30 different genes have been
implicated in the disease, of which about half have been identi¬
fied (http://www.sph.uth.tmc.edu/RetNet/disease.htm). X-linked
RP (xlRP) affects 10-20% of patients in most populations and is
one of the most severe forms of RP, with a prevalence in the
region of 1 in 25 000 (3,4). xlRP has been genetically mapped
to six loci, RP2 (5), RP3 (6), RP6 (7), RP15 (8), RP23 (9) and
RP24 (10). The RPGR gene is mutated in the RP3 form of
xlRP, which accounts for 70-80% of patients (11). The
N-terminal half of RPGR shows homology to RCC1, a guanine
nucleotide exchange factor (GEF) for the small nuclear GTPase
Ran, which is concerned with nucleocytoplasmic transport and
cell cycle control (6,12-13). RPGR shows a complex pattern of
alternative splicing, although disease-causing mutations are
confined to a single low abundance transcript, consisting of the
RCCl-like domain and a novel acidic domain of unknown
function (11). The RCC1 domain occurs in several other
proteins, including p532 (14), which appears to act as a GEF
for Rab and Arf GTPases, suggesting that this domain may
generally indicate GEF activity. The crystal structure of RCC1
shows a seven-bladed (3-propeller structure, which is similar to
the predicted structure of RPGR (15).
The yeast two-hybrid system (16,17) allows the identifi¬
cation of interacting partners for a gene of interest by exploiting
the modular nature of transcription factors. Two potentially inter¬
acting proteins are expressed in Saccharomyces cerevisiae, one
of which contains the protein of interest (bait) fused to the
DNA-binding domain of a yeast transcription factor such as
GAL4, whereas the other is fused to the corresponding
activation domain. Binding of the bait to an interacting partner
leads to activation of the DNA-binding domain and creates a
functional transcription factor, which activates downstream
reporter genes.
Recently, the yeast two-hybrid system was used to screen a
mouse embryo cDNA library using the first 392 amino acids
(RCCl-like domain, RLD) of RPGR as bait (18). The 8-subunit
of rod cGMP phosphodiesterase (PDED) was identified as an
RPGR-interactor in this way. Rod cGMP phosphodiesterase is
a component of the visual transduction cascade of vertebrate
photoreceptor cells (19). PDED is an abundant, ubiquitous and
highly conserved protein which is proposed to have a role in
the solubilization of specific membrane proteins (20). The role
of RPGR in this interaction is unknown, but it is interesting that
PDED also interacts with small GTPases Rab 13 and Arl3 (21).
Here, a bovine retina cDNA library has been screened with
the RCCl-like domain of RPGR (RPGRrld) as bait in the yeast
two-hybrid system, in order to identify RPGR-interacting
proteins. A novel bovine protein was identified which bears no
homology to any characterized protein. The human homologue
was identified and characterized and its product shown to
interact with RPGR in a specific manner, using mutant
constructs and in vitro co-immunoprecipitation. The human
gene is expressed in a subset of tissues, including testis and
retina, and was mapped to chromosomal region 14q 1 1.
RESULTS
Yeast two-hybrid library screening
A GAL4-based yeast two-hybrid system was used to search for
proteins that interact with RPGR. A bovine retina cDNA
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Figure 1. (A) A novel protein interacts with the RCCl-like domain of RPGR (RP~N) in the yeast two-hybrid system but does not interact with the C-terminal half of
RPGR (RP~C), RCC1 or an unrelated protein (SNF1). Y190 yeast transformed with bait and prey constructs were plated onto SC -leu/-trp to confirm transformation
and SC -leu/-trp/-his/+3AT to test for interacting proteins (pAS 1 construct/pACTII construct: hIP, human RPGRIP; blP, bovine RPGRIP; RC, RCC1; S1, SNF1;
S4, SNF4). (B) The novel human protein interacts with wild-type RPGR and with G2 i 5V and G275S RPGR mutants but does not interact with other (V36F, G60V,
H9SQ, F130C, P235S or C250R) RPGR mutants. Y190 yeast contain the human RPGRIP subcloned into pACTII and pASl.RPGR mutants. SC -leu/-trp,
synthetic complete medium lacking leucine and tryptophan; SC -leu/-trp/-his/+3AT, synthetic complete medium containing 25 mM 3-aminotriazole, lacking
leucine, tryptophan and histidine.
library (22) containing 2 x 106 independent clones was
screened using the first 12 exons of RPGR, including the
whole of the RCCl-like domain (RPGRrld), as bait. The
majority of the published RP3 mutations are found in this
domain, suggesting an important functional role for this part of
the protein (23). Selection for interaction was performed in the
Y190 strain, which has conditional lacZ and H1S3 reporter
genes. Screening 2 x 106 clones led to the identification of
10 clones showing (3-galactosidase activity and histidine
prototrophy. Library plasmids were isolated from 8 of the
10 yeast colonies (the remaining 2 were resistant to plasmid
recovery) and re-tested for the ability to interact with RPGR.
Seven of the eight gave strong positive results and were
sequenced. Six of them were found to contain the same insert
of 804 bp.
The positive clones were tested for the ability to activate the
Y190 reporter genes in the absence of the RPGR bait plasmid
and also for the ability to interact with RCC1, Ran and SNF1
(an unrelated protein) (Fig. 1A). The results of these tests were
negative, suggesting that the original positive result was
specific for and dependent on the presence of RPGR.
Isolation of human RPGRIP
A search of the expressed sequence tag (EST) databases for
sequences similar to the bovine interactor identified nine
human and seven mouse previously uncharacterized homo-
logues, which showed 86% (human) and 76% (mouse) nucleo¬
tide identity to the bovine sequence. A human IMAGE EST
clone was obtained (accession no. r93221), and the 678 bp
insert, which contained an open reading frame (ORF), was
subcloned into the pACTII vector. This human clone was
tested as a candidate RPGR-interactor in the yeast two-hybrid
system (Fig. 1 A). It was found to interact with the N-terminal,
RCCl-like domain but not with the C-terminal domain of
RPGR (the last seven exons), or with RCC1, Ran, PDED or
SNF1. In addition, it did not activate the Y190 reporter genes
in the absence of a bait construct. The new RPGR-interacting
protein was given the name RPGRIP (RPGR-interacting
protein).
A partial human RPGRIP (hRPGRIP) cDNA was obtained
by PCR amplification of a human testis cDNA using primers
derived from overlapping ESTs. 5' and 3' rapid amplification
of cDNA ends (RACE) experiments were carried out to extend
the sequence. Using a primer complementary to the 5' end of
human EST r93221, a 1.2 kb 5' RACE product was amplified
from a human testis Marathon Ready cDNA pool. This was
sequenced on both strands and extended the ORF to 1758 bp.
The nucleotide context of the first ATG triplet conforms well
to the Kozak consensus (24) (Fig. 2). 5' RACE experiments
using human retina cDNA identified a transcript starting 12 bp
downstream of the testis transcript. Like the testis 5' RACE
product, the retina transcript contains in-frame stop codons
upstream of the translation initiation codon, consistent with it
containing the first exon.
Similarly, 3' RACE experiments identified a transcript
extending 84 bp beyond the end of the ORF. Neither of the two
most commonly used hexameric polyadenylation signals
(AATAAA and ATTAAA) is present at the 3' end of the
cDNA; however, 31 bp upstream of the 3' end of the RACE
product is a hexamer that differs from the canonical AATAAA by
a single nucleotide (AGTAAA), which according to Graber et al.
(25) is the fifth most commonly used hexameric polyadenylation
signal. In addition, eight of the nine human ESTs located at
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the 3' end (ai964059, ai655818, ai632512, ai05922, aa782963,
aw681763, aa928161 and w26173) terminate 81-83 bp 3' to
the end of the termination codon, consistent with this being the
correct polyadenylation signal, since each EST was oligo(dT)
primed. The remaining EST (aa476670) is also oligo(dT) primed
but ends 315 bp 3' to the end of the termination codon. Immedi¬
ately 3' to the end of this EST is an A-rich region (17/20),
suggesting that an extended transcript has false-primed within
this region. The length of the cDNA from the start of the
5'-untranslated region (UTR) to the major polyadenylation
signal is 1909 bp, of which 1758 bp are an ORF, sufficient to
code for a 586 amino acid protein with a predicted size of
67 kDa (Fig. 2).
Genomic structure of hRPGRIP
The genomic structure of the hRPGRIP gene was obtained
from a 196 kb sequence submission (GenBank accession no.
AL135744) from a chromosome 14 contig, which includes the
entire hRPGRIP gene sequence. The exon-intron boundaries
and intron sizes are shown in Table 1. Twelve exons were
detected initially. The boundaries conform to the GT/AG rule
(26), with the exception of the splice donor site at the end of
exon 4. The sequence at the exon 4—intron 4 junction was
checked repeatedly and confirmed as CTGIgcaagt. It is rare to
observe a GC instead of the conserved GT present at most
splice donor sites, but other examples of functional splice sites
with this sequence have been reported (27).
A panel of bioinformatics programs was applied to the
genomic sequence containing RPGRIP. The GENSCAN
program (28) strongly predicted three extra exons in the
middle of intron 4 that had not been detected in cDNAs or
RACE products using primers flanking this region. Twelve
exons were also predicted to lie upstream of the first detected
exon. Primers were designed to anneal to these exons and were
used in conjunction with primers from downstream exons.
Human retina-derived cDNA was used as the template source
in attempts to amplify these exons by PCR. The three exons
predicted to lie in intron 4 were detected and maintained the
ORF of the shorter transcript, but the 12 upstream exons were
not detected. The boundaries of the new exons were sequenced
at the genomic level and found to have canonical splice site
boundaries (Table 1), as predicted by GENSCAN. The extra
exons extend the cDNA from 1946 to 2894 bp and the ORF to
2706 bp, predicting a protein of 902 amino acids and a size of
97 kDa.
The full-length hRPGRIP cDNA and intron-exon bounda¬
ries are shown in Figure 2A and a schematic representation of
the two detected major transcripts in Figure 2B. The arrow in
Figure 2B indicates the position of the non-canonical splice
site at the exon 3-exon 4 junction. It is interesting to note that
the three exons immediately 3' of this splice site are absent
from PCR-amplified RPGRIP transcripts.
Interaction of hRPGRIP with mutant RPGR peptides
An experiment was carried out to determine whether the inter¬
action between hRPGRIP and RPGR is disrupted when point
mutations associated with xlRP are present in the RPGR
coding sequence. Eight mutant RPGRrld constructs were
tested in the yeast two-hybrid system. The wild-type RPGRrld
was found to interact with RPGRIP, but the mutants showed
either absent (V36F, G60V, H98Q, F130C, G215V, P235S and
C250R) or slightly decreased (G215V and G275S) reporter
gene activity (Fig. IB). All of the disease-causing mutations
tested, with the exception of F130C, are situated within
conserved residues of the RPGRrld (15), and are therefore
likely to be important for correct folding and function.
Co-immunoprecipitation of RPGR and RPGRIP
The interaction between RPGR and the RPGRIP was
confirmed by in vitro co-immunoprecipitation. In vitro trans¬
cribed/translated and 35S-labelled epitope-tagged RPGR,
RPGRIP, Max and lamin proteins were prepared. From a
mixture of RPGR-myc and RPGRIP-haemagglutinin (HA), it
was possible to co-immunoprecipitate both proteins using
either anti-myc or anti-HA antibodies (Fig. 3). From a mixture
of RPGR-myc and Max-HA, only RPGR-myc was irnmuno-
precipitated by anti-myc. Similarly, from a mixture of
RPGRIP-HA and lamin-myc, only RPGRIP-HA was immuno-
precipitated by anti-HA. These results suggest that the inter¬
action between RPGR and RPGRIP is specific and not an
artefact of the yeast two-hybrid system. The bands obtained
with anti-c-myc mouse monoclonal antibody (lanes 1 and 3)
are weaker than those with anti-HA rabbit polyclonal antibody
(lanes 2 and 4), either because protein G, used to capture
antigen-antibody complexes, binds more strongly to rabbit
than to mouse antibodies or because the polyclonal antibody
binds with higher avidity than the monoclonal (29).
Expression of RPGRIP
A human multiple tissue northern blot (MTN2) was probed
using radiolabelled RPGRIP cDNA. Two different transcripts
were detected in the testis lane, a strong band of 2.0 kb and a
weak band of 3.1 kb, but no signal was detected in spleen,
thymus, prostate, ovary, small intestine, colon or peripheral
leukocytes (Fig. 4). A second human multiple tissue northern
blot (MTN1) was probed in the same way, and only a very
weak 6.2 kb band was identified in the lane containing skeletal
muscle RNA, which is presumed to be non-specific, but no
signal was obtained in other tissues, including pancreas,
kidney, liver, lung, placenta, brain and heart (data not shown).
In addition, no signal was obtained with a northern blot
containing human retina (data not shown). RPGRIP ESTs were
identified from a limited range of human tissues, namely fetal
liver/spleen (r93221), retina (w28191 and w26173), testis
(aiO 15922 and aa782963), mixed fetal lung, testis and B-cell
(aa928161 and aw081763) and pooled germ cell tumour
(ai964059, ai655818 and ai632512).
In order to carry out a more sensitive screen for low level
RPGRIP expression, samples of human and bovine total RNA
were used to amplify bovine RPGRIP by a single round ofRT-
PCR. Transcripts were amplified from human retina and testis
RNA after one round of amplification (35 cycles) but not from
adrenal, brain, heart, kidney, liver, lung or spleen RNAs (Fig.
5A). The lower retina band was sequenced and found to lack
exon 12. One round of amplification was sufficient to produce
a band of the correct size from the majority of the bovine
samples, suggesting that the transcript is more widely
expressed (Fig. 5B). When a second round of amplification
was carried out (using a single nested primer), a signal was
detected in most human tissues (data not shown), as in the case
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of bovine tissues, but this may be detecting illegitimate trans¬
cription products (30).
Chromosomal mapping of hRPGRIP
Database searching identified a sequence-tagged site (STS
hl4al407, GenBank accession no. G35988) with homology to
RPGRIP. The STS contains 320 bp of RPGRIP genomic
sequence covering the intron 12-exon 13 boundary and had
been mapped to chromosomal region 14q 11 in the course of
HAPPY mapping of human chromosome 14 by random frag¬
mentation of haploid cells (31).
A panel of human monochromosomal somatic cell hybrid
DNAs was also screened by PCR to determine the chromo¬
some in which RPGRIP is located. Human chromosome 14
was found to provide a template for amplification of a genomic
fragment of RPGRIP, whereas none of the other panel
samples, including the rodent control, produced fragments of
the expected size.
In order to determine a more precise chromosomal location
for RPGRIP, a PCR analysis was performed on the HGMP-RC
subset of the Genebridge 4 radiation hybrid panel (32). The
results were submitted to the Whitehead Institute and showed
that RPGRIP is located between markers DI4S264 and
DI4S275 (6.94 cRays from D14S264), which are located in
14q11.
Amino acid sequence analysis
The predicted RPGRIP amino acid sequence was analysed
using the HGMP-RC PIX assembly of bioinformatics
programs in an attempt to identify possible secondary or
tertiary structural features. RPGRIP is predicted to be a soluble
protein by the SOSUI system, which analyses proteins on the
basis of the physicochemical properties of the amino acid
sequence (33). The protein was analysed with the Coils
program (34), which predicted RPGRIP to have two coiled-coil
domains at the N-terminus, the first encompassing residues 14-
78, and the second encompassing residues 150-200 (Fig. 2).
BLAST and FASTA searches of dbSPTR identified only a
single protein, KIAA1005 (accession no. AB023222), as
homologous to RPGRIP. This is an uncharacterized protein of
1055 amino acids, which is 34% identical and 53% similar to
RPGRIP (35). No other predicted motifs or domains were
identified.
DISCUSSION
The yeast two-hybrid system is a widely used method for
detecting interacting proteins and gaining insights into protein
function and pathways (36). This is an in vivo method for
detecting protein-protein interactions and requires confirma¬
tion with one or more independent methods, but provides a
powerful means of screening large numbers of cDNA clones
for interacting products (16,17). The function of the RPGR
protein is unknown, although Linari et al. (18) previously
showed by screening an embryonic mouse cDNA library using
the yeast two-hybrid system that it interacts with PDED. This
interaction was confirmed by in vitro protein binding (pull¬
down) assays and affinity measurements (XD = 90 nM), which
was consistent with a physiological interaction. Although the
function of PDED is still unclear, it has been shown to interact
with small GTPases Rabl3 and Arl3 (21) and may have a role
in the solubilization of Rabl3 from membranes (20). It has
been postulated that RPGR also interacts with a small GTPase
on the basis of its homology to RCCI. a GEF for the Ran
GTPase; however, this has yet to be demonstrated.
It is not clear why PDED was not detected on two-hybrid
screening of the bovine retina library, since it is known to be
expressed in this tissue (37). Possible reasons include differ¬
ences in the RPGR 'bait', a species difference or the
exhaustiveness of library screening. Linari et al. (18) used an
RPGR bait containing amino acids 1-392, whereas here a bait
consisting of amino acids 1-502 was used (the RLD consists of
residues 39-365). It seems unlikely that this difference would
account for the failure to identify PDED. A second possibility
is a species difference, since the RPGR-PDED interaction was
detected by screening a mouse library with human RPGR,
whereas a bovine library was used in this study. Human, mouse
and bovine PDE are unusually well conserved, with 98% of
amino acids identical between the three species (38). Only one
conservative substitution of 150 residues separates bovine
from human (Thr68Ala, human:mouse) and three substitutions
separate mouse from human (Thr68Ala, GlulOAsp and
Argl44Lys). This also seems unlikely, leaving the third possi¬
bility, namely a difference in transcript abundance between the
mouse embryo and bovine retina libraries. An estimated
2 x 106 bovine retina clones were screened, but it remains a
possibility that further screening would identify PDED.
Here, we identify a second interacting protein, RPGRIP, by
screening a bovine retinal cDNA library with a clone
containing the first 12 exons of human RPGR (RCCI-like
domain) using the yeast two-hybrid system. Six of seven
strongly positive clones were shown to contain fragments of
the bovine RPGRIP gene, and the interaction was confirmed
with human RPGRIP. Two full-length human cDNAs of 1.95
and 2.89 kb were identified, which appeared to be alternatively
spliced orthologues of the bovine gene. The predicted products
would yield proteins of 586 and 902 amino acids, respectively,
with molecular masses of 67 and 97 kDa.
Further confirmation of the specificity of this interaction
came from showing that six of eight xlRP disease-associated
RPGR mutations abolish the interaction in yeast two-hybrid
experiments. The failure of the G215V and G275S mutants to
abolish this interaction, while both abolished interaction with
PDED (18), is interesting. Conversely, the V36F variant.
Figure 2. (A) cDNA and predicted amino acid sequence of the RPGRIP gene (GenBank accession no. AF260257). The translation initiation codon is boxed and
an in-frame upstream stop codon is double underlined. The stop codon at the 3' end of the sequence is in bold. The predicted coiled-coil domains are shaded, and
the three alternatively spliced exons (exons 5-7) are underlined. Exon-intron boundaries are shown. (B) Schematic representations of the RPGRIP transcript with
(upper) and without (top) exons 5-7 (bottom). The two predicted coiled-coil-encoding regions are in black and the arrow shows the position of the non-canonical
splice site at the exon 4-exon 5 junction. Numbers indicate amino acid positions.
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Table 1. Genomic structure of the human RPGRIP gene
Exon Sequence at intron-exon junction Intron















































































The exonic sequence is in upper case, and the genomic sequence in lower case. The atypical splice donor site at the exon—intron junction at the end of exon 4 is
underlined.
which is associated with X-linked congenital stationary night
blindness (T. Meitinger, personal communication), does
abolish the interaction with RPGRIP, which it does not for
PDED (18). These results suggest that different RPGR
subdomains within the RLD are likely to be involved in inter¬
action with RPGRIP and PDED, and that the latter may be
more important for full expression of the xlRP disease.
Further evidence relating to the specificity of the RPGR-
RPGRIP interaction comes from expression studies. RPGR
shows multiple alternatively spliced products in human, mouse
and bovine tissues, most of which are widely expressed, but
one of which (exon ORF14/15 transcript) is expressed exclu¬
sively in bovine retina and testis (11). Human retinal RPGR
transcripts have only been found using RT-PCR, and show a
complex pattern of expression, with two major and several
minor transcripts (11). In northern analyses of multiple human
tissue RNA samples, RPGRIP is only detectable in testis,
although it is also readily detected in retina using more sensi¬
tive RT-PCR analyses (Fig. 5A). In bovine tissues, RPGRIP
expression is detectable by RT-PCR in a wide range of tissues
(Fig. 5B). This difference between human and bovine tissues
may reflect a genuine species difference or a difference in
mRNA quality. Human retina RNA could only be obtained
24 h post-mortem compared with <30 min for bovine tissues.
The observation that RPGRIP could be detected in a wide
range of human tissues following two rounds of RT-PCR
amplification supports the latter possibility, although there is a
danger "of detecting illegitimate transcription products in this
way (30). The predicted full-length RPGRIP cDNAs are
2.89 kb, which includes exons 5-7, and 1.95 kb if these exons
are absent, consistent with the observed bands of 2.0 and 3.1 kb
detected in testis by northern analysis. Failure to detect a signal
in retina by northern analysis may again be related to mRNA
quality.
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Figure 5. (A) Amplification of human RPGRIP (top) and G3PDH (bottom) by
RT-PCR from RNA from a variety of tissues (Ad, adrenal; Br, brain; He, heart;
Ki, kidney; Li, liver; Lu, lung; Re, retina; Sp, spleen; Te, testis). (B) Amplifi¬
cation of bovine RPGRIP (top) and G3PDH (bottom) by RT-PCR from RNA
from a variety of tissues (AC, adrenal cortex; AM, adrenal medulla; He, heart;
Ki, kidney; Li, liver; Lu, lung; Sk, skeletal muscle; Ov, ovary; Pa, pancreas;
Re, retina; Te, testis). The low signal from the pancreatic sample appears to
result from poor quality RNA.
Figure 3. Co-immunoprecipitation of RPGR and RPGRIP in vitro transcribed/
translated proteins. Lane 1, RPGR-myc plus RPGRIP-HA immunoprecipitated
with anti-myc antibody; lane 2, RPGR-myc plus RPGRIP-HA immunoprecipi¬
tated with anti-HA antibody; lane 3, RPGR-myc plus Max-HA
immunopreciptated with anti-myc antibody; lane 4, RPGR1P-HA plus lamin-
myc immunoprecipitated with anti-HA antibody. The four lanes on the right
hand side of the gel contain undiluted in vitro transcription/translation products
for size comparison with proteins on the left hand side. The dashed lines on the
left of the gel indicate the position of molecular weight markers; sizes in kDa
from top to bottom: 87.0, 51.8, 35.0, 28.4, 20.0 and 7.2.




Figure 4. Multiple tissue northern blot probed with (A) radiolabeled RPGRIP
probe (30; and (B) a glyceraldehyde-3-phosphate dehydrogenase (G3PDH)
probe. Sp, spleen; Th, thymus; Pr, prostate; Ts, testis; Ov, ovary; S.I., small
intestine; Co, colon; P.B.L., peripheral blood leukocyte. Sizes on the left side
of the blot are in kilobases.
The human RPGRIP gene is located on the long arm of chro¬
mosome 14 in band 14q 11, a region containing no known
retinal disease genes; however, only a minority of retinitis
pigmentosa patients are accounted for by known or mapped
genes (approximately one-third; http://www.sph.uth.tmc.edu/
RetNet/disease.htm ). The amino acid sequence of RPGRIP
gives little indication of its function. Sequence analysis indi¬
cates a soluble protein with two coiled-coil domains at the
N-terminus of the protein and identifies an uncharacterized
human homologue, KIAA1005. Further work will be necessary
to elucidate its function, but RPGRIP remains a strong candi¬
date gene for human retinal degenerations.
MATERIALS AND METHODS
Two-hybrid screening
A bovine retina cDNA library, kindly provided by Dr C.H. Sung,
was used in the GAL4 yeast two-hybrid activation domain
vector pACTII as previously described (22). The first 12 exons
of RPGR were cloned into the two-hybrid bait vector pASl
(39). The bait construct and the bovine retina library were then
co-transfected into S.cerevisiae strain Y190 (40). Y190 (Tip ,
Leu , His", gaI4", gal80") contains two genomically integrated
conditional reporter genes, HIS3 and LacZ, which are under
the control of GAL4-responsive upstream activation sites.
Transformants were plated onto synthetic complete medium
lacking histidine, leucine and tryptophan, and grown at 30°C in
the presence of 25 mM 3-aminotriazole. Putative positive colo¬
nies were selected by growth on medium lacking histidine and
by expression of (3-galactosidase activity, as described previ¬
ously (41). Plasmids were recovered from yeast colonies by
glass bead homogenization and phenol-chloroform extraction
(42). Library plasmids (containing a gene encoding leucine
prototrophy) were amplified selectively in the leucine auxo-
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trophic bacterial strain HB101 (Gibco BRL. Paisley, UK)
grown on medium lacking leucine. Mutant RPGR constructs
were obtained from Dr J. Becker (Max Planck Institut fur
Molekulare Physiologie, Dortmund, Germany) and the inserts
subcloned into pASl. These were then tested in the yeast
two-hybrid system for their ability to interact with RPGR1P as
described above. Ran and RCC1 were amplified by PCR from
a cDNA library, subcloned into pAS 1 and sequenced. As the
positive control for yeast two-hybrid experiments, Y190 cells
were transfected with pASl.SNFl and pACTII.SNF4. SNF1
and SNF4 are two yeast proteins known to interact (16).
Co-immunopreeipitation
The inserts from the pAS.RPGR and pACT.RPGRIP
constructs were amplified by PCR. One of the primers used in
each case contained a non-annealing 5' end encoding an epitope
tag (myc in the case of RPGR and HA for RPGRIP). The ampli¬
fied sequences were used to produce [35S]methionine-labelled
proteins by in vitro transcription-translation using a TnT rabbit
reticulocyte lysate system (Promega, Southampton, UK). The
proteins were mixed and immunoprecipitated by the addition
of either anti-myc or anti-HA antibody in the presence of protein
G-agarose (Clontech, Basingstoke, UK). Control experiments
were performed by mixing RPGR-myc with HA-tagged radio-
labelled Max protein and RPGR1P-HA with myc-tagged lamin
protein and immunoprecipitating with anti-myc and anti-HA,
respectively. The immunoprecipitation products were separated
on a 12% polyacrylamide gel, which subsequently was soaked
in Amplify Fluorographic Reagent (Amersham Pharmacia
Biotech, Little Chalfont, UK). The gel was dried and exposed
to Biomax X-ray film (Kodak, Cambridge, UK) overnight.
Northern blot analysis
A PCR fragment encompassing the C-terminal 678 bp of
RPGRIP was used to prepare a random primed 32P-labelled
probe using the High Prime kit (Boehringer Mannheim,
Mannheim, Germany). The probe was hybridized to human RNA
blots (MTN1 and MTN2; Clontech) using the Ultrahyb
(Ambion, Austin, TX) hybridization solution at 42°C over¬
night. The blot was washed twice for 5 min in 2x SSC, 0.1%
SDS at 42°C and then exposed to a phosphor screen overnight.
Reverse transcriptase-PCR
The Access RT-PCR kit (Promega) was used to amplify
human and bovine RPGRIP from samples of total human and
bovine RNA. The reactions were carried out in an MJ Research
(Waltham, MA) PTC-200 Peltier thermal cycler using the
following programme: 48°C for 45 min, 94°C for 2 min, then
35 cycles of 94°C for 1 min, 53°C (human) or 60°C (bovine)
for 1 min and 72°C for 2 min, then 72°C for 10 min.
RACE
Human retina and testis Marathon ready cDNAs (Clontech)
were used to obtain 5' and 3' RACE products specific for
RPGRIP. Two rounds of PCR were carried out using nested
primers and the Expand High Fidelity proof-reading polymerase
mix (Boehringer Mannheim) in a Perkin Elmer-Cetus (Foster
City, CA) DNA thermal cycler. The sequences of the RACE
products were determined on both strands.
Chromosomal assignment
A human monochromosomal somatic cell hybrid DNA panel
(43) [UK Human Genome Mapping Project Resource Centre
(HGMP-RC, Cambridge, UK)] and the HGMP subset of the
Genebridge 4 radiation hybrid panel (32) were screened by
PCR using a Perkin Elmer-Cetus DNA thermal cycler using
the following programme: 94°C for 2 min, then 30 cycles of
94°C for 30 min, 52°C for 1 min, 72°C for 1 min, then 72°C for
7 min.
Protein prediction programs
The PIX suite of protein prediction programs was used
(HGMP-RC; http://www.hgmp.mrc.ac.uk/RegisteredAVebapp/
pix/ ) which includes prediction of cell localization [Psort
(44)], solubility analysis [SOSUI (33)], BLAST searches
against domain databases [SBASE (45) and PRODOM (46)],
searches against motif and domain databases [Pfam (47),
PRINTS (48), BLOCKS (49) and PROSITE (50)], trans¬
membrane predictions [Tmpred (51), Tmap (52), DAS (53)
and Phd (54)] and signal peptide predictions [Sigcleave (55)].
The protein was also analysed with the Coils program, which
calculates the probability that a sequence will adopt a coiled-
coil conformation (34). The four alternative options were run,
i.e. using the MTK scoring matrix weighted and unweighted and
using the MTIDK scoring matrix weighted and unweighted.
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